Processing 00000000.tx.1: Membrane Phosphoinositides Control Insulin Secretion Through Their Effects on ATP-Sensitive K+ Channel Activity Chia-Wei Lin1, Feifei Yan1, Satoko Shimamura1, Sebastian Barg2, and Show-Ling Shyng1 1 Center for Research on Occupational and Environmental Toxicology, Oregon Health & Science University, Portland, Oregon 2 Vollum Institute, Oregon Health & Science University, Portland, Oregon  ABSTRACT TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  ATP-sensitive K+ channels (KATP channels) of pancreatic -cells play key roles in glucose-stimulated insulin secretion by linking metabolic signals to cell excitability. 

Phrase: "Membrane Phosphoinositides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031621:Phosphoinositides [Biologically Active Substance,Lipid]

Phrase: "Control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "Insulin Secretion Through Their Effects"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C1256369:insulin secretion [Cell Function]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "on ATP-Sensitive K+ Channel Activity Chia-Wei Lin1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1413217:LIN1 [Gene or Genome]

Phrase: "Feifei Yan1,"

Phrase: "Satoko Shimamura1,"

Phrase: "Sebastian Barg2,"

Phrase: "and"

Phrase: "Show-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "Ling Shyng1 1 Center for Research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0683939:center research [Manufactured Object,Organization]
   753   C0205099:Center [Spatial Concept]

Phrase: "on Occupational"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521127:Occupational [Functional Concept]

Phrase: "and"

Phrase: "Environmental Toxicology,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0178621:Environmental Toxicology [Biomedical Occupation or Discipline]
   861   C0040541:Toxicology [Biomedical Occupation or Discipline]
   861   C1548006:Toxicology [Intellectual Product]
   789 E C0205472:Toxicologic [Functional Concept]

Phrase: "Oregon Health & Science University,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0018684:Health [Idea or Concept]
   812   C0029195:Oregon [Geographic Area]
   812   C0036397:Science [Occupation or Discipline]
   812   C0041740:University [Manufactured Object,Organization]
   712 E C0031206:healthiness [Finding]

Phrase: "Portland,"

Phrase: "Oregon 2 Vollum Institute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0021622:institute [Organization]
   812   C1272753:Institute [Idea or Concept]

Phrase: "Oregon Health & Science University,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0018684:Health [Idea or Concept]
   812   C0029195:Oregon [Geographic Area]
   812   C0036397:Science [Occupation or Discipline]
   812   C0041740:University [Manufactured Object,Organization]
   712 E C0031206:healthiness [Finding]

Phrase: "Portland,"

Phrase: "Oregon  ABSTRACT TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "ATP-sensitive K+ channels"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0332324:Sensitive [Functional Concept]
   812   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C1550474:sensitive [Idea or Concept]
   812   C1708601:K' [Quantitative Concept]
   779   C0439799:Channel [Spatial Concept]
   779   C1706095:Channel [Conceptual Entity]

Phrase: "(KATP channels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1955862:KATP Channels [Amino Acid, Peptide, or Protein]
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: ")"

Phrase: "of pancreatic -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "key roles in glucose-stimulated insulin secretion"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0035820:Roles [Social Behavior]
   714 E C1705810:Role [Conceptual Entity]

Phrase: "by linking metabolic signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1710082:Signal [Phenomenon or Process]

Phrase: "to cell excitability."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0235169:Excitability [Sign or Symptom]
   789 E C0857393:excitable [Sign or Symptom]
Processing 00000000.tx.2: Membrane phosphoinositides, in particular phosphatidylinositol 4,5-bisphosphates (PIP2), stimulate KATP channels and decrease channel sensitivity to ATP inhibition; 

Phrase: "Membrane phosphoinositides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031621:Phosphoinositides [Biologically Active Substance,Lipid]

Phrase: "in particular phosphatidylinositol 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   827   C2348046:Phosphatidylinositol [Lipid]

Phrase: "5-bisphosphates"

Phrase: "(PIP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0070798:PIP2 [Biologically Active Substance,Lipid,Organophosphorus Compound]
  1000   C3538724:PIP2 [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: ","

Phrase: "stimulate"

Phrase: "KATP channels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1955862:KATP Channels [Amino Acid, Peptide, or Protein]
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: "and"

Phrase: "decrease channel sensitivity to ATP inhibition"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C1547341:Channel sensitivity [Idea or Concept]
   754   C0332324:Sensitive to [Functional Concept]
   753   C0036667:Sensitivity [Quantitative Concept]
   753   C0312418:Sensitivity [Mental Process]
   753   C0427965:Sensitivity [Finding]
   753   C1511883:Sensitivity [Quantitative Concept]
   753   C1522640:Sensitivity [Qualitative Concept]
   753   C2346484:SENSITIVITY [Phenomenon or Process]
   753   C2349185:Sensitivity [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.3: as such, they have been postulated as critical regulators of KATP channels and hence of insulin secretion in -cells. 

Phrase: "as"

Phrase: "such,"

Phrase: "they"

Phrase: "have"

Phrase: "been"

Phrase: "postulated as critical regulators of KATP channels"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   778   C1955862:KATP Channels [Amino Acid, Peptide, or Protein]
   748   C0182953:regulators [Medical Device]
   748   C1511545:Critical [Qualitative Concept]
   714   C0439799:Channel [Spatial Concept]
   714 E C1704734:Regulator [Medical Device]
   714 E C1704735:Regulator [Conceptual Entity]
   714   C1706095:Channel [Conceptual Entity]

Phrase: "and"

Phrase: "hence of insulin secretion in -cells."
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   790   C1256369:insulin secretion [Cell Function]
   767   C0030281:Insulin Cell [Cell]
   767   C1327616:Cell secretion [Cell Function]
   753   C0007634:Cells [Cell]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.4: Here, we tested this hypothesis by manipulating the interactions between KATP channels and membrane phospholipids in a -cell line, INS-1, and assessing how the manipulations affect membrane excitability and insulin secretion. 

Phrase: "Here,"

Phrase: "we"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "this hypothesis by manipulating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1512571:Hypothesis [Idea or Concept]

Phrase: "the interactions between KATP channels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "membrane phospholipids in a -cell line,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0031676:Phospholipids [Biologically Active Substance,Lipid]
   719 E C0202177:Phospholipid [Laboratory Procedure]

Phrase: "INS-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "assessing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1516048:Assess [Activity]

Phrase: "how"

Phrase: "the manipulations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0185111:MANIPULATIONS [Therapeutic or Preventive Procedure]
  1000   C0947647:Manipulations NOS [Therapeutic or Preventive Procedure]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "membrane excitability"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0235169:Excitability [Sign or Symptom]
   789 E C0857393:excitable [Sign or Symptom]

Phrase: "and"

Phrase: "insulin secretion."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.5: We demonstrate that disruption of channel interactions with PIP2 by overexpressing PIP2-insensitive channel subunits leads to membrane depolarization and elevated basal level insulin secretion at low glucose concentrations. 

Phrase: "We"

Phrase: "demonstrate"

Phrase: "that disruption of channel interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332453:Disruption [Functional Concept]

Phrase: "with PIP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0070798:PIP2 [Biologically Active Substance,Lipid,Organophosphorus Compound]
  1000   C3538724:PIP2 [Body Part, Organ, or Organ Component]

Phrase: "by overexpressing PIP2-insensitive channel subunits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C1711351:Subunit [Quantitative Concept]

Phrase: "leads to membrane depolarization"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C1816453:membrane depolarization [Cell Function]
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0025255:Membrane [Tissue]
   770   C0181586:leads [Medical Device]
   770   C0596901:Membrane [Cell Component]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C1706182:Membrane [Manufactured Object]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "elevated basal level insulin secretion at low glucose concentrations."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   764   C0428405:level insulin [Laboratory or Test Result]
   764   C1256369:insulin secretion [Cell Function]
   762 E C0202098:Insulin level [Laboratory Procedure]
   762   C0650607:Basal insulin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   762   C0861023:insulin low [Finding]
   762   C1719133:Glucose/Insulin [Quantitative Concept]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0036536:secretion [Biologic Function]
   742   C0036537:Secretion [Body Substance]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
Processing 00000000.tx.6: By contrast, facilitation of channel interactions with PIP2 by upregulating PIP2 levels via overexpression of a lipid kinase, phosphatidylinositol 4-phosphate 5 kinase, decreases the ATP sensitivity of endogenous KATP channels by 26-fold and renders INS-1 cells hyperpolarized, unable to secrete insulin properly in the face of high glucose. 

Phrase: "By contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "facilitation of channel interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0234112:Facilitation [Organ or Tissue Function]

Phrase: "with PIP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0070798:PIP2 [Biologically Active Substance,Lipid,Organophosphorus Compound]
  1000   C3538724:PIP2 [Body Part, Organ, or Organ Component]

Phrase: "by upregulating PIP2 levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "via overexpression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514559:Overexpression [Genetic Function]

Phrase: "of a lipid kinase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "phosphatidylinositol 4-phosphate 5 kinase,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0207206:phosphatidylinositol-4-phosphate 5-kinase [Amino Acid, Peptide, or Protein,Enzyme]
           phosphatidylinositol 4-phosphate kinase
   911   C0089793:Phosphatidylinositol 4-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0070799:phosphatidylinositol 4-phosphate [Lipid]

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the ATP sensitivity of endogenous KATP channels"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   757   C1547341:Channel sensitivity [Idea or Concept]
   748   C0036667:Sensitivity [Quantitative Concept]
   748   C0312418:Sensitivity [Mental Process]
   748   C0427965:Sensitivity [Finding]
   748   C1511883:Sensitivity [Quantitative Concept]
   748   C1522640:Sensitivity [Qualitative Concept]
   748   C2346484:SENSITIVITY [Phenomenon or Process]
   748   C2349185:Sensitivity [Qualitative Concept]

Phrase: "by 26-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "and"

Phrase: "renders INS-1 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C1414685:INS-1 [Gene or Genome]
   833   C3538717:INS-1 [Gene or Genome]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "hyperpolarized"

Phrase: ","

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "secrete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:secrete [Cell Function]

Phrase: "insulin properly in the face of high glucose."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0020459:high insulin [Disease or Syndrome]
   767   C1719133:Glucose/Insulin [Quantitative Concept]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
Processing 00000000.tx.7: Our results establish an important role of the interaction between membrane phosphoinositides and KATP channels in regulating insulin secretion. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "an important role of the interaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "between membrane phosphoinositides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031621:Phosphoinositides [Biologically Active Substance,Lipid]

Phrase: "and"

Phrase: "KATP channels in"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C1955862:KATP Channels [Amino Acid, Peptide, or Protein]
   756   C0439799:Channel [Spatial Concept]
   756   C1706095:Channel [Conceptual Entity]

Phrase: "regulating"

Phrase: "insulin secretion."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.8: Pancreatic -cells secrete insulin in response to glucose stimulus. 

Phrase: "Pancreatic -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "secrete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:secrete [Cell Function]

Phrase: "insulin in response"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "to glucose stimulus."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0234402:Stimulus [Phenomenon or Process]
Processing 00000000.tx.9: The ATP-sensitive K+ (KATP) channel, a complex of four inwardly rectifying K+ channel Kir6.2 subunits and four sulfonylurea receptor 1 (SUR1) subunits, is a key component in this stimulus-secretion coupling process (13). 

Phrase: "The ATP-sensitive K+ (KATP) channel,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0439799:Channel [Spatial Concept]
   804   C1706095:Channel [Conceptual Entity]

Phrase: "a complex of four inwardly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439855:Complex [Qualitative Concept]
   760   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "rectifying"

Phrase: "K+ channel Kir6.2 subunits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C1711351:Subunit [Quantitative Concept]

Phrase: "and"

Phrase: "four sulfonylurea receptor 1 (SUR1) subunits,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C1711351:Subunit [Quantitative Concept]

Phrase: "is"

Phrase: "a key component in this stimulus-secretion coupling process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0449432:Component [Manufactured Object]
   742   C1705248:Component [Conceptual Entity]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.10: The hallmark features of KATP channels are their sensitivities to intracellular nucleotides ATP and ADP, the derivatives of glucose metabolism (1,2). 

Phrase: "The hallmark features of KATP channels"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   719   C1521970:Feature [Qualitative Concept]
   719   C1706388:Feature [Conceptual Entity]
   719   C2346469:Feature [Qualitative Concept]
   719   C2348519:Feature [Qualitative Concept]

Phrase: "are"

Phrase: "their sensitivities to intracellular nucleotides ATP"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
   753   C0427965:Sensitivities [Finding]
   748   C0332324:Sensitive to [Functional Concept]
   719 E C0036667:Sensitivity [Quantitative Concept]
   719 E C0312418:Sensitivity [Mental Process]
   719 E C1511883:Sensitivity [Quantitative Concept]
   719 E C1522640:Sensitivity [Qualitative Concept]
   719 E C2346484:SENSITIVITY [Phenomenon or Process]
   719 E C2349185:Sensitivity [Qualitative Concept]

Phrase: "and"

Phrase: "ADP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0523452:ADP [Laboratory Procedure]

Phrase: "the derivatives of glucose metabolism"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0243072:derivatives [Chemical Viewed Structurally]
   726 E C1527240:Derivative [Functional Concept]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.11: ATP inhibits channel activity, whereas ADP, in complex with Mg2+, stimulates channel activity. 

Phrase: "ATP"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "channel activity,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1153410:channel activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "whereas"

Phrase: "ADP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0523452:ADP [Laboratory Procedure]

Phrase: "in complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "with Mg2+,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417500:MG2 [Gene or Genome]
  1000   C2346927:Mg2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "stimulates"

Phrase: "channel activity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1153410:channel activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.12: It is now generally accepted that the physiological activity of KATP channels is regulated primarily by the relative concentrations of ATP and ADP (1,4,5). 

Phrase: "It"

Phrase: "is"

Phrase: "now generally"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1948052:Now [Temporal Concept]

Phrase: "accepted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1272684:Accepted [Qualitative Concept]
  1000   C1548435:Accepted [Idea or Concept]
   966 E C1548601:Accept [Idea or Concept]

Phrase: "that"

Phrase: "the physiological activity of KATP channels"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C1153410:channel activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "regulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "primarily by the relative concentrations of ATP"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C0080103:Relative [Family Group]
   748   C0086045:Concentrations [Mental Process]
   748   C0205345:Relative [Qualitative Concept]
   748   C1547039:*Relative [Quantitative Concept]
   714 E C1446561:Concentration [Quantitative Concept]

Phrase: "and"

Phrase: "ADP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0523452:ADP [Laboratory Procedure]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "4,"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.13: As plasma glucose increases, ATP concentration increases and ADP concentration decreases, resulting in KATP channel closure, membrane depolarization, Ca2+ influx, and insulin release. 

Phrase: "As plasma glucose increases,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0442805:increases [Functional Concept]
   734   C0202042:Plasma glucose [Laboratory Procedure]
   734   C0455280:plasma glucose [Laboratory or Test Result]

Phrase: "ATP concentration increases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0442805:increases [Functional Concept]

Phrase: "and"

Phrase: "ADP concentration decreases,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0547047:decreases [Quantitative Concept]
   793 E C0392756:Decrease [Qualitative Concept]

Phrase: "resulting in KATP channel closure,"
Meta Candidates (Total=12; Excluded=6; Pruned=0; Remaining=6)
   806   C0332294:Resulting in [Functional Concept]
   760   C0185003:Closure [Therapeutic or Preventive Procedure]
   760   C0439799:Channel [Spatial Concept]
   760   C0678226:resulting [Functional Concept]
   760   C1521802:Closure [Research Activity]
   760   C1706095:Channel [Conceptual Entity]
   726 E C1274040:Result [Functional Concept]
   726 E C1546471:Result [Idea or Concept]
   726 E C2825142:Result [Finding]
   704 E C0447303:Occlusal [Body Location or Region]
   704 E C0591895:occlusal [Organic Chemical,Pharmacologic Substance]
   704 E C1947917:Occlusal [Functional Concept]

Phrase: "membrane depolarization,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1816453:membrane depolarization [Cell Function]

Phrase: "Ca2+ influx,"

Phrase: "and"

Phrase: "insulin release."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0030685:Release [Health Care Activity]
   861   C0391871:Release [Functional Concept]
   861   C0439180:% release [Quantitative Concept]
   861   C0680255:release [Health Care Activity]
   861   C1283071:Release [Functional Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C1963578:Release [Therapeutic or Preventive Procedure]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.14: Conversely, when glucose decreases, the concentration ratio of ATP to ADP decreases, leading to KATP channel opening, membrane hyperpolarization, and termination of insulin secretion. 

Phrase: "Conversely,"

Phrase: "when"

Phrase: "glucose decreases,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0547047:decreases [Quantitative Concept]
   827 E C0392756:Decrease [Qualitative Concept]

Phrase: "the concentration ratio of ATP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0086045:Concentration [Mental Process]
   760   C0456603:Ratio [Quantitative Concept]
   760   C1446561:Concentration [Quantitative Concept]
   760   C1547037:Ratio [Intellectual Product]

Phrase: "to ADP decreases,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0547047:decreases [Quantitative Concept]
   827 E C0392756:Decrease [Qualitative Concept]

Phrase: "leading to KATP channel opening,"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   760   C0175566:Opening [Spatial Concept]
   760   C0332152:Leading [Temporal Concept]
   760   C0439799:Channel [Spatial Concept]
   760   C1522538:Leading [Functional Concept]
   760   C1706095:Channel [Conceptual Entity]
   760   C1882151:Opening [Spatial Concept]
   726 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   726 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   726 E C2348269:Lead [Element, Ion, or Isotope]
   726 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "membrane hyperpolarization,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2262820:membrane hyperpolarization [Cell Function]

Phrase: "and"

Phrase: "termination of insulin secretion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1549081:Termination [Intellectual Product]
   770   C1692758:termination [Idea or Concept]
Processing 00000000.tx.15: The importance of ATP and ADP in regulating KATP channels in vivo has been confirmed by the finding that mutations that reduce channel sensitivity to ATP or MgADP are causative in permanent neonatal diabetes or congenital hyperinsulinism, respectively (59). 

Phrase: "The importance of ATP"

Phrase: "and"

Phrase: "ADP in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0523452:ADP [Laboratory Procedure]

Phrase: "regulating"

Phrase: "KATP channels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1955862:KATP Channels [Amino Acid, Peptide, or Protein]
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "has"

Phrase: "been"

Phrase: "confirmed by the finding"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   770   C0037088:Finding [Sign or Symptom]
   770   C0243095:Finding [Finding]
   770   C0750484:Confirmed [Idea or Concept]
   770   C2825141:Finding [Finding]
   737 E C1456348:Confirm [Qualitative Concept]

Phrase: "that mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "reduce"

Phrase: "channel sensitivity to ATP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C1547341:Channel sensitivity [Idea or Concept]
   797   C0332324:Sensitive to [Functional Concept]
   770   C0036667:Sensitivity [Quantitative Concept]
   770   C0312418:Sensitivity [Mental Process]
   770   C0427965:Sensitivity [Finding]
   770   C1511883:Sensitivity [Quantitative Concept]
   770   C1522640:Sensitivity [Qualitative Concept]
   770   C2346484:SENSITIVITY [Phenomenon or Process]
   770   C2349185:Sensitivity [Qualitative Concept]

Phrase: "or"

Phrase: "MgADP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024468:MgADP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "are"

Phrase: "causative in permanent neonatal diabetes"

Phrase: "or"

Phrase: "congenital hyperinsulinism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2931834:Congenital Hyperinsulinism [Disease or Syndrome]
   861   C0020459:Hyperinsulinism [Disease or Syndrome]

Phrase: "respectively"

Phrase: "(59"

Phrase: ")."
Processing 00000000.tx.16: The discovery that membrane phosphoinositides, in particular the most abundant phosphoinositide phosphatidylinositol 4,5-bisphosphate (PIP2) (10), stimulate KATP channel activity and antagonize the inhibitory effect of ATP in isolated membrane patches (11,12) has led to the proposal that in addition to ATP and ADP, PIP2 may also be important in controlling the physiological activity of KATP channels in -cells (1114). 

Phrase: "The discovery"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880355:Discovery [Activity]

Phrase: "that membrane phosphoinositides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031621:Phosphoinositides [Biologically Active Substance,Lipid]

Phrase: "in particular"

Phrase: "the most abundant phosphoinositide phosphatidylinositol 4,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
           phosphoinositide
   804   C0205393:Most [Quantitative Concept]
   804   C2346714:Abundant [Qualitative Concept]
   804   C2348046:Phosphatidylinositol [Lipid]

Phrase: "5-bisphosphate"

Phrase: "(PIP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0070798:PIP2 [Biologically Active Substance,Lipid,Organophosphorus Compound]
  1000   C3538724:PIP2 [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: "(10"

Phrase: ")"

Phrase: ","

Phrase: "stimulate"

Phrase: "KATP channel activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1153410:channel activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "antagonize"

Phrase: "the inhibitory effect of ATP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "in isolated membrane patches"
Meta Candidates (Total=9; Excluded=8; Pruned=0; Remaining=1)
   827   C0994894:Patches [Medical Device]
   793 E C0332461:Patch [Finding]
   793 E C0445403:Patch [Biomedical or Dental Material]
   793 E C0991556:Patch [Medical Device]
   793 E C1305400:Patch [Medical Device]
   793 E C1533128:Patch [Biomedical or Dental Material]
   793 E C1706366:{Patch} [Quantitative Concept]
   793 E C1707974:Patch [Biomedical or Dental Material]
   743 E C0205413:Patchy [Qualitative Concept]

Phrase: "(11,"

Phrase: "12"

Phrase: ")"

Phrase: "has"

Phrase: "led to the proposal"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   770   C1555306:proposal [Idea or Concept]
   770   C1708698:LED [Manufactured Object]
   770   C1948033:Proposal [Intellectual Product]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C1522538:Lead [Functional Concept]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "that in addition to ATP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1883712:Addition [Functional Concept]

Phrase: "and"

Phrase: "ADP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0523452:ADP [Laboratory Procedure]

Phrase: "PIP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0070798:PIP2 [Biologically Active Substance,Lipid,Organophosphorus Compound]
  1000   C3538724:PIP2 [Body Part, Organ, or Organ Component]

Phrase: "may"

Phrase: "also"

Phrase: "be"

Phrase: "important in controlling"

Phrase: "the physiological activity of KATP channels in -cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   750   C1153410:channel activity [Molecular Function]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "(1114"

Phrase: ")."
Processing 00000000.tx.17: However, to date, direct evidence for a role of membrane phosphoinositides in regulating KATP channel activity, hence regulation of insulin secretion, in -cells is still lacking (15). 

Phrase: "However,"

Phrase: "to date,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011008:Date [Temporal Concept]
  1000   C2348077:Date [Food]

Phrase: "direct evidence for a role of membrane phosphoinositides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "in"

Phrase: "regulating"

Phrase: "KATP channel activity,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1153410:channel activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "hence regulation of insulin secretion,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   926   C1325895:regulation of insulin secretion [Cell Function]
   844   C1523071:regulation of secretion [Cell Function]
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "in -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "still"

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.18: In addition to modulating the activity of transporters and ion channels, phosphoinositides play significant roles in membrane trafficking and cytoskeleton organization (16,17). 

Phrase: "In addition to modulating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:Modulating [Spatial Concept]

Phrase: "the activity of transporters"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   802   C1152949:transporter activity [Molecular Function]
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]
   767 E C1621573:active transporter [Molecular Function]

Phrase: "and"

Phrase: "ion channels,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022009:Ion Channels [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: "phosphoinositides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031621:Phosphoinositides [Biologically Active Substance,Lipid]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "significant roles in membrane"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0035820:Roles [Social Behavior]
   737 E C1705810:Role [Conceptual Entity]

Phrase: "trafficking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599896:trafficking [Cell Function]

Phrase: "and"

Phrase: "cytoskeleton organization"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1155964:cytoskeleton organisation [Cell Function]
   861   C0029237:Organisation [Physiologic Function]
   861   C0029246:Organization [Organization]
   861   C0220885:organization [Qualitative Concept]
   861   C1300196:Organization [Functional Concept]
   861   C1522486:Organization [Professional or Occupational Group]

Phrase: "(16,"

Phrase: "17"

Phrase: ")."
Processing 00000000.tx.19: Recent studies show that adequate PIP2 levels are necessary for cytoskeleton rearrangement and priming of insulin secretory granules (18,19). 

Phrase: "Recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that adequate PIP2 levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "necessary for cytoskeleton rearrangement"

Phrase: "and"

Phrase: "priming of insulin secretory granules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0871133:Priming [Functional Concept]

Phrase: "(18,"

Phrase: "19"

Phrase: ")."
Processing 00000000.tx.20: These studies highlight the complex role of phosphoinositides in insulin secretion and the need to elucidate the physiological relevance of KATP channel gating by PIP2 in the context of -cell function and insulin secretion. 

Phrase: "These studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "highlight"

Phrase: "the complex role of phosphoinositides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "the need to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027552:Need [Qualitative Concept]
   861   C0686904:need [Functional Concept]

Phrase: "elucidate"

Phrase: "the physiological relevance of KATP channel gating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2347946:Relevance [Qualitative Concept]

Phrase: "by PIP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0070798:PIP2 [Biologically Active Substance,Lipid,Organophosphorus Compound]
  1000   C3538724:PIP2 [Body Part, Organ, or Organ Component]

Phrase: "in the context of -cell function"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   861   C0007613:Cell Function [Cell Function]
   812   C0007634:Cell [Cell]
   812   C0031843:function [Physiologic Function]
   812   C0542341:Function [Functional Concept]
   812   C0700205:FUNCTION [Classification]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1705273:Function [Intellectual Product]
   812   C1948049:Cell [Spatial Concept]
   741 E C0205245:Functional [Functional Concept]
   741 E C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "insulin secretion."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.21: In this study, we manipulated the interactions between KATP channels and membrane PIP2 in insulin-secreting cells and examined the effects of such manipulations on KATP channel activity and insulin secretion. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "manipulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0947647:Manipulate [Therapeutic or Preventive Procedure]

Phrase: "the interactions between KATP channels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "membrane PIP2 in insulin-secreting cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0070798:PIP2 [Biologically Active Substance,Lipid,Organophosphorus Compound]
   753   C3538724:PIP2 [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the effects of such manipulations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on KATP channel activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1153410:channel activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "insulin secretion."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.22: We show that disrupting the interaction between KATP channels and PIP2 by overexpressing Kir6.2 mutants with decreased sensitivity to PIP2 causes persistent membrane depolarization and elevated basal level insulin secretion. 

Phrase: "We"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that disrupting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupting [Qualitative Concept]

Phrase: "the interaction between KATP channels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "PIP2 by overexpressing Kir6.2 mutants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0070798:PIP2 [Biologically Active Substance,Lipid,Organophosphorus Compound]
   753   C3538724:PIP2 [Body Part, Organ, or Organ Component]

Phrase: "with decreased sensitivity"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C0020580:Decreased Sensitivity [Finding]
  1000   C1880261:DECREASED SENSITIVITY [Phenomenon or Process]
  1000   C2348085:DECREASED SENSITIVITY [Phenomenon or Process]
   861   C0036667:Sensitivity [Quantitative Concept]
   861   C0312418:Sensitivity [Mental Process]
   861   C0427965:Sensitivity [Finding]
   861   C1511883:Sensitivity [Quantitative Concept]
   861   C1522640:Sensitivity [Qualitative Concept]
   861   C2346484:SENSITIVITY [Phenomenon or Process]
   861   C2349185:Sensitivity [Qualitative Concept]
   789 E C0332324:Sensitive [Functional Concept]
   789 E C1550474:sensitive [Idea or Concept]

Phrase: "to PIP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0070798:PIP2 [Biologically Active Substance,Lipid,Organophosphorus Compound]
  1000   C3538724:PIP2 [Body Part, Organ, or Organ Component]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "persistent membrane depolarization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1816453:membrane depolarization [Cell Function]

Phrase: "and"

Phrase: "elevated basal level insulin secretion."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   853   C0650607:Basal insulin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   840   C0428405:level insulin [Laboratory or Test Result]
   840   C1256369:insulin secretion [Cell Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0036536:secretion [Biologic Function]
   804   C0036537:Secretion [Body Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.23: On the other hand, promoting channel-PIP2 interactions by expressing a murine type I phosphatidylinositol 4-phosphate 5 kinase (PIP5K) (20,21), which increases PIP2 levels and thereby KATP channel activity, renders INS-1 cells less able to couple glucose stimulation to insulin secretion. 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "promoting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promoting [Activity]

Phrase: "channel-PIP2 interactions by expressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1704675:Interaction [Functional Concept]

Phrase: "a murine type I phosphatidylinositol 4-phosphate 5 kinase (PIP5K)"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   892   C0044602:Type I Phosphatidylinositol Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   890   C0207206:phosphatidylinositol-4-phosphate 5-kinase [Amino Acid, Peptide, or Protein,Enzyme]
           phosphatidylinositol 4-phosphate kinase
   855   C0089793:Phosphatidylinositol 4-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(20,"

Phrase: "21"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "PIP2 levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "thereby KATP channel activity,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1153410:channel activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "renders INS-1 cells less able to"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   778   C1414685:INS-1 [Gene or Genome]
   778   C3538717:INS-1 [Gene or Genome]
   748   C0007634:Cells [Cell]
   748   C0085732:Able [Organism Attribute]
   748   C1299581:Able [Finding]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "couple"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010222:couple [Family Group]
  1000   C1948027:Couple [Functional Concept]

Phrase: "glucose stimulation to insulin secretion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   760   C1948023:Stimulation [Natural Phenomenon or Process]
Processing 00000000.tx.24: The results provide direct evidence that regulation of KATP channel activity by phosphoinositides plays an integral role in insulin secretion.  

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "direct evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that regulation of KATP channel activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "by phosphoinositides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031621:Phosphoinositides [Biologically Active Substance,Lipid]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "an integral role in insulin secretion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.25: RESEARCH DESIGN AND METHODS TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Molecular biology. 

Phrase: "RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0035171:Research Design [Research Activity]
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]
   861   C1707689:Design [Activity]
   861   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   875   C0086912:methods research [Research Activity]
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Molecular biology."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.26: Kir6.2 containing point mutations or the influenza A virus hemagglutinin (HA)epitope tag (YPYDVPDYA inserted between amino acid 100 and 101 of Kir6.2; an extra nine amino acids, DLYAYMEKG, inserted between amino acid 98 and 99 to aid accessibility of the epitope) were prepared using the QuickChange site-directed mutagenesis kit (Stratagene) and subcloned into the pCMV6b vector. 

Phrase: "Kir6.2 containing point mutations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   840   C0162735:Point Mutations [Cell or Molecular Dysfunction]
   804   C0026882:Mutations [Genetic Function]
   804   C1552961:Point [Quantitative Concept]
   804   C2347617:point [Quantitative Concept]
   771 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "or"

Phrase: "the influenza A virus hemagglutinin (HA)epitope tag (YPYDVPDYA"

Phrase: "inserted between amino acid 100"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   806   C2917660:Amino Acid [Pharmacologic Substance]
   760   C0001128:Acid [Chemical]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0441587:Inserted [Health Care Activity]
   726 E C1743766:Insert [Medical Device]
   726 E C1883719:Insert [Functional Concept]

Phrase: "and"

Phrase: "101 of Kir6.2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1416578:Kir6.2 [Gene or Genome]

Phrase: ";"

Phrase: "an extra nine amino acids,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acids [Chemical]
   779 E C0202406:Acid [Laboratory Procedure]

Phrase: "DLYAYMEKG,"

Phrase: "inserted between amino acid 98"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   806   C2917660:Amino Acid [Pharmacologic Substance]
   760   C0001128:Acid [Chemical]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0441587:Inserted [Health Care Activity]
   726 E C1743766:Insert [Medical Device]
   726 E C1883719:Insert [Functional Concept]

Phrase: "and"

Phrase: "99 to"

Phrase: "aid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0018896:Aid [Social Behavior]
  1000   C0449435:Aid [Manufactured Object]
  1000   C3540469:AID [Gene or Genome]

Phrase: "accessibility of the epitope"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0814423:accessibility [Qualitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the QuickChange site-directed mutagenesis kit (Stratagene"

Phrase: ")"

Phrase: "and"

Phrase: "subcloned into the pCMV6b vector."
Processing 00000000.tx.27: Recombinant adenoviruses were constructed using the AdEasy system (Stratagene). 

Phrase: "Recombinant adenoviruses"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0001483:Adenoviruses [Virus]
   861   C1514798:recombinant [Organism]
   827 E C0001486:Adenovirus [Disease or Syndrome]
   827 E C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "constructed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the AdEasy system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "(Stratagene"

Phrase: ")."
Processing 00000000.tx.28: The cDNAs encoding wild-type PIP5K I (PIP5K:WT) or a deletion mutant lacking the NH2-terminal 238 amino acids (PIP5K:1--238) (20) or the various rat Kir6.2 wild type and mutants were subcloned into the pCMV shuttle vector (pShuttle). 

Phrase: "The cDNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "wild-type PIP5K I (PIP5K"

Phrase: ":"

Phrase: "WT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: ")"

Phrase: "or"

Phrase: "a deletion mutant lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0332268:Lacking [Qualitative Concept]

Phrase: "the NH2-terminal 238 amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   840   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   806 E C2917660:Amino Acid [Pharmacologic Substance]
   804   C0001128:Acids [Chemical]
   771 E C0202406:Acid [Laboratory Procedure]

Phrase: "(PIP5K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "--"

Phrase: "238"

Phrase: ")"

Phrase: "(20"

Phrase: ")"

Phrase: "or"

Phrase: "the various rat Kir6.2 wild type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1883559:Wild Type [Organism Attribute]
   799   C0332307:Type [Qualitative Concept]
   799   C0445392:Wild [Intellectual Product]
   799   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "subcloned into the pCMV shuttle vector (pShuttle)."
Processing 00000000.tx.29: They were then recombined with the pAdEasy vector in the BJ5183 strain of Escherichia Coli. 

Phrase: "They"

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "recombined with the pAdEasy vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0442335:Vector [Spatial Concept]
   760   C1705099:Vector [Idea or Concept]

Phrase: "in the BJ5183 strain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0080194:Strain [Injury or Poisoning]
   861   C0456178:strain [Intellectual Product]
   861   C1518614:Strain [Organism]
   861   C2987481:Strain [Mental Process]

Phrase: "of Escherichia Coli."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014834:Escherichia coli [Bacterium]
   861   C0014833:Escherichia [Bacterium]
Processing 00000000.tx.30: Positive recombinants were selected, and pAdEasy plasmids containing the correct insert were used to transfect HEK293 cells for virus production. 

Phrase: "Positive recombinants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1514798:Recombinants [Organism]

Phrase: "were"

Phrase: "selected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Select [Activity]

Phrase: ","

Phrase: "and"

Phrase: "pAdEasy plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the correct insert"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441587:Insert [Health Care Activity]
   861   C1743766:Insert [Medical Device]
   861   C1883719:Insert [Functional Concept]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "transfect"

Phrase: "HEK293 cells for virus production."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   806   C2936239:HEK293 Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.31: Single plaques were isolated for further amplification in HEK293 cells. 

Phrase: "Single plaques"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0333463:plaques [Acquired Abnormality]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]

Phrase: "were"

Phrase: "isolated for further amplification"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   770   C0205409:Isolated [Functional Concept]
   770   C1517331:Further [Spatial Concept]
   770   C1517480:Amplification [Molecular Biology Research Technique]
   770   C1521871:Amplification [Phenomenon or Process]
   770   C1548221:Isolated [Idea or Concept]
   770   C1705759:Amplification [Cell or Molecular Dysfunction]
   737 E C0205108:far [Spatial Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "in HEK293 cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK293 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.32: Recombinant viruses were purified on a CsCl gradient and titers determined by spectrometry. 

Phrase: "Recombinant viruses"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   983   C0597363:recombinant virus [Virus]
   861   C0042776:Viruses [Virus]
   861   C0521026:viruses [Functional Concept]
   827 E C0319157:virus [Virus]

Phrase: "were"

Phrase: "purified on a CsCl gradient"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0055134:CsCl [Inorganic Chemical,Pharmacologic Substance]
   760   C0439182:% gradient [Quantitative Concept]
   760   C0812409:Gradient [Quantitative Concept]
   760   C1998793:Purified [Functional Concept]

Phrase: "and"

Phrase: "titers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0475208:Titer [Quantitative Concept]

Phrase: "determined by spectrometry."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0436196:Spectrometry [Laboratory Procedure]
Processing 00000000.tx.33: All constructs were sequenced to verify the correct mutations. 

Phrase: "All constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "were"

Phrase: "sequenced"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "verify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711411:Verify [Functional Concept]

Phrase: "the correct mutations."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.34: Infection of INS-1 cells with adenovirus. 

Phrase: "Infection of"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   833   C0009450:Infection, NOS [Disease or Syndrome]
   761 E C0439663:Infected [Functional Concept]
   722 E C0030657:infectivity [Qualitative Concept]

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "with adenovirus."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001483:Adenovirus, NOS [Virus]
  1000   C0001486:Adenovirus [Disease or Syndrome]
  1000   C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.35: For protein expression in INS-1 cells, recombinant adenoviruses with desired titers were used for infection as follows. 

Phrase: "For protein expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1171362:protein expression [Genetic Function]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in"

Phrase: "INS-1 cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "recombinant adenoviruses with desired titers"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0001483:Adenoviruses [Virus]
   760   C1514798:recombinant [Organism]
   726 E C0001486:Adenovirus [Disease or Syndrome]
   726 E C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "used for infection"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0009450:Infection, NOS [Disease or Syndrome]
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]
   718 E C0439663:Infected [Functional Concept]

Phrase: "as"

Phrase: "follows."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]
Processing 00000000.tx.36: INS-1 cells [clone 832/13, a gift from Dr. Chris Newgard (ref. 22)] were plated at 106 cells/35-mm dish and cultured in RPMI-1640 with 11.1 mmol/l D-glucose (Invitrogen) supplemented with 10% FBS, 100 U/ml penicillin, 100 g/ml streptomycin, 10 mmol/l HEPES, 2 mmol/l glutamine, 1 mmol/l sodium pyruvate, and 50 mol/l -mercaptoethanol. 

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "[clone 832/13,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0009013:Clone [Cell]
   827   C1522642:Clone [Tissue]
   755 E C1704387:Clonal [Qualitative Concept]
   727 E C0796368:clonality [Diagnostic Procedure]

Phrase: "a gift from Dr. Chris Newgard"

Phrase: "(ref. 22"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: ")"

Phrase: "]"

Phrase: "were"

Phrase: "plated at 106 cells/35-mm dish"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   774   C2347576:Cells/dish [Quantitative Concept]
   757   C1166718:cells plate [Cell Component]
   748   C0007634:Cells [Cell]
   748   C0020498:DISH [Disease or Syndrome]
   748   C3282337:Cells [Cell]
   714   C0005971:Plate [Medical Device]
   714   C1139930:plate [Medical Device]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]
   714   C3537155:Plate [Manufactured Object]

Phrase: "and"

Phrase: "cultured in RPMI-1640"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "with 11.1 mmol/l D-glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: "supplemented with 10% FBS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0242295:Supplement [Food]
   737   C1947943:Supplement [Intellectual Product]
   737   C2348609:Supplement [Functional Concept]

Phrase: "100 U/ml penicillin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0030842:Penicillin [Antibiotic,Organic Chemical]
   812   C0220892:Penicillin [Antibiotic,Organic Chemical]

Phrase: "100 g/ml streptomycin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0038425:Streptomycin [Antibiotic,Carbohydrate]

Phrase: "10 mmol/l HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "2 mmol/l glutamine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017797:Glutamine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "1 mmol/l sodium pyruvate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C1576824:Sodium Pyruvate [Organic Chemical,Pharmacologic Substance]
   804   C0034354:pyruvate [Organic Chemical]
   804   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]

Phrase: "and"

Phrase: "50 mol/l -mercaptoethanol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0025402:Mercaptoethanol [Organic Chemical]
Processing 00000000.tx.37: Twenty-four hours later, cells were infected with appropriate titer of each adenovirus diluted in 1 ml OptiMEM at 37C for 1.5 h. 

Phrase: "Twenty-four hours later,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0439227:hours [Temporal Concept]
   779 E C0564385:/hour [Quantitative Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "infected with appropriate titer of each adenovirus"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0001483:Adenovirus, NOS [Virus]
   748   C0001486:Adenovirus [Disease or Syndrome]
   748   C0439663:Infected [Functional Concept]
   748   C0475208:Titer [Quantitative Concept]
   748   C1548787:Appropriate [Qualitative Concept]
   748   C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "diluted in 1 ml OptiMEM"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439526:/mL [Quantitative Concept]
   726   C1720119:Dilute [Functional Concept]
   726   C1948037:Dilute [Functional Concept]

Phrase: "at 37C"

Phrase: "for 1.5 h."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C0700308:1 H [Element, Ion, or Isotope]
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]
   734   C0450316:1/5 [Quantitative Concept]
Processing 00000000.tx.38: One milliliter of RPMI-1640 with 2x supplement was then added to each dish for overnight incubation. 

Phrase: "One milliliter of RPMI-1640"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439242:milliliter [Quantitative Concept]

Phrase: "with 2x supplement"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0242295:Supplement [Food]
   861   C1947943:Supplement [Intellectual Product]
   861   C2348609:Supplement [Functional Concept]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "added to each dish"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0020498:DISH [Disease or Syndrome]
   770   C1524062:Added [Functional Concept]
   737 E C1883712:Add [Functional Concept]

Phrase: "for overnight incubation."
Processing 00000000.tx.39: The next day, the infection medium was replaced with regular medium and incubated for another day before the experiment. 

Phrase: "The next day,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "the infection medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "replaced with regular medium"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0009458:Medium [Intellectual Product]
   770   C0205272:Regular [Qualitative Concept]
   770   C0439536:Medium [Quantitative Concept]
   770   C0559956:Replaced [Functional Concept]
   770   C1299987:replaced [Functional Concept]
   770   C1705217:Medium [Substance]
   770   C3244283:medium [Intellectual Product]
   737 E C1554078:Replace [Idea or Concept]

Phrase: "and"

Phrase: "incubated for another day"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0332173:/day [Temporal Concept]
   770   C0439228:day [Temporal Concept]
   770   C0439505:/day [Temporal Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "before the experiment."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.40: Immunoblotting and immunostaining. 

Phrase: "Immunoblotting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "and"

Phrase: "immunostaining."
Processing 00000000.tx.41: INS-1 cells were lysed 24 h postinfection in 20 mmol/l HEPES, pH 7.0, 5 mmol/l EDTA,150 mmol/l NaCl, and 1% Nonidet P-40 (IGAPEL) with Complete protease inhibitors (Roche Applied Science, Indianapolis, IN). 

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "lysed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lysed [Pathologic Function]

Phrase: "24 h"

Phrase: "postinfection in 20 mmol/l HEPES,"

Phrase: "pH 7.0,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "5 mmol/l EDTA,150 mmol/l NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   793   C1959973:% NaCl [Quantitative Concept]

Phrase: "and"

Phrase: "1% Nonidet P-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   812   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   812   C0439509:/40 [Temporal Concept]

Phrase: "(IGAPEL"

Phrase: ")"

Phrase: "with Complete protease inhibitors"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   867 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   827   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0243077:inhibitors [Chemical Viewed Functionally]
   827   C1947941:Protease [Enzyme]
   793 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(Roche Applied Science,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0681834:Applied Science [Research Activity]
   827   C0036397:Science [Occupation or Discipline]
   827   C0185125:Applied [Health Care Activity]
   793 E C1632850:Apply [Functional Concept]
   793 E C1879355:Apply [Functional Concept]

Phrase: "Indianapolis,"

Phrase: "IN"

Phrase: ")."
Processing 00000000.tx.42: Proteins were separated by SDS/PAGE, transferred to nitrocellulose membrane, probed with appropriate primary antibodies followed by horseradish peroxidaseconjugated secondary antibodies (Amersham Biosciences, Piscataway, NJ), and visualized by enhanced chemiluminescence (Super Signal West Femto; Pierce, Rockford, IL). 

Phrase: "Proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "separated by SDS/PAGE,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0086972:Separated [Finding]
   770   C0443299:separated [Spatial Concept]
   770   C0687118:Separated [Functional Concept]
   770   C1704732:Page [Intellectual Product]

Phrase: "transferred"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0348011:transferred [Functional Concept]
   966 E C0040671:Transfer [Mental Process]
   966 E C1705822:Transfer [Activity]

Phrase: "to nitrocellulose membrane,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0025255:Membrane [Tissue]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "probed with appropriate primary antibodies"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0205225:Primary [Qualitative Concept]
   760   C0439631:Primary [Therapeutic or Preventive Procedure]
   760   C1548787:Appropriate [Qualitative Concept]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   726   C0182400:Probe [Medical Device]
   726   C1704681:Probe [Gene or Genome]
   726   C2347609:Probe [Chemical Viewed Functionally]
   726   C3536729:Probe [Manufactured Object]

Phrase: "followed by horseradish peroxidaseconjugated secondary antibodies"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   790   C0332283:Followed by [Temporal Concept]
           followed
   753   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0027627:secondary [Neoplastic Process]
   753   C0175668:Secondary [Temporal Concept]
   753   C0205436:Secondary [Quantitative Concept]
   753   C0330510:Horseradish [Food]
   753   C0939835:HORSERADISH [Organic Chemical,Pharmacologic Substance]
   753   C1110641:Horseradish [Plant]
   719 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   719 E C1719822:Follow [Intellectual Product]

Phrase: "(Amersham Biosciences,"

Phrase: "Piscataway,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551491:Piscataway [Population Group]

Phrase: "NJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027971:NJ [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "visualized by enhanced chemiluminescence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0162524:Chemiluminescence [Natural Phenomenon or Process]
   770   C0234621:Visualized [Functional Concept]
   770   C1450278:Chemiluminescence [Natural Phenomenon or Process]
   770   C2349975:Enhanced [Activity]

Phrase: "(Super Signal West Femto"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1553038:Femto [Quantitative Concept]

Phrase: "; Pierce,"

Phrase: "Rockford,"

Phrase: "IL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020898:IL [Geographic Area]
  1000   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0022271:IL [Geographic Area]

Phrase: ")."
Processing 00000000.tx.43: The primary antibodies used were rabbit polyclonal anti-Kir6.2 for Kir6.2 (Santa Cruz Biotechnology, Santa Cruz, CA) and rabbit polyclonal anti-PIP5K, which recognizes both the wild type and the 1-238 mutant (kindly provided by Dr. J. Nathan Davis), for PIP5K:WT and PIP5K:1-238. 

Phrase: "The primary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "were"

Phrase: "rabbit polyclonal anti-Kir6.2 for Kir6.2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1416578:Kir6.2 [Gene or Genome]
   744   C0034493:Rabbit [Mammal]

Phrase: "(Santa Cruz Biotechnology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: "Santa Cruz,"

Phrase: "CA)"

Phrase: "and"

Phrase: "rabbit polyclonal anti-PIP5K,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "which"

Phrase: "recognizes"

Phrase: "both the wild type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "the 1-238 mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "(kindly"

Phrase: "provided by Dr. J. Nathan Davis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0031831:DR [Professional or Occupational Group]
   753   C1707664:DR [Biomedical or Dental Material]
   753   C1999230:Provided [Activity]
   753   C2348314:Dr. [Conceptual Entity]
   753   C3540849:DR [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "for PIP5K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ":"

Phrase: "WT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "PIP5K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ":"

Phrase: "1-238."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]
Processing 00000000.tx.44: To confirm expression of mutant Kir6.2 at the cell surface, living INS-1 cells infected with a virus carrying HA-tagged R206A Kir6.2 were immunostained for surface HA using protocols described previously (23). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "expression of mutant Kir6.2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "at the cell surface,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0699040:Cell surface [Cell Component]
   861   C0205148:Surface [Spatial Concept]

Phrase: "living INS-1 cells"
Meta Candidates (Total=11; Excluded=6; Pruned=0; Remaining=5)
   833   C1414685:INS-1 [Gene or Genome]
   833   C3538717:INS-1 [Gene or Genome]
   770   C0007634:Cells [Cell]
   770   C0376558:Living [Idea or Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1548795:Live [Qualitative Concept]
   737 E C1634625:% live [Qualitative Concept]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
   737 E C2982691:Live [Activity]

Phrase: "infected with a virus carrying HA-tagged R206A Kir6.2"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   760   C1416578:Kir6.2 [Gene or Genome]
   739   C0018909:Haemagglutinin, NOS [Immunologic Factor]
   739   C0042776:Virus [Virus]
   739   C0206243:Carrying [Activity]
   739   C0319157:virus [Virus]
   739   C0439663:Infected [Functional Concept]
   739   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   739   C1708632:Tagged [Qualitative Concept]
   706 E C0037293:Tag [Neoplastic Process]
   706 E C0181496:Tag [Manufactured Object]
   706 E C0699809:carry [Finding]
   706 E C1710492:TAG [Gene or Genome]

Phrase: "were"

Phrase: "immunostained for surface HA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0018909:Haemagglutinin, NOS [Immunologic Factor]
   770   C0205148:Surface [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "protocols"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0442711:Protocols [Intellectual Product]
   966 E C1507394:Protocol [Intellectual Product]
   966 E C1522729:Protocol [Intellectual Product]
   966 E C2348563:Protocol [Intellectual Product]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.45: Phospholipids assays. 

Phrase: "Phospholipids assays."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.46: INS-1 cells were grown on 35-mm dishes and infected with PIP5K:WT or PIP5K:1-238 viruses. 

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown on 35-mm dishes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0020498:DISH [Disease or Syndrome]

Phrase: "and"

Phrase: "infected with PIP5K"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0439663:Infected [Functional Concept]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: ":"

Phrase: "WT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "PIP5K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ":"

Phrase: "1-238 viruses."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0042776:Viruses [Virus]
   827   C0521026:viruses [Functional Concept]
   793 E C0319157:virus [Virus]
Processing 00000000.tx.47: Twenty-four hours postinfection, cells were preincubated for 1 h in a phosphate-free medium before labeling with 20 Ci 32P for 4 h. 

Phrase: "Twenty-four hours postinfection, cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "preincubated for 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C0700308:h 1 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "in a phosphate-free medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0009458:Medium [Intellectual Product]
   827   C0439536:Medium [Quantitative Concept]
   827   C1705217:Medium [Substance]
   827   C3244283:medium [Intellectual Product]

Phrase: "before labeling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1167624:Labeling [Mental Process]
  1000   C1947902:Labeling [Manufactured Object]
  1000   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "with 20 Ci 32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1553631:32p [Medical Device]

Phrase: "for 4 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.48: Cells were then washed twice with phosphate-free medium and scraped into 1 ml MeOH:HCl (10:1). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice with phosphate-free medium"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   760   C0009458:Medium [Intellectual Product]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0332296:free [Functional Concept]
   760   C0439536:Medium [Quantitative Concept]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   760   C1705217:Medium [Substance]
   760   C1720725:Twice [Intellectual Product]
   760   C1880497:Free [Qualitative Concept]
   760   C1948050:Twice [Quantitative Concept]
   760   C1996904:Free [Qualitative Concept]
   760   C3244283:medium [Intellectual Product]

Phrase: "and"

Phrase: "scraped into 1 ml MeOH"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0184933:scraped [Therapeutic or Preventive Procedure]
   760   C0439526:/mL [Quantitative Concept]
   760   C0444082:scraped [Body Substance]

Phrase: ":"

Phrase: "HCl (10"

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.49: After scraping, the dish was washed again with 1 ml of 2-mmol/l AlCl3 in H2O, and the wash was combined with the cell lysate. 

Phrase: "After scraping,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0184933:Scraping [Therapeutic or Preventive Procedure]
   966 E C0444082:scrape [Body Substance]

Phrase: "the dish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020498:DISH [Disease or Syndrome]

Phrase: "was"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "again with 1 ml of 2-mmol/l AlCl3"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   764   C1532563:mmol/L [Quantitative Concept]
   762   C0347982:mmol/mL [Quantitative Concept]
   762   C1635169:mL/L [Quantitative Concept]
   762   C2827854:mL/mmol [Quantitative Concept]
   742   C0102840:AlCl3 [Inorganic Chemical,Pharmacologic Substance]
   742   C0439190:MMOLE [Quantitative Concept]
   742   C0439526:/mL [Quantitative Concept]

Phrase: "in H2O,"

Phrase: "and"

Phrase: "the wash"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441648:Wash [Activity]

Phrase: "was"

Phrase: "combined with the cell lysate."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C1881488:Cell Lysate [Physical Object]
           Lysate
   760   C0007634:Cell [Cell]
   760   C0205195:Combined [Qualitative Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726 E C0336789:Combine [Manufactured Object]
Processing 00000000.tx.50: The lipids were extracted by 2 ml CHCl3. 

Phrase: "The lipids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023779:Lipids [Lipid]

Phrase: "were"

Phrase: "extracted by 2 ml CHCl3."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0185115:Extracted [Therapeutic or Preventive Procedure]
   760   C0439526:/mL [Quantitative Concept]
   760   C3541890:EXTRACTED [Finding]
   726 E C2828366:Extract [Substance]
Processing 00000000.tx.51: The aqueous phase was transferred to a new tube and extraction repeated twice. 

Phrase: "The aqueous phase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205390:Phase [Temporal Concept]

Phrase: "was"

Phrase: "transferred to a new tube"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0175730:Tube [Medical Device]
   760   C0205314:New [Temporal Concept]
   760   C0348011:transferred [Functional Concept]
   760   C1547937:Tube NOS [Intellectual Product]
   760   C1561954:tube [Conceptual Entity]
   760   C1704730:TUBE [Medical Device]
   726 E C0040671:Transfer [Mental Process]
   726 E C1705822:Transfer [Activity]

Phrase: "and"

Phrase: "extraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0185115:Extraction [Therapeutic or Preventive Procedure]
  1000   C0684295:extraction [Laboratory Procedure]

Phrase: "repeated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205341:Repeated [Functional Concept]
   966 E C1547730:Repeat [Temporal Concept]
   966 E C1705914:Repeat [Conceptual Entity]

Phrase: "twice."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720725:Twice [Intellectual Product]
  1000   C1948050:Twice [Quantitative Concept]
Processing 00000000.tx.52: The CHCl3 phase from the three extractions was combined and extracted with 2 ml MeOH:HCl (1:1). 

Phrase: "The CHCl3 phase from the three extractions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205390:Phase [Temporal Concept]

Phrase: "was"

Phrase: "combined"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205195:Combined [Qualitative Concept]
   966 E C0336789:Combine [Manufactured Object]

Phrase: "and"

Phrase: "extracted with 2 ml MeOH"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0185115:Extracted [Therapeutic or Preventive Procedure]
   760   C0439526:/mL [Quantitative Concept]
   760   C3541890:EXTRACTED [Finding]
   726 E C2828366:Extract [Substance]

Phrase: ":"

Phrase: "HCl (1"

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.53: The final lipid extract was dried and resuspended in 15 l solvent (CHCl3:MeOH:10 mmol/l HCl [20:10:1]) and analyzed by thin-layer chromatography using oxalate-coated plates. 

Phrase: "The final lipid extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "was"

Phrase: "dried"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1512080:Dried [Qualitative Concept]
  1000   C2827485:Dried [Body Substance]
   966 E C0011682:Dry [Natural Phenomenon or Process]
   966 E C0205222:Dry [Qualitative Concept]

Phrase: "and"

Phrase: "resuspended in 15 l solvent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0037638:Solvent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(CHCl3"

Phrase: ":"

Phrase: "MeOH"

Phrase: ":"

Phrase: "10 mmol/l HCl [20"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C1532563:mmol/L [Quantitative Concept]
   804   C0439190:MMOLE [Quantitative Concept]

Phrase: ":"

Phrase: "10"

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "]"

Phrase: ")"

Phrase: "and"

Phrase: "analyzed by thin-layer chromatography"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C0008569:Thin Layer Chromatography [Laboratory Procedure]
   760   C0008550:Chromatography [Laboratory Procedure]
   760   C0205168:Thin [Qualitative Concept]
   760   C0934502:Layer [Body Part, Organ, or Organ Component]
   760   C0936012:Analyzed [Research Activity]
   760   C1522408:Layer [Qualitative Concept]
   760   C1561599:Layer [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "oxalate-coated plates."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1139930:plates [Medical Device]
   793 E C0005971:Plate [Medical Device]
   793 E C3537155:Plate [Manufactured Object]
Processing 00000000.tx.54: Approximately 30 g of each lipid standard in the same solvent was run simultaneously. 

Phrase: "Approximately 30 g of each lipid standard"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0439267:g% [Quantitative Concept]

Phrase: "in the same solvent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037638:Solvent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "was"

Phrase: "run"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0035953:run [Daily or Recreational Activity]
  1000   C0600140:run [Finding]
  1000   C1704688:Run [Functional Concept]
  1000   C2346414:Run [Finding]

Phrase: "simultaneously."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521115:simultaneously [Temporal Concept]
Processing 00000000.tx.55: The plates were developed with CHCl3:MeOH:H2O:NH4OH (90:90:20:7) and the labeled phospholipids quantified by phosphorimaging. 

Phrase: "The plates"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1139930:plates [Medical Device]
   966 E C0005971:Plate [Medical Device]
   966 E C3537155:Plate [Manufactured Object]

Phrase: "were"

Phrase: "developed with CHCl3"

Phrase: ":"

Phrase: "MeOH"

Phrase: ":"

Phrase: "H2O"

Phrase: ":"

Phrase: "NH4OH"

Phrase: "(90"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: ":"

Phrase: "90"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: ":"

Phrase: "20"

Phrase: ":"

Phrase: "7"

Phrase: ")"

Phrase: "and"

Phrase: "the labeled phospholipids"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0031676:Phospholipids [Biologically Active Substance,Lipid]
   827 E C0202177:Phospholipid [Laboratory Procedure]

Phrase: "quantified by phosphorimaging."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1709793:Quantify [Quantitative Concept]
Processing 00000000.tx.56: Lipid standards were visualized by iodine staining. 

Phrase: "Lipid standards"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0038137:standards [Intellectual Product]
   861   C0175675:Standards [Qualitative Concept]
   827 E C1442989:Standard [Qualitative Concept]
   827 E C2828392:Standard [Intellectual Product]

Phrase: "were"

Phrase: "visualized by iodine staining."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0021966:Iodine- [Inorganic Chemical]
   770   C0021968:Iodine [Element, Ion, or Isotope,Pharmacologic Substance]
   770   C0234621:Visualized [Functional Concept]
   770   C0487602:Staining [Laboratory Procedure]
   770   C0885449:iodine [Pharmacologic Substance]
   770   C1704680:Staining [Finding]
   770   C2348268:Iodine [Element, Ion, or Isotope]
Processing 00000000.tx.57: Electrophysiology. 

Phrase: "Electrophysiology."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013865:Electrophysiology [Biomedical Occupation or Discipline]
  1000   C1446476:Electrophysiology [Diagnostic Procedure]
Processing 00000000.tx.58: Resting membrane potential (RMP) of INS-1 cells was measured at room temperature using whole-cell or perforated patch-clamp recording with the Axopatch 1D amplifier and Clampex 8.1 (Axon, Foster City, CA). 

Phrase: "Resting membrane potential (RMP) of"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   909   C0025251:resting membrane potential [Cell Function]
           Membrane Potential
           potential resting
   909   C1704297:Resting Membrane Potential [Cell Function]
           Resting Potential
   770   C0025255:Membrane [Tissue]
   770   C0035253:Resting [Daily or Recreational Activity]
   770   C0596901:Membrane [Cell Component]
   770   C1512899:resting [Cell]
   770   C1706182:Membrane [Manufactured Object]
   770   C3245505:Potential [Qualitative Concept]
   737 E C1622890:ResT [Molecular Function]

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "measured at room temperature"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   770   C0005903:temperature [Organism Attribute]
   770   C0039476:*Temperature [Quantitative Concept]
   770   C0444706:Measured [Qualitative Concept]
   770   C1547703:Room [Spatial Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "whole-cell"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0007634:Cell [Cell]
   861   C0444667:Whole [Quantitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "perforated patch-clamp recording with the Axopatch 1D amplifier"

Phrase: "and"

Phrase: "Clampex 8.1"

Phrase: "(Axon,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004461:Axon [Cell Component]

Phrase: "Foster City,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0008848:City [Geographic Area]
   861   C0242298:foster [Daily or Recreational Activity]
   861   C0344349:foster [Family Group]
   861   C3262831:City [Clinical Attribute]

Phrase: "CA)."
Processing 00000000.tx.59: For measuring the RMP in 3 or 12 mmol/l glucose, cells were preincubated in indicated glucose concentrations for 3 h before recording. 

Phrase: "For measuring"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:measuring [Qualitative Concept]
  1000   C0449770:measuring [Quantitative Concept]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "the RMP in 3"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   833   C0025251:resting membrane potential [Cell Function]
           Membrane Potential
           potential resting
   833   C1704297:Resting Membrane Potential [Cell Function]
           Resting Potential
   753   C0025255:Membrane [Tissue]
   753   C0035253:Resting [Daily or Recreational Activity]
   753   C0596901:Membrane [Cell Component]
   753   C1512899:resting [Cell]
   753   C1706182:Membrane [Manufactured Object]
   753   C3245505:Potential [Qualitative Concept]
   719 E C1622890:ResT [Molecular Function]

Phrase: "or"

Phrase: "12 mmol/l glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "preincubated in indicated glucose concentrations"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   797   C0427743:concentrations glucose [Laboratory Procedure]
   797   C1287281:concentrations glucose [Laboratory or Test Result]
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0086045:Concentrations [Mental Process]
   760   C1444656:Indicated [Finding]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "for 3 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0041119:3 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "before recording."
Processing 00000000.tx.60: During recording, cells were bathed in Tyrodes solution consisting of (in mmol/l) 137 NaCl, 5.4 KCl, 1.8 CaCl2, 0.5 MgCl2, 5 HEPES, 3 NaHCO3, and 0.16 NaH2PO4, with glucose as specified in the figure legends. 

Phrase: "During recording,"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "bathed in Tyrodes solution"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   816   C0077548:Tyrode's solution [Clinical Drug]
   770   C0037633:Solution [Substance]
   770   C0150141:bathed [Therapeutic or Preventive Procedure]
   770   C0525069:Solution [Biomedical or Dental Material]

Phrase: "consisting"

Phrase: "of (in mmol/l) 137 NaCl,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332285:Of [Spatial Concept]

Phrase: "5.4 KCl,"

Phrase: "1.8 CaCl2,"

Phrase: "0.5 MgCl2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]
   734   C0444499:0/5 [Quantitative Concept]

Phrase: "5 HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "3 NaHCO3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0074722:NaHCO3 [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "0.16 NaH2PO4,"

Phrase: "with glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "as"

Phrase: "specified in the figure legends."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0205369:Specified [Qualitative Concept]
   726 E C1521902:Specify [Qualitative Concept]
   726   C2729544:Legend [Pharmacologic Substance]
Processing 00000000.tx.61: Pipette solution contained (in mmol/l) 140 KCl, 10 HEPES, 1 EGTA, 1 EDTA (referred to as K-INT), and 1 ATP plus 1 MgCl2 for experiments shown in Fig. 

Phrase: "Pipette"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0182301:Pipette [Medical Device]
  1000   C1706407:Pipette [Medical Device]

Phrase: "solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037633:Solution [Substance]
  1000   C0525069:Solution [Biomedical or Dental Material]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "("

Phrase: "in mmol/l) 140 KCl,"

Phrase: "10 HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "1 EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "1 EDTA ("
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "referred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205543:referred [Functional Concept]
  1000   C1691010:Referred [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "as"

Phrase: "K-INT"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0063789:INT [Organic Chemical]
   861   C3272375:INT [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "1 ATP plus 1 MgCl2 for experiments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0004221:ATP-MgCl2 [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   748   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.62: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.63: For measuring RMP at 12 mmol/l glucose using whole-cell patch-clamp recording, pipette solution contained (in mmol/l) 10 KCl, 130 Kgluconate, 10 HEPES, 1 EGTA, 3 MgCl2, and 5 ATP. 

Phrase: "For measuring RMP"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   923   C0025251:resting membrane potential [Cell Function]
           resting potential
           Membrane Potential
   923   C1704297:Resting Membrane Potential [Cell Function]
           Resting Potential
   812   C0025255:Membrane [Tissue]
   812   C0035253:Resting [Daily or Recreational Activity]
   812   C0596901:Membrane [Cell Component]
   812   C1512899:resting [Cell]
   812   C1706182:Membrane [Manufactured Object]
   812   C3245505:Potential [Qualitative Concept]
   779 E C1622890:ResT [Molecular Function]
   741 E C0205287:Membranous [Qualitative Concept]

Phrase: "at 12 mmol/l glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "whole-cell patch-clamp recording,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   911   C0242624:Whole-Cell Recording [Research Activity]

Phrase: "pipette solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037633:Solution [Substance]
   861   C0525069:Solution [Biomedical or Dental Material]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "("

Phrase: "in mmol/l) 10 KCl,"

Phrase: "130 Kgluconate,"

Phrase: "10 HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "1 EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "3 MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "5 ATP."
Processing 00000000.tx.64: The pH of all solutions was adjusted to 7.2. 

Phrase: "The pH of all solutions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0020283:[pH] [Quantitative Concept]
   760   C0450407:ph+ [Finding]
   760   C0450408:ph++ [Finding]
   760   C0450409:ph+++ [Finding]

Phrase: "was"

Phrase: "adjusted to 7.2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0456081:Adjusted [Functional Concept]
Processing 00000000.tx.65: To measure RMP without dialyzing internal cellular contents, the perforated patch was adopted. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "measure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]

Phrase: "RMP without dialyzing internal cellular contents,"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   800   C0025251:resting membrane potential [Cell Function]
           Membrane Potential
           potential resting
   800   C1704297:Resting Membrane Potential [Cell Function]
           Resting Potential
   767   C0007603:Cellular membrane [Cell Component]
   767   C3161472:Cellular Membrane [Cell Component]
   744   C0025255:Membrane [Tissue]
   744   C0035253:Resting [Daily or Recreational Activity]
   744   C0596901:Membrane [Cell Component]
   744   C1512899:resting [Cell]
   744   C1706182:Membrane [Manufactured Object]
   744   C3245505:Potential [Qualitative Concept]
   711 E C1622890:ResT [Molecular Function]

Phrase: "the perforated patch"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   861   C0332461:Patch [Finding]
   861   C0445403:Patch [Biomedical or Dental Material]
   861   C0991556:Patch [Medical Device]
   861   C1305400:Patch [Medical Device]
   861   C1533128:Patch [Biomedical or Dental Material]
   861   C1706366:{Patch} [Quantitative Concept]
   861   C1707974:Patch [Biomedical or Dental Material]
   789 E C0205413:Patchy [Qualitative Concept]

Phrase: "was"

Phrase: "adopted."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0425382:Adopted [Finding]
Processing 00000000.tx.66: The pipette resistance ranged between 3 and 5 M. 

Phrase: "The pipette resistance"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "ranged between 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1514721:Range [Quantitative Concept]
   756   C2348147:Range [Quantitative Concept]
   756   C3542016:Range [Intellectual Product]

Phrase: "and"

Phrase: "5 M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.67: The tip solution was first filled up to 0.5 mm with the clean pipette solution containing (in mmol/l) 76 K2SO4, 10 NaCl, 10 KCl, 1 MgCl2, and 5 HEPES, pH7.2; 

Phrase: "The tip solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037633:Solution [Substance]
   861   C0525069:Solution [Biomedical or Dental Material]

Phrase: "was"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "filled up to 0.5 mm"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0444499:0/5 [Quantitative Concept]
   753   C1708059:Filled [Activity]

Phrase: "with the clean pipette solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037633:Solution [Substance]
   827   C0525069:Solution [Biomedical or Dental Material]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "("

Phrase: "in mmol/l) 76 K2SO4,"

Phrase: "10 NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "10 KCl,"

Phrase: "1 MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "5 HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "pH7.2"

Phrase: ";"
Processing 00000000.tx.68: the pipette was then backfilled with the pipette solution containing 160250 g/ml amphotericin B (Sigma). 

Phrase: "the pipette"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0182301:Pipette [Medical Device]
  1000   C1706407:Pipette [Medical Device]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "backfilled with the pipette solution"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0037633:Solution [Substance]
   760   C0182301:Pipette [Medical Device]
   760   C0525069:Solution [Biomedical or Dental Material]
   760   C1706407:Pipette [Medical Device]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "160250 g/ml amphotericin B"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   840   C0002679:Amphotericin B [Antibiotic,Organic Chemical]
   804   C0085795:Amphotericin [Antibiotic,Carbohydrate,Pharmacologic Substance]
   784 E C0812405:Fungizone [Antibiotic,Organic Chemical]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.69: The stable perforated patch usually followed after 610 min of initial Giga seal. 

Phrase: "The stable perforated patch usually"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   812   C0332461:Patch [Finding]
   812   C0445403:Patch [Biomedical or Dental Material]
   812   C0991556:Patch [Medical Device]
   812   C1305400:Patch [Medical Device]
   812   C1533128:Patch [Biomedical or Dental Material]
   812   C1706366:{Patch} [Quantitative Concept]
   812   C1707974:Patch [Biomedical or Dental Material]
   741 E C0205413:Patchy [Qualitative Concept]

Phrase: "followed after 610 min of initial Giga seal."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   744   C0036492:Seal [Mammal]
   744   C0205265:Initial [Temporal Concept]
   744   C0325125:seal [Mammal]
   744   C0332283:followed [Temporal Concept]
   744   C0702093:/min [Temporal Concept]
   744   C1279901:Initial [Qualitative Concept]
   744   C1553027:Giga [Quantitative Concept]
   744   C1555582:Initial [Idea or Concept]
   744   C1704637:Seal [Manufactured Object]
   744   C1705685:INITIAL [Functional Concept]
   711 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.70: For ATP sensitivity measurement, inside-out patch-clamp recording was used as described previously (21). 

Phrase: "For ATP sensitivity measurement,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0242485:Measurement [Functional Concept]

Phrase: "inside-out patch-clamp recording"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.71: K-INT was used in both the bath and pipette solution. 

Phrase: "K-INT"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0063789:INT [Organic Chemical]
   861   C3272375:INT [Intellectual Product]

Phrase: "was"

Phrase: "used in both"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "the bath"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0150141:Bath [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "pipette solution."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037633:Solution [Substance]
   861   C0525069:Solution [Biomedical or Dental Material]
Processing 00000000.tx.72: All currents were measured at a membrane potential of 50 mV (pipette voltage = +50 mV). 

Phrase: "All currents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521116:currents [Temporal Concept]
   966 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "were"

Phrase: "measured at a membrane potential of 50 mV (pipette voltage"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   760   C0025251:Membrane Potential [Cell Function]
   739   C0025255:Membrane [Tissue]
   739   C0182301:Pipette [Medical Device]
   739   C0444706:Measured [Qualitative Concept]
   739   C0596901:Membrane [Cell Component]
   739   C0598352:Voltage [Quantitative Concept]
   739   C1706182:Membrane [Manufactured Object]
   739   C1706407:Pipette [Medical Device]
   739   C3245505:Potential [Qualitative Concept]
   739   C3541902:MEASURED [Diagnostic Procedure]
   706 E C0079809:Measure [Quantitative Concept]
   706 E C0242485:Measure [Functional Concept]

Phrase: "= +50 mV"

Phrase: ")."
Processing 00000000.tx.73: ATP dose-response curves were fitted by the Hill equation: Irel = 1/{1 + [(ATP)/Ki]H}, where Irel = current in [ATP]/current in 0 ATP, H = Hill coefficient, and K1/2 = [ATP] causing half-maximal inhibition. 

Phrase: "ATP dose-response curves"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   890   C0683162:dose-response curve [Quantitative Concept]
   812   C0178602:Dose [Quantitative Concept]
   812   C0869039:Dose [Quantitative Concept]
   812   C0871261:Response [Organism Attribute]
   812   C1114758:Dose # [Clinical Attribute]
   812   C1704632:Response [Finding]
   812   C1706817:Response [Intellectual Product]
   812   C2911692:Response [Mental Process]
   779   C0205134:Curve [Spatial Concept]

Phrase: "were"

Phrase: "fitted by the Hill equation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0036572:Fit [Sign or Symptom]
   760   C0424576:Fit [Finding]
   760   C0442532:Hill [Spatial Concept]
   760   C0552449:Equation [Conceptual Entity]
   760   C2349186:Fit [Activity]

Phrase: ":"

Phrase: "Irel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419336:IREL [Gene or Genome]

Phrase: "= 1/{1 +"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "["

Phrase: "(ATP"

Phrase: ")"

Phrase: "/Ki]H},"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "where Irel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419336:IREL [Gene or Genome]

Phrase: "= current in [ATP"

Phrase: "]/current in 0 ATP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0521116:Current [Temporal Concept]
   770   C1705970:Current [Natural Phenomenon or Process]

Phrase: "H = Hill coefficient,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0442532:Hill [Spatial Concept]
   827   C1707429:*Coefficient [Quantitative Concept]

Phrase: "and"

Phrase: "K1/2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1721009:K1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C3272787:K1 [Gene or Genome]

Phrase: "="

Phrase: "[ATP"

Phrase: "] causing half-maximal inhibition."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0021467:Inhibition [Mental Process]
   812   C0021469:Inhibition [Molecular Function]
   812   C1628982:% inhibition [Quantitative Concept]
   812   C3463820:Inhibition [Activity]
   741 E C0311403:Inhibited [Qualitative Concept]
Processing 00000000.tx.74: All data are presented as means  SE. 

Phrase: "All data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "presented as means  SE."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   770   C0449450:Presented [Idea or Concept]
   770   C1704970:Means [Conceptual Entity]
   737 E C0150312:Present [Quantitative Concept]
   737 E C0444504:Mean [Quantitative Concept]
   737 E C2347634:Mean [Quantitative Concept]
   737 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.75: View larger version (18K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(18K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.76: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.77: Effects of PIP2-insensitive mutants on INS-1 cell membrane potential (MP). 

Phrase: "Effects of PIP2-insensitive mutants"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on"

Phrase: "INS-1 cell membrane potential (MP)."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025251:Membrane Potential [Cell Function]
   812   C3245505:Potential [Qualitative Concept]
Processing 00000000.tx.78: A: INS-1 cell membrane potential was monitored by whole-cell recordings in current clamp mode. 

Phrase: "A"

Phrase: ":"

Phrase: "INS-1 cell membrane potential"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025251:Membrane Potential [Cell Function]
   812   C3245505:Potential [Qualitative Concept]

Phrase: "was"

Phrase: "monitored by whole-cell recordings"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   862   C0242624:Whole-Cell Recordings [Research Activity]
   760   C0007634:Cell [Cell]
   760   C0444667:Whole [Quantitative Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726   C0030695:monitor [Health Care Activity]
   726   C0150369:monitor [Health Care Activity]
   726   C0181904:Monitor [Medical Device]
   726   C0596972:Monitor [Medical Device]
   726   C1521743:Monitor [Professional or Occupational Group]
   726   C1704646:Monitor [Manufactured Object]

Phrase: "in current clamp mode."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1513371:Mode [Functional Concept]
   827   C1705738:Mode [Quantitative Concept]
   827   C2347637:Mode [Quantitative Concept]
   827   C2348146:Mode [Quantitative Concept]
Processing 00000000.tx.79: Cells were bathed in Tyrodes solution with 3 mmol/l glucose. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "bathed in Tyrodes solution"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   816   C0077548:Tyrode's solution [Clinical Drug]
   770   C0037633:Solution [Substance]
   770   C0150141:bathed [Therapeutic or Preventive Procedure]
   770   C0525069:Solution [Biomedical or Dental Material]

Phrase: "with 3 mmol/l glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.80: The pipette solution contained 1 mmol/l ATP and 1 mmol/l MgCl2. 

Phrase: "The pipette solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037633:Solution [Substance]
   861   C0525069:Solution [Biomedical or Dental Material]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "1 mmol/l ATP"

Phrase: "and"

Phrase: "1 mmol/l MgCl2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.81: Shown are representative recordings from uninfected cells or cells infected with wild type (WT), R176A, or the R206A-Kir6.2 virus. 

Phrase: "Shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "representative recordings from uninfected cells"

Phrase: "or"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "infected with wild type (WT), R176A,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0332307:Type [Qualitative Concept]
   760   C0439663:Infected [Functional Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "the R206A-Kir6.2 virus."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0042776:Virus [Virus]
   812   C0319157:virus [Virus]
Processing 00000000.tx.82: While the RMP of an uninfected cell or a cell infected with WT Kir6.2 virus hyperpolarized to a steady value of approximatley 70 mV soon after break-in (due to perfusion with 1 mmol/l MgATP, which is likely lower than the intracellular MgATP concentration before break-in), that of a cell infected with the R176A or R206A-Kir6.2 virus was much more depolarized (approximately 40 mV) and remained depolarized even after perfusion with pipette solution containing 1 mmol/l ATP. 

Phrase: "While"

Phrase: "the RMP of an uninfected cell"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   800   C0025251:resting membrane potential [Cell Function]
           Membrane Potential
           potential resting
   800   C1704297:Resting Membrane Potential [Cell Function]
           Resting Potential
   767   C0007603:Cell Membrane [Cell Component]
   767   C1512899:Resting Cell [Cell]
           resting
   767   C3161472:Cell Membrane [Cell Component]
   744   C0025255:Membrane [Tissue]
   744   C0035253:Resting [Daily or Recreational Activity]
   744   C0596901:Membrane [Cell Component]
   744   C1706182:Membrane [Manufactured Object]
   744   C3245505:Potential [Qualitative Concept]
   711 E C1622890:ResT [Molecular Function]

Phrase: "or"

Phrase: "a cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "infected with WT Kir6.2 virus"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C1416578:Kir6.2 [Gene or Genome]
   778   C1883559:Wild Type [Organism Attribute]
   774   C0441730:Type 2 [Classification]
   774   C0449572:Virus type [Intellectual Product]
   748   C0042776:Virus [Virus]
   748   C0319157:virus [Virus]
   748   C0332307:Type [Qualitative Concept]
   748   C0439663:Infected [Functional Concept]
   748   C0445392:Wild [Intellectual Product]
   748   C1547052:*Type [Quantitative Concept]

Phrase: "hyperpolarized to a steady value of approximatley 70 mV soon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0205361:Steady [Qualitative Concept]
   739   C1522609:Value [Quantitative Concept]

Phrase: "after"

Phrase: "break-in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1881704:BREAK [Phenomenon or Process]

Phrase: "("

Phrase: "due to perfusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031001:Perfusion [Therapeutic or Preventive Procedure]

Phrase: "with 1 mmol/l MgATP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0024471:MgATP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "which"

Phrase: "is"

Phrase: "likely lower than the intracellular MgATP concentration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0441994:Lower [Spatial Concept]
   748   C1548802:Lower [Body Location or Region]
   748   C2003888:Lower [Activity]

Phrase: "before break-in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1881704:BREAK [Phenomenon or Process]

Phrase: ")"

Phrase: ","

Phrase: "that of a cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0007634:Cell [Cell]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]

Phrase: "infected with the R176A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439663:Infected [Functional Concept]

Phrase: "or"

Phrase: "R206A-Kir6.2 virus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0042776:Virus [Virus]
   812   C0319157:virus [Virus]

Phrase: "was"

Phrase: "much more"

Phrase: "depolarized"

Phrase: "(approximately 40 mV)"

Phrase: "and"

Phrase: "remained"

Phrase: "depolarized"

Phrase: "even"

Phrase: "after"

Phrase: "perfusion with pipette solution"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0031001:Perfusion [Therapeutic or Preventive Procedure]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1 mmol/l ATP."
Processing 00000000.tx.83: The depolarized membrane potential could be hyperpolarized to the level close to that seen in uninfected cells by adding 250 mol/l KATP channel opener diazoxide to the bath solution. 

Phrase: "The depolarized membrane potential"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0025251:Membrane Potential [Cell Function]
   827   C0025255:Membrane [Tissue]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   827   C3245505:Potential [Qualitative Concept]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "could"

Phrase: "be"

Phrase: "hyperpolarized to the level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1547707:Level [Geographic Area]
   770   C2946261:Level [Pharmacologic Substance]

Phrase: "close to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0587267:Close [Functional Concept]

Phrase: "seen in uninfected cells"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C0205397:Seen [Qualitative Concept]
   770   C3282337:Cells [Cell]
   737 E C0042789:see [Organism Function]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1947903:See [Activity]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "by adding 250 mol/l KATP channel opener diazoxide"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   793   C0012022:Diazoxide [Organic Chemical,Pharmacologic Substance]
   737 E C0699324:Hyperstat [Organic Chemical,Pharmacologic Substance]

Phrase: "to the bath solution."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037633:Solution [Substance]
   861   C0525069:Solution [Biomedical or Dental Material]
Processing 00000000.tx.84: B: Averaged steady-state RMP using whole-cell patch clamp recording shown in A (n = 1839). 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "Averaged steady-state RMP"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   861   C0025251:resting membrane potential [Cell Function]
           resting potential
           Membrane Potential
   861   C1704297:Resting Membrane Potential [Cell Function]
           Resting Potential
   799   C0025255:Membrane [Tissue]
   799   C0035253:Resting [Daily or Recreational Activity]
   799   C0596901:Membrane [Cell Component]
   799   C1512899:resting [Cell]
   799   C1706182:Membrane [Manufactured Object]
   799   C3245505:Potential [Qualitative Concept]
   766 E C1622890:ResT [Molecular Function]
   727 E C0205287:Membranous [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "whole-cell patch clamp recording"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   911   C0242624:Whole-Cell Recording [Research Activity]

Phrase: "shown in A (n = 1839"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.85: C: Averaged membrane potential measured by perforated patch-clamp recording in uninfected cells or cells infected with the wild type or the R177A mutant Kir6.2 virus at 3 mmol/l glucose (n = 813). 

Phrase: "C"

Phrase: ":"

Phrase: "Averaged membrane potential"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0025251:Membrane Potential [Cell Function]
   827   C0025255:Membrane [Tissue]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   827   C3245505:Potential [Qualitative Concept]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "measured by perforated patch-clamp recording"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   790   C0920630:patch clamp [Research Activity]
   753   C0175721:Clamp [Medical Device]
   753   C0332461:Patch [Finding]
   753   C0444706:Measured [Qualitative Concept]
   753   C0445403:Patch [Biomedical or Dental Material]
   753   C0549099:Perforated [Finding]
   753   C0991556:Patch [Medical Device]
   753   C1305400:Patch [Medical Device]
   753   C1533128:Patch [Biomedical or Dental Material]
   753   C1705942:Clamp [Manufactured Object]
   753   C1706366:{Patch} [Quantitative Concept]
   753   C1707974:Patch [Biomedical or Dental Material]
   753   C1883710:Clamp [Functional Concept]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]

Phrase: "in uninfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "infected with the wild type"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0332307:Type [Qualitative Concept]
   760   C0439663:Infected [Functional Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "the R177A mutant Kir6.2 virus at 3 mmol/l glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0042776:Virus [Virus]
   738   C0319157:virus [Virus]

Phrase: "(n = 813"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.86: In both B and C, the error bar is the SE. 

Phrase: "In both B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "C,"

Phrase: "the error bar"

Phrase: "is"

Phrase: "the SE."
Processing 00000000.tx.87: *P < 0.001 using Students t test for paired data (the same statistical analysis was used in all subsequent figures).  

Phrase: "*P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Students t test for paired data"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   820   C1709451:Paired t-Test [Intellectual Product]
   753   C0022885:Test [Laboratory Procedure]
   753   C0038492:Students [Professional or Occupational Group]
   753   C0039593:Test [Functional Concept]
   753   C0392366:test [Intellectual Product]
   719 E C1551041:student [Idea or Concept]
   719 E C1552573:student [Intellectual Product]

Phrase: "("

Phrase: "the same statistical analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0871424:statistical analysis [Research Activity]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "used in all subsequent figures"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0332282:Subsequent [Temporal Concept]
   760   C1273517:used [Finding]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.88: Membrane capacitance measurements were carried out in the standard whole-cell configuration using an EPC-9 amplifier and Pulse software (version 8.4; Heka Elektronik, Lambrecht, Germany). 

Phrase: "Membrane capacitance measurements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0242485:measurements [Functional Concept]

Phrase: "were"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out in the standard whole-cell configuration"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   748   C0007634:Cell [Cell]
   748   C0439787:Out [Spatial Concept]
   748   C0444667:Whole [Quantitative Concept]
   748   C0449830:Configuration [Spatial Concept]
   748   C0849355:Out [Qualitative Concept]
   748   C1269647:Cell [Cell]
   748   C1442989:Standard [Qualitative Concept]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   748   C2827597:Configuration [Conceptual Entity]
   748   C2828392:Standard [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an EPC-9 amplifier"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0002684:amplifier [Manufactured Object]
   827   C1706099:Amplifier [Manufactured Object]

Phrase: "and"

Phrase: "Pulse software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(version 8.4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0333052:Version [Functional Concept]
   827   C2607870:Version [Spatial Concept]

Phrase: "; Heka Elektronik,"

Phrase: "Lambrecht,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")."
Processing 00000000.tx.89: Patch electrodes were made from borosilicate glass capillaries, coated with dental wax (Kerr, Romulus, MI) at the tips, and fire polished. 

Phrase: "Patch electrodes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013812:Electrodes [Medical Device]
   827 E C1705652:Electrode [Medical Device]

Phrase: "were"

Phrase: "made from borosilicate glass capillaries,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0006901:Capillaries [Body Part, Organ, or Organ Component]
   760   C0017596:Glass [Manufactured Object]
   760   C0935624:Capillaries [Body Part, Organ, or Organ Component]
   760   C1947936:Glass [Medical Device]
   726 E C1280521:Capillary [Body Part, Organ, or Organ Component]
   726   C1881534:Make [Functional Concept]

Phrase: "coated with dental wax"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0180365:Dental wax [Biomedical or Dental Material]
   770   C0043076:wax [Biologically Active Substance,Biomedical or Dental Material,Lipid]
   770   C0226984:Dental [Qualitative Concept]
   770   C0740486:Wax [Body Substance]
   770   C1522408:Coated [Qualitative Concept]
   737 E C0453946:Coat [Manufactured Object]
   737 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "(Kerr,"

Phrase: "Romulus,"

Phrase: "MI) at the tips,"

Phrase: "and"

Phrase: "fire"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0016141:Fire [Phenomenon or Process]
  1000   C0700614:Fire [Natural Phenomenon or Process]
  1000   C0702194:Fire [Human-caused Phenomenon or Process]
  1000   C1880775:FIRE [Event]

Phrase: "polished."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220896:polished [Population Group]
Processing 00000000.tx.90: The cells were constantly perfused with prewarmed extracellular solution consisting of (in mmol/l) 138 NaCl, 5.6 KCl, 1.2 MgCl2, 2.6 CaCl2, and 5 HEPES (pH 7.4 with NaOH). 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "constantly"

Phrase: "perfused with prewarmed extracellular solution"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0037633:Solution [Substance]
   760   C0521119:Extracellular [Cell Component]
   760   C0525069:Solution [Biomedical or Dental Material]
   760   C1441704:Prewarmed [Laboratory Procedure]
   726   C1549542:Perfuse [Functional Concept]

Phrase: "consisting"

Phrase: "of (in mmol/l) 138 NaCl,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332285:Of [Spatial Concept]

Phrase: "5.6 KCl,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0442749:5 6 [Finding]

Phrase: "1.2 MgCl2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]
   734   C0580272:1/2 [Intellectual Product]
   734   C1519043:1-2 [Research Activity]

Phrase: "2.6 CaCl2,"

Phrase: "and"

Phrase: "5 HEPES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(pH 7.4 with NaOH"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1882074:pH 7 [Qualitative Concept]
   797   C2678549:PH-4 [Gene or Genome]
   760   C0020283:[pH] [Quantitative Concept]
   760   C0450407:ph+ [Finding]
   760   C0450408:ph++ [Finding]
   760   C0450409:ph+++ [Finding]

Phrase: ")."
Processing 00000000.tx.91: The pipette solution contained (in mmol/l) 125 CsMeSO, 25 CsCl, 10 NaCl, 1 MgCl2, 10 HEPES, 0.05 EGTA, 3 Mg ATP, and 0.01 GTP, pH 7.2. 

Phrase: "The pipette solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037633:Solution [Substance]
   861   C0525069:Solution [Biomedical or Dental Material]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "("

Phrase: "in mmol/l) 125 CsMeSO,"

Phrase: "25 CsCl,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0055134:CsCl [Inorganic Chemical,Pharmacologic Substance]

Phrase: "10 NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "1 MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "10 HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "0.05 EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "3 Mg ATP,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0439269:mg% [Quantitative Concept]
   827   C1960952:mg % [Quantitative Concept]
   827   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and"

Phrase: "0.01 GTP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "pH 7.2."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]
Processing 00000000.tx.92: The temperature close to the cell was 3234C. 

Phrase: "The temperature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005903:temperature [Organism Attribute]
  1000   C0039476:*Temperature [Quantitative Concept]

Phrase: "close to the cell"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0007634:Cell [Cell]
   770   C0587267:Close [Functional Concept]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "3234C."
Processing 00000000.tx.93: Exocytosis was elicited by a train of six (at 1 Hz) 300-ms voltage-clamp depolarization from 70 mV to 0 and detected as changes in cell capacitance estimated by the Lindau-Neher technique ("Sine + DC" feature of the lock-in software module). 

Phrase: "Exocytosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015283:Exocytosis [Cell Function]

Phrase: "was"

Phrase: "elicited by a train of six"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0449265:Elicited by [Qualitative Concept]
           elicited
   753   C0205452:Six [Quantitative Concept]
   753   C0336809:Train [Manufactured Object]
   753   C1552514:Train [Manufactured Object]

Phrase: "(at 1 Hz) 300-ms voltage-clamp depolarization"

Phrase: "from 70 mV"

Phrase: "to 0"

Phrase: "and"

Phrase: "detected as changes in cell capacitance"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   753   C0007634:Cell [Cell]
   753   C0242264:capacitance [Quantitative Concept]
   753   C0392747:changes [Functional Concept]
   753   C0442726:Detected [Finding]
   753   C0443172:changes [Quantitative Concept]
   753   C1269647:Cell [Cell]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "estimated by the Lindau-Neher technique"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449851:Technique [Functional Concept]
   753   C0750572:Estimated [Quantitative Concept]

Phrase: "(""Sine + DC"" feature of the lock-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C1521970:Feature [Qualitative Concept]
   753   C1706388:Feature [Conceptual Entity]
   753   C2346469:Feature [Qualitative Concept]
   753   C2348519:Feature [Qualitative Concept]

Phrase: "in software module"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1709061:Module [Conceptual Entity]
   761 E C1031041:Modulus [Eukaryote]

Phrase: ")."
Processing 00000000.tx.94: The amplitude of the sine wave was 20 mV, and the frequency set as 500 Hz. 

Phrase: "The amplitude of the sine wave"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0678555:wave amplitude [Natural Phenomenon or Process]
   753   C2346753:Amplitude [Spatial Concept]

Phrase: "was"

Phrase: "20 mV,"

Phrase: "and"

Phrase: "the frequency"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0376249:frequency [Quantitative Concept]
  1000   C0439603:Frequency [Temporal Concept]
  1000   C0871396:Frequency [Quantitative Concept]
  1000   C1561548:Frequency [Qualitative Concept]
  1000   C1705502:Frequency [Quantitative Concept]
   928 E C0332183:Frequent [Temporal Concept]

Phrase: "set as 500 Hz."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0036849:Set [Mental Process]
   770   C0439482:Hz [Quantitative Concept]
   770   C1442518:Set [Functional Concept]
   770   C1705195:Set [Conceptual Entity]
Processing 00000000.tx.95: Insulin secretion assay. 

Phrase: "Insulin secretion assay."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]
   734   C1256369:insulin secretion [Cell Function]
Processing 00000000.tx.96: INS-1 cells were seeded in 24-well tissue culture plates at 5 x 105/well, cultured for 24 h, and infected with viruses as described above. 

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "seeded in 24-well tissue culture plates"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   778   C0040284:Tissue culture [Laboratory Procedure]
   778   C0180454:culture plates [Medical Device]
   748   C0010453:Culture [Idea or Concept]
   748   C0040300:Tissue [Tissue]
   748   C0205170:Well [Qualitative Concept]
   748   C0220814:culture [Functional Concept]
   748   C0430400:Culture [Laboratory Procedure]
   748   C1139930:plates [Medical Device]
   748   C1547928:Tissue [Intellectual Product]
   748   C2242979:Culture [Laboratory Procedure]
   748   C3146287:Well [Manufactured Object]
   714 E C0005971:Plate [Medical Device]
   714   C0036563:Seed [Plant]
   714   C1705192:Seed [Laboratory Procedure]
   714   C1882540:{Seed} [Quantitative Concept]
   714   C2346495:Seed [Conceptual Entity]
   714 E C3537155:Plate [Manufactured Object]

Phrase: "at 5 x 105/well,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0205170:Well [Qualitative Concept]
   812   C0439084:>5 [Quantitative Concept]
   812   C0728893:+5 [Quantitative Concept]
   812   C3146287:Well [Manufactured Object]

Phrase: "cultured for 24 h,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "infected with viruses"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0042776:Viruses [Virus]
   790   C0439663:Infected [Functional Concept]
   790   C0521026:viruses [Functional Concept]
   756 E C0319157:virus [Virus]

Phrase: "as described above."
Processing 00000000.tx.97: Twenty-four hours postinfection, the culture medium was replaced by RPMI-1640 with 5 mmol/l glucose and cells incubated for at least 18 h. 

Phrase: "Twenty-four hours"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439227:hours [Temporal Concept]
   793 E C0564385:/hour [Quantitative Concept]

Phrase: "postinfection,"

Phrase: "the culture medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C2242979:Culture [Laboratory Procedure]
   861   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "replaced by RPMI-1640"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C1299987:Replaced by [Functional Concept]
           replaced
   770   C0559956:Replaced [Functional Concept]
   737 E C1554078:Replace [Idea or Concept]

Phrase: "with 5 mmol/l glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   708   C2348935:.5 L [Quantitative Concept]

Phrase: "and"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "incubated for"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1439852:Incubated [Laboratory Procedure]

Phrase: "at least 18 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.98: Insulin secretion was assayed in HEPES balanced salt solution (HBSS) consisting of (in mmol/l) 114 NaCl, 4.7 KCl, 1 MgCl2, 1.2 KH2PO4, 1.16 MgSO4, 20 HEPES, 2.5 CaCl2, 25.5 NaHCO3, and 0.2% BSA, pH 7.2 (22). 

Phrase: "Insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "assayed in HEPES balanced salt solution (HBSS)"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   833   C0543134:Balanced salt solution [Inorganic Chemical,Pharmacologic Substance]
   773   C0598357:balance salt [Organism Function]
   753   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0036140:Salt [Chemical Viewed Structurally]
   753   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   753   C0037633:Solution [Substance]
   753   C0205415:Balanced [Functional Concept]
   753   C0206136:Salt [Food,Inorganic Chemical]
   753   C0525069:Solution [Biomedical or Dental Material]
   719   C0005507:Assay [Laboratory Procedure]
   719 E C0014653:Balance [Organism Function]
   719   C0243073:assay [Qualitative Concept]
   719 E C0560184:Balance [Finding]
   719   C1510438:Assay [Laboratory Procedure]

Phrase: "consisting"

Phrase: "of (in mmol/l) 114 NaCl,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332285:Of [Spatial Concept]

Phrase: "4.7 KCl,"

Phrase: "1 MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "1.2 KH2PO4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0580272:1/2 [Intellectual Product]
   734   C1519043:1-2 [Research Activity]

Phrase: "1.16 MgSO4,"

Phrase: "20 HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "2.5 CaCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0450346:2 5 [Quantitative Concept]

Phrase: "25.5 NaHCO3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0074722:NaHCO3 [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "0.2% BSA,"

Phrase: "pH 7.2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.99: Cells were washed twice with prewarmed (37C) HBSS buffer with 3 mmol/l glucose followed by 2-h incubation in the same buffer before stimulation with 0.8 ml/well prewarmed HBSS buffer containing 3 or 12 mmol/l glucose for 2 h. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice with prewarmed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1441704:Prewarmed [Laboratory Procedure]
   790   C1720725:Twice [Intellectual Product]
   790   C1948050:Twice [Quantitative Concept]

Phrase: "(37C"

Phrase: ")"

Phrase: "HBSS buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   717   C0543134:Balanced salt solution [Inorganic Chemical,Pharmacologic Substance]

Phrase: "with 3 mmol/l glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "followed by 2-h incubation"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0332283:Followed by [Temporal Concept]
           followed
   797   C0011744:h 2 [Element, Ion, or Isotope]
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441932:H+ [Classification]
   760   C0564385:/h [Quantitative Concept]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "in the same buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "before stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1292856:Stimulation [Therapeutic or Preventive Procedure]
  1000   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "with 0.8 ml/well"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205170:Well [Qualitative Concept]
   812   C0439526:/mL [Quantitative Concept]
   812   C3146287:Well [Manufactured Object]

Phrase: "prewarmed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441704:Prewarmed [Laboratory Procedure]

Phrase: "HBSS buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   717   C0543134:Balanced salt solution [Inorganic Chemical,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "or"

Phrase: "12 mmol/l glucose for 2 h."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.100: The medium was harvested and insulin content determined using Immunochem coated-tube insulin radioimmunoassay from ICN Pharmaceuticals (Costa Mesa, CA). 

Phrase: "The medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "harvested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]

Phrase: "and"

Phrase: "insulin content"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Immunochem"

Phrase: "coated-"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1522408:Coated [Qualitative Concept]
   966 E C0453946:Coat [Manufactured Object]
   966 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "tube insulin radioimmunoassay from ICN Pharmaceuticals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0034580:Radioimmunoassay [Laboratory Procedure]

Phrase: "(Costa Mesa,"

Phrase: "CA)."
Processing 00000000.tx.101: Insulin release in different concentrations of glucose was normalized to that observed at 3 mmol/l glucose and expressed as fold increase.  

Phrase: "Insulin release in different concentrations of glucose"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   774   C1719133:Glucose/Insulin [Quantitative Concept]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0030685:Release [Health Care Activity]
   748   C0391871:Release [Functional Concept]
   748   C0439180:% release [Quantitative Concept]
   748   C0680255:release [Health Care Activity]
   748   C1283071:Release [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "normalized to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1882115:Normalized [Research Activity]

Phrase: "observed at 3 mmol/l glucose"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1532563:mmol/L [Quantitative Concept]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0439190:MMOLE [Quantitative Concept]
   753   C1441672:Observed [Functional Concept]

Phrase: "and"

Phrase: "expressed as fold increase."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332462:Fold [Spatial Concept]
   770   C0442805:Increase [Functional Concept]
   770   C1880834:FOLD [Phenomenon or Process]
Processing 00000000.tx.102: RESULTS TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Disruption of KATP channelPIP2 interactions in INS-1 cells results in depolarized membrane potential and increased basal level insulin secretion. 

Phrase: "RESULTS TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Disruption of KATP channelPIP2 interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332453:Disruption [Functional Concept]

Phrase: "in"

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "results in depolarized membrane potential"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0025251:Membrane Potential [Cell Function]
   760   C0025255:Membrane [Tissue]
   760   C0596901:Membrane [Cell Component]
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C1706182:Membrane [Manufactured Object]
   760   C2825142:Result [Finding]
   760   C3245505:Potential [Qualitative Concept]

Phrase: "and"

Phrase: "increased basal level insulin secretion."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   911   C1372360:Increased Insulin Secretion [Organ or Tissue Function]
   875   C0020459:increased insulin [Disease or Syndrome]
   853   C0650607:Basal insulin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   840   C0428405:level insulin [Laboratory or Test Result]
   840   C1256369:insulin secretion [Cell Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0036536:secretion [Biologic Function]
   804   C0036537:Secretion [Body Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.103: PIP2 exerts its effect on KATP channel gating largely via the Kir6.2 subunit (11,12). 

Phrase: "PIP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0070798:PIP2 [Biologically Active Substance,Lipid,Organophosphorus Compound]
  1000   C3538724:PIP2 [Body Part, Organ, or Organ Component]

Phrase: "exerts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "its effect on KATP channel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "gating"

Phrase: "largely via the Kir6.2 subunit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1416578:Kir6.2 [Gene or Genome]
   753   C1711351:Subunit [Quantitative Concept]

Phrase: "(11,"

Phrase: "12"

Phrase: ")."
Processing 00000000.tx.104: There is evidence that binding of the negatively charged phosphate groups of membrane PIP2 to the cytoplasmic domain of Kir6.2 leads to channel opening (11,12,2427). 

Phrase: "There"

Phrase: "is"

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that binding of the negatively charged phosphate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]

Phrase: "groups of membrane PIP2"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   770   C0025255:Membrane [Tissue]
   770   C0070798:PIP2 [Biologically Active Substance,Lipid,Organophosphorus Compound]
   770   C0441833:Group [Idea or Concept]
   770   C0596901:Membrane [Cell Component]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1552839:groups [Idea or Concept]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]
   770   C1706182:Membrane [Manufactured Object]
   770   C3538724:PIP2 [Body Part, Organ, or Organ Component]

Phrase: "to the cytoplasmic domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1511625:Cytoplasmic Domain [Cell Component]
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "of Kir6.2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416578:Kir6.2 [Gene or Genome]

Phrase: "leads"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
  1000   C0181586:leads [Medical Device]
  1000   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
  1000   C1522538:Lead [Functional Concept]
  1000   C2348269:Lead [Element, Ion, or Isotope]
  1000   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "channel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439799:Channel [Spatial Concept]
  1000   C1706095:Channel [Conceptual Entity]

Phrase: "opening"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0175566:Opening [Spatial Concept]
  1000   C1882151:Opening [Spatial Concept]

Phrase: "(11,"

Phrase: "12,"

Phrase: "2427"

Phrase: ")."
Processing 00000000.tx.105: Several positively charged Kir6.2 residues critical for channel gating by PIP2 have been identified, including R176, R177, and R206 (27,11). 

Phrase: "Several positively charged Kir6.2 residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   766   C1709915:Residue [Conceptual Entity]
   766   C1882936:RESIDUE [Phenomenon or Process]
   716 E C1609982:Residual [Qualitative Concept]

Phrase: "critical for channel gating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1511545:Critical [Qualitative Concept]

Phrase: "by PIP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0070798:PIP2 [Biologically Active Substance,Lipid,Organophosphorus Compound]
  1000   C3538724:PIP2 [Body Part, Organ, or Organ Component]

Phrase: "have"

Phrase: "been"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: ","

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "R176,"

Phrase: "R177,"

Phrase: "and"

Phrase: "R206"

Phrase: "(27,"

Phrase: "11"

Phrase: ")."
Processing 00000000.tx.106: Mutation of these residues to the neutral amino acid alanine either reduces or abolishes channel activity in inside-out membrane patches in the absence of inhibitory ATP (these mutants are referred to as PIP2-insensitive mutants hereinafter). 

Phrase: "Mutation of these residues"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0026882:Mutation [Genetic Function]
   770   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "to the neutral amino acid alanine either"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0001898:Alanine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0301715:Neutral amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "reduces"

Phrase: "or"

Phrase: "abolishes"

Phrase: "channel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439799:Channel [Spatial Concept]
  1000   C1706095:Channel [Conceptual Entity]

Phrase: "activity in inside-out membrane"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0596897:membrane activity [Cell Function]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "patches in the absence of inhibitory ATP"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   748   C0332197:absence [Quantitative Concept]
   748   C0332461:Patch [Finding]
   748   C0445403:Patch [Biomedical or Dental Material]
   748   C0991556:Patch [Medical Device]
   748   C0994894:Patches [Medical Device]
   748   C1305400:Patch [Medical Device]
   748   C1533128:Patch [Biomedical or Dental Material]
   748   C1689985:Absence [Anatomical Abnormality]
   748   C1706366:{Patch} [Quantitative Concept]
   748   C1707974:Patch [Biomedical or Dental Material]
   748   C3463820:Inhibitory [Activity]

Phrase: "("

Phrase: "these mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "referred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205543:referred [Functional Concept]
  1000   C1691010:Referred [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "as"

Phrase: "PIP2-insensitive mutants hereinafter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: ")."
Processing 00000000.tx.107: To elucidate the role of KATP channelPIP2 interactions in -cell excitability and insulin secretion, we sought to disrupt channel-PIP2 interactions by overexpressing PIP2-insensitive Kir6.2 mutants in the rat -cell line INS-1 clone 832/13, which exhibits robust insulin response to glucose stimulation (22). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "elucidate"

Phrase: "the role of KATP channelPIP2 interactions in -cell excitability"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "insulin secretion,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "we"

Phrase: "sought"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "disrupt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "channel-PIP2 interactions by overexpressing PIP2-insensitive Kir6.2 mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   706   C1704675:Interaction [Functional Concept]

Phrase: "in the rat -cell line"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1514733:Rat Cell Line [Cell]
   901   C0007600:Cell Line [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:Line [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "INS-1 clone 832/13,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   812   C0009013:Clone [Cell]
   812   C1522642:Clone [Tissue]
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]
   741 E C1704387:Clonal [Qualitative Concept]
   712 E C0796368:clonality [Diagnostic Procedure]

Phrase: "which"

Phrase: "exhibits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "robust insulin response to glucose stimulation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.108: In COS cells, coexpression of the PIP2-insensitive Kir6.2 mutant with wild-type Kir6.2 (WT Kir6.2) at 1:1 molar ratio in the presence of SUR1 led to a >50% reduction in total KATP currents (data not shown). 

Phrase: "In COS cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0376702:COS Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "coexpression of the PIP2-insensitive Kir6.2 mutant"

Phrase: "with wild-type Kir6.2 (WT Kir6.2) at 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   876   C0441729:Type 1 [Classification]
   858   C1416589:Kir6.1 [Gene or Genome]

Phrase: ":"

Phrase: "1 molar ratio in the presence of SUR1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C2825550:Molar Ratio [Quantitative Concept]
   739   C0456603:Ratio [Quantitative Concept]
   739   C1547037:Ratio [Intellectual Product]

Phrase: "led to a >50% reduction"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]
   760   C1708698:LED [Manufactured Object]
   726 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   726 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   726 E C1522538:Lead [Functional Concept]
   726 E C2348269:Lead [Element, Ion, or Isotope]
   726 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in total KATP currents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0521116:currents [Temporal Concept]
   793 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.109: Mutant Kir6.2 expressed in INS-1 cells is therefore expected to compete with endogenous WT Kir6.2 for incorporation into the channel complex and reduces overall channel sensitivity to PIP2. 

Phrase: "Mutant Kir6.2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1416578:Kir6.2 [Gene or Genome]
   827   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "expressed in"

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "therefore"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compete with endogenous WT Kir6.2"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C1416578:Kir6.2 [Gene or Genome]
   778   C1883559:Wild Type [Organism Attribute]
   774   C0441730:Type 2 [Classification]
   748   C0205227:Endogenous [Functional Concept]
   748   C0332307:Type [Qualitative Concept]
   748   C0445392:Wild [Intellectual Product]
   748   C1547052:*Type [Quantitative Concept]

Phrase: "for incorporation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243126:incorporation [Functional Concept]

Phrase: "into the channel complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "reduces"

Phrase: "overall"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282416:Overall [Intellectual Product]
  1000   C1561607:Overall [Qualitative Concept]

Phrase: "channel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439799:Channel [Spatial Concept]
  1000   C1706095:Channel [Conceptual Entity]

Phrase: "sensitivity to PIP2."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   847   C0332324:Sensitive to [Functional Concept]
       E   Sensitive
   790   C0036667:Sensitivity [Quantitative Concept]
   790   C0312418:Sensitivity [Mental Process]
   790   C0427965:Sensitivity [Finding]
   790   C1511883:Sensitivity [Quantitative Concept]
   790   C1522640:Sensitivity [Qualitative Concept]
   790   C2346484:SENSITIVITY [Phenomenon or Process]
   790   C2349185:Sensitivity [Qualitative Concept]
   718 E C1550474:sensitive [Idea or Concept]
Processing 00000000.tx.110: Reduced KATP channel activity is in turn expected to cause membrane depolarization even in the absence of glucose stimulation (28). 

Phrase: "Reduced KATP channel activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   902   C0086439:Reduced Activity [Sign or Symptom]
   861   C1153410:channel activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "in turn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0541749:turn [Finding]
   861   C1709743:Turn [Spatial Concept]

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "membrane depolarization even in the absence of glucose stimulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   764   C1816453:membrane depolarization [Cell Function]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.111: We have chosen the recombinant adenovirus approach for expressing mutant Kir6.2 in INS-1 cells because it is much more efficient than conventional transfection methods (29); 

Phrase: "We"

Phrase: "have"

Phrase: "chosen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707391:Chosen [Activity]

Phrase: "the recombinant adenovirus approach for expressing mutant Kir6.2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0449445:Approach [Spatial Concept]

Phrase: "in"

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "because"

Phrase: "it"

Phrase: "is"

Phrase: "much more efficient than conventional transfection methods"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442799:Efficient [Qualitative Concept]

Phrase: "(29"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.112: infection with adenoviruses carrying the green fluorescence protein (GFP) gene yielded >95% GFP-positive cells 12 h after infection. 

Phrase: "infection with adenoviruses"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   841   C0001486:Adenovirus infection [Disease or Syndrome]
   790   C0009450:Infection, NOS [Disease or Syndrome]
   718 E C0439663:Infected [Functional Concept]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "the green fluorescence protein (GFP) gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0017337:Gene [Gene or Genome]
   733   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "yielded"

Phrase: ">95% GFP-positive cells 12 h after infection."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0033727:H+ [Element, Ion, or Isotope]
   739   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0441932:H+ [Classification]
   739   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.113: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.114: 1, in cells expressing the R176A, R177A, or the R206A Kir6.2 mutant, the RMP (as assessed by whole-cell patch-clamp recording with pipette solution containing 1 mmol/l ATP and 1 mmol/l MgCl2) in low (3 mmol/l) glucose was indeed significantly more depolarized (approximately 35 to 40 mV) than that observed in uninfected control cells (approximately 72 mV) or cells expressing either GFP (approximately 74 mV) or WT Kir6.2 (approximately 69 mV). 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "the R176A,"

Phrase: "R177A,"

Phrase: "or"

Phrase: "the R206A Kir6.2 mutant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "the RMP"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
  1000   C0025251:resting membrane potential [Cell Function]
           resting potential
           Membrane Potential
  1000   C1704297:Resting Membrane Potential [Cell Function]
           Resting Potential
   827   C0025255:Membrane [Tissue]
   827   C0035253:Resting [Daily or Recreational Activity]
   827   C0596901:Membrane [Cell Component]
   827   C1512899:resting [Cell]
   827   C1706182:Membrane [Manufactured Object]
   827   C3245505:Potential [Qualitative Concept]
   793 E C1622890:ResT [Molecular Function]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "("

Phrase: "as"

Phrase: "assessed by whole-cell patch-clamp recording"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   804   C0242624:Whole-Cell Recording [Research Activity]
   778   C0920630:patch clamp [Research Activity]
   748   C0007634:Cell [Cell]
   748   C0175721:Clamp [Medical Device]
   748   C0332461:Patch [Finding]
   748   C0444667:Whole [Quantitative Concept]
   748   C0445403:Patch [Biomedical or Dental Material]
   748   C0991556:Patch [Medical Device]
   748   C1269647:Cell [Cell]
   748   C1305400:Patch [Medical Device]
   748   C1516048:Assessed [Activity]
   748   C1533128:Patch [Biomedical or Dental Material]
   748   C1704653:Cell [Medical Device]
   748   C1705942:Clamp [Manufactured Object]
   748   C1706366:{Patch} [Quantitative Concept]
   748   C1707974:Patch [Biomedical or Dental Material]
   748   C1883710:Clamp [Functional Concept]
   748   C1948049:Cell [Spatial Concept]

Phrase: "with pipette solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037633:Solution [Substance]
   861   C0525069:Solution [Biomedical or Dental Material]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1 mmol/l ATP"

Phrase: "and"

Phrase: "1 mmol/l MgCl2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "in low"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205251:low [Qualitative Concept]
  1000   C1299352:Low [Qualitative Concept]
  1000   C1550472:low [Idea or Concept]

Phrase: "(3 mmol/l) glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "was"

Phrase: "indeed significantly more"

Phrase: "depolarized"

Phrase: "(approximately 35 to 40 mV)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332232:Approximately [Qualitative Concept]
   760   C0439509:/40 [Temporal Concept]

Phrase: "than that"

Phrase: "observed in uninfected control cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   760   C0007634:Cells [Cell]
   760   C0243148:control [Qualitative Concept]
   760   C1441672:Observed [Functional Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "(approximately 72 mV)"

Phrase: "or"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "either GFP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   899   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(approximately 74 mV)"

Phrase: "or"

Phrase: "WT Kir6.2"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   875   C0441730:Type 2 [Classification]
   861   C1416578:Kir6.2 [Gene or Genome]
   861   C1883559:Wild Type [Organism Attribute]
   812   C0332307:Type [Qualitative Concept]
   812   C0445392:Wild [Intellectual Product]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "(approximately 69 mV"

Phrase: ")."
Processing 00000000.tx.115: To further validate the membrane potential obtained using whole-cell patch-clamp recording, we also measured membrane potential using perforated patch-clamp recording, a procedure that better preserves the intracellular milieu. 

Phrase: "To further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "validate"

Phrase: "the membrane potential"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0025251:Membrane Potential [Cell Function]
   861   C0025255:Membrane [Tissue]
   861   C0596901:Membrane [Cell Component]
   861   C1706182:Membrane [Manufactured Object]
   861   C3245505:Potential [Qualitative Concept]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "whole-cell patch-clamp recording,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   911   C0242624:Whole-Cell Recording [Research Activity]

Phrase: "we also measured membrane potential"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0025251:Membrane Potential [Cell Function]
   812   C0025255:Membrane [Tissue]
   812   C0596901:Membrane [Cell Component]
   812   C1706182:Membrane [Manufactured Object]
   812   C3245505:Potential [Qualitative Concept]
   741 E C0205287:Membranous [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "perforated patch-clamp recording,"

Phrase: "a procedure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
  1000   C1948041:Procedure [Therapeutic or Preventive Procedure]
  1000   C2700391:Procedure [Activity]
  1000   C3274430:PROCEDURE [Health Care Activity]
  1000   C3538935:Procedure [Idea or Concept]
  1000   C3539779:Procedure [Intellectual Product]

Phrase: "that better"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332272:Better [Qualitative Concept]

Phrase: "preserves"

Phrase: "the intracellular milieu."
Processing 00000000.tx.116: A substantially more depolarized membrane potential was again observed in cells infected with the PIP2-insenstive R177A Kir6.2 mutant compared with uninfected cells or cells infected with WT Kir6.2 at low (3 mmol/l) glucose (Fig. 1C) but not at high (12 mmol/l) glucose (not shown). 

Phrase: "A substantially more depolarized membrane potential"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   840   C0025251:Membrane Potential [Cell Function]
   804   C0025255:Membrane [Tissue]
   804   C0596901:Membrane [Cell Component]
   804   C1706182:Membrane [Manufactured Object]
   804   C3245505:Potential [Qualitative Concept]
   733 E C0205287:Membranous [Qualitative Concept]

Phrase: "was"

Phrase: "again"

Phrase: "observed in cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C1441672:Observed [Functional Concept]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "infected with the PIP2-insenstive R177A Kir6.2 mutant"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C1416578:Kir6.2 [Gene or Genome]
   742   C0070798:PIP2 [Biologically Active Substance,Lipid,Organophosphorus Compound]
   742   C0439663:Infected [Functional Concept]
   742   C0596988:Mutant [Cell or Molecular Dysfunction]
   742   C3538724:PIP2 [Body Part, Organ, or Organ Component]

Phrase: "compared with uninfected cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C1707455:Compared [Activity]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "infected with WT Kir6.2"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1416578:Kir6.2 [Gene or Genome]
   790   C1883559:Wild Type [Organism Attribute]
   783   C0441730:Type 2 [Classification]
   753   C0332307:Type [Qualitative Concept]
   753   C0439663:Infected [Functional Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1547052:*Type [Quantitative Concept]

Phrase: "at low"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205251:low [Qualitative Concept]
  1000   C1299352:Low [Qualitative Concept]
  1000   C1550472:low [Idea or Concept]

Phrase: "(3 mmol/l) glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(Fig. 1C"

Phrase: ")"

Phrase: "but"

Phrase: "not at high"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205250:High [Qualitative Concept]
   790   C1299351:High [Qualitative Concept]
   790   C1518422:Not [Functional Concept]
   790   C2700149:HIGH [Intellectual Product]

Phrase: "(12 mmol/l) glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.117: Note that the membrane potential obtained using the perforated patch-clamp technique was 20 mV more depolarized than that obtained by whole-cell recording after dialysis with 1 mmol/l MgATP. 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "the membrane potential"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0025251:Membrane Potential [Cell Function]
   861   C0025255:Membrane [Tissue]
   861   C0596901:Membrane [Cell Component]
   861   C1706182:Membrane [Manufactured Object]
   861   C3245505:Potential [Qualitative Concept]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the perforated patch-clamp technique"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   923   C0242625:Technique, Patch-Clamp [Research Activity]
   861   C0920630:patch clamp [Research Activity]
   812   C0175721:Clamp [Medical Device]
   812   C0332461:Patch [Finding]
   812   C0445403:Patch [Biomedical or Dental Material]
   812   C0449851:Technique [Functional Concept]
   812   C0991556:Patch [Medical Device]
   812   C1305400:Patch [Medical Device]
   812   C1533128:Patch [Biomedical or Dental Material]
   812   C1705942:Clamp [Manufactured Object]
   812   C1706366:{Patch} [Quantitative Concept]
   812   C1707974:Patch [Biomedical or Dental Material]
   812   C1883710:Clamp [Functional Concept]
   741 E C0205413:Patchy [Qualitative Concept]
   729 E C0025664:techniques [Intellectual Product]

Phrase: "was"

Phrase: "20 mV more"

Phrase: "depolarized than that"

Phrase: "obtained by whole-cell recording"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   862   C0242624:Whole-Cell Recording [Research Activity]
   760   C0007634:Cell [Cell]
   760   C0444667:Whole [Quantitative Concept]
   760   C1269647:Cell [Cell]
   760   C1301820:Obtained [Functional Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726 E C1706701:Obtain [Activity]

Phrase: "after dialysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0011945:Dialysis [Natural Phenomenon or Process]
  1000   C0011946:dialysis [Therapeutic or Preventive Procedure]
  1000   C0917873:dialysis [Therapeutic or Preventive Procedure]
  1000   C1059964:Dialysis [Eukaryote]

Phrase: "with 1 mmol/l MgATP."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0024471:MgATP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.118: The difference likely reflects the higher intracellular MgATP concentration in intact INS-1 cells. 

Phrase: "The difference likely"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1705241:*Difference [Quantitative Concept]
   861   C1705242:Difference [Qualitative Concept]
   789 E C0443199:Differential [Qualitative Concept]

Phrase: "reflects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "the higher intracellular MgATP concentration in intact"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0086045:Concentration [Mental Process]
   748   C1446561:Concentration [Quantitative Concept]

Phrase: "INS-1 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.119: The above results are consistent with the notion that KATP channelmembrane PIP2 interactions are necessary to sustain KATP channel activity and maintain the membrane potential at the resting hyperpolarized state in the absence of glucose stimulation. 

Phrase: "The above results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "are"

Phrase: "consistent with the notion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that KATP channelmembrane PIP2 interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1704675:Interaction [Functional Concept]

Phrase: "are"

Phrase: "necessary to"

Phrase: "sustain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443318:sustain [Functional Concept]
  1000   C2732140:Sustain [Organic Chemical,Pharmacologic Substance]

Phrase: "KATP channel activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1153410:channel activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "maintain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024501:Maintain [Activity]

Phrase: "the membrane potential at the resting hyperpolarized state"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   793   C0025251:resting membrane potential [Cell Function]
           Membrane Potential
           potential resting
   793   C1704297:Resting Membrane Potential [Cell Function]
           Resting Potential
   744   C0025255:Membrane [Tissue]
   744   C0596901:Membrane [Cell Component]
   744   C1706182:Membrane [Manufactured Object]
   744   C3245505:Potential [Qualitative Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of glucose stimulation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1948023:Stimulation [Natural Phenomenon or Process]
Processing 00000000.tx.120: The depolarized membrane potential in cells expressing mutant Kir6.2 could largely be hyperpolarized to the level seen in uninfected cells (R206A, for example) by adding the KATP channel opener diazoxide in the bath solution, demonstrating that the depolarized membrane potential is not due to adverse effects of virus infection or mutant Kir6.2 expression on the health of the cell. 

Phrase: "The depolarized membrane potential in cells"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0025251:Membrane Potential [Cell Function]
   783   C0007603:cells membrane [Cell Component]
   767 E C3161472:Cell Membrane [Cell Component]
   753   C0025255:Membrane [Tissue]
   753   C0596901:Membrane [Cell Component]
   753   C1706182:Membrane [Manufactured Object]
   753   C3245505:Potential [Qualitative Concept]

Phrase: "expressing"

Phrase: "mutant Kir6.2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1416578:Kir6.2 [Gene or Genome]
   827   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "could"

Phrase: "largely"

Phrase: "be"

Phrase: "hyperpolarized to the level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1547707:Level [Geographic Area]
   770   C2946261:Level [Pharmacologic Substance]

Phrase: "seen in uninfected cells"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C0205397:Seen [Qualitative Concept]
   770   C3282337:Cells [Cell]
   737 E C0042789:see [Organism Function]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1947903:See [Activity]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(R206A,"

Phrase: "for example"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: ")"

Phrase: "by adding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1883712:Add [Functional Concept]

Phrase: "the KATP channel opener diazoxide in the bath solution,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0012022:Diazoxide [Organic Chemical,Pharmacologic Substance]

Phrase: "demonstrating"

Phrase: "that"

Phrase: "the depolarized membrane potential"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0025251:Membrane Potential [Cell Function]
   827   C0025255:Membrane [Tissue]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   827   C3245505:Potential [Qualitative Concept]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "is"

Phrase: "not due to adverse effects of virus infection"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   770   C0001688:adverse effects [Functional Concept]
   770   C0042769:virus infection [Disease or Syndrome]
   770   C0678226:Due to [Functional Concept]
           due
   770   C0879626:Adverse effects [Pathologic Function]
   744   C0009450:Infection, NOS [Disease or Syndrome]
   744   C0042776:Virus [Virus]
   744   C0319157:virus [Virus]
   744   C1280500:effects [Qualitative Concept]
   744   C1518422:Not [Functional Concept]
   744   C3146286:Due [Idea or Concept]
   737 E C0559546:Adverse Effect [Finding]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "or"

Phrase: "mutant Kir6.2 expression on the health of the cell."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.121: Although PIP2-insenstive Kir6.2 mutants have been reported to render the channel less responsive to diazoxide (30,31), residual sensitivity of mutant channels to the channel opener as well as endogenous WT Kir6.2 subunits present in some channels may be sufficient to confer the diazoxide sensitivity we observed. 

Phrase: "Although"

Phrase: "PIP2-insenstive Kir6.2 mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "render"

Phrase: "the channel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439799:Channel [Spatial Concept]
  1000   C1706095:Channel [Conceptual Entity]

Phrase: "less responsive to diazoxide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205342:Responsive [Functional Concept]

Phrase: "(30,"

Phrase: "31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "residual sensitivity of mutant channels"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   781   C1547341:Channel sensitivity [Idea or Concept]
   760   C0036667:Sensitivity [Quantitative Concept]
   760   C0312418:Sensitivity [Mental Process]
   760   C0427965:Sensitivity [Finding]
   760   C1511883:Sensitivity [Quantitative Concept]
   760   C1522640:Sensitivity [Qualitative Concept]
   760   C2346484:SENSITIVITY [Phenomenon or Process]
   760   C2349185:Sensitivity [Qualitative Concept]

Phrase: "to the channel opener"

Phrase: "as well as"

Phrase: "endogenous WT Kir6.2 subunits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   766   C1711351:Subunit [Quantitative Concept]

Phrase: "present in some channels"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]
   737   C0439799:Channel [Spatial Concept]
   737   C1706095:Channel [Conceptual Entity]

Phrase: "may"

Phrase: "be"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "confer"

Phrase: "the diazoxide sensitivity"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0036667:Sensitivity [Quantitative Concept]
   861   C0312418:Sensitivity [Mental Process]
   861   C0427965:Sensitivity [Finding]
   861   C1511883:Sensitivity [Quantitative Concept]
   861   C1522640:Sensitivity [Qualitative Concept]
   861   C2346484:SENSITIVITY [Phenomenon or Process]
   861   C2349185:Sensitivity [Qualitative Concept]
   789 E C0332324:Sensitive [Functional Concept]
   789 E C1550474:sensitive [Idea or Concept]

Phrase: "we"

Phrase: "observed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]
Processing 00000000.tx.122: To ensure that the titer of each recombinant Kir6.2 adenovirus used for infection gives rise to similar protein expression level, we analyzed Kir6.2 protein level by immunoblotting. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "that"

Phrase: "the titer of each recombinant Kir6.2 adenovirus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0475208:Titer [Quantitative Concept]

Phrase: "used for infection"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0009450:Infection, NOS [Disease or Syndrome]
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]
   718 E C0439663:Infected [Functional Concept]

Phrase: "gives"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "rise to similar protein expression level,"

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "Kir6.2 protein level by immunoblotting."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0428479:Protein level [Laboratory or Test Result]
   783   C0456948:Level 2 [Intellectual Product]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.123: Furthermore, to confirm that the mutant Kir6.2 subunit is incorporated into the channel complex and expressed on the surface of INS-1 cells, we tagged one of the mutant R206A with a HA-epitope tag in the extracellular domain between amino acids 100 and 101 (HA-R206A-Kir6.2). 

Phrase: "Furthermore,"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "the mutant Kir6.2 subunit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1711351:Subunit [Quantitative Concept]

Phrase: "is"

Phrase: "incorporated into the channel complex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439799:Channel [Spatial Concept]
   760   C0439855:Complex [Qualitative Concept]
   760   C1704241:Complex [Chemical Viewed Structurally]
   760   C1706095:Channel [Conceptual Entity]

Phrase: "and"

Phrase: "expressed on the surface of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205148:Surface [Spatial Concept]

Phrase: "INS-1 cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "we"

Phrase: "tagged"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
  1000   C1708632:Tagged [Qualitative Concept]
   966 E C0037293:Tag [Neoplastic Process]
   966 E C0181496:Tag [Manufactured Object]
   966 E C1710492:TAG [Gene or Genome]

Phrase: "one of the mutant R206A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205447:One [Quantitative Concept]

Phrase: "with a HA-epitope tag"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0037293:Tag [Neoplastic Process]
   827   C0181496:Tag [Manufactured Object]
   827   C1710492:TAG [Gene or Genome]

Phrase: "in the extracellular domain"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1517050:Extracellular Domain [Spatial Concept]
   861   C0521119:Extracellular [Cell Component]
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "between amino acids 100"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "101"

Phrase: "(HA-R206A-Kir6.2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1416578:Kir6.2 [Gene or Genome]
   812   C0018909:Haemagglutinin, NOS [Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.124: This extracellular epitope tag allows for evaluation of surface expression of the mutant without permeabilizing the cell; 

Phrase: "This extracellular epitope tag"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0037293:Tag [Neoplastic Process]
   827   C0181496:Tag [Manufactured Object]
   827   C1710492:TAG [Gene or Genome]

Phrase: "allows for evaluation of surface expression of the mutant"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0185117:Expression [Therapeutic or Preventive Procedure]
   742   C0205148:Surface [Spatial Concept]
   742   C0220825:Evaluation [Functional Concept]
   742   C0596988:Mutant [Cell or Molecular Dysfunction]
   742   C0683607:allow [Social Behavior]
   742   C1261322:Evaluation [Health Care Activity]

Phrase: "without permeabilizing"

Phrase: "the cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.125: the HA-tag does not interfere with the function of the channel (data not shown). 

Phrase: "the HA-tag"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037293:Tag [Neoplastic Process]
   861   C0181496:Tag [Manufactured Object]
   861   C1710492:TAG [Gene or Genome]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "interfere with the function of the channel"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0031843:function [Physiologic Function]
   748   C0439799:Channel [Spatial Concept]
   748   C0521102:Interfere [Qualitative Concept]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1705273:Function [Intellectual Product]
   748   C1706095:Channel [Conceptual Entity]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.126: As Fig. 

Phrase: "As Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.127: 2A illustrates, the titer of each of the WT-, R176A-, R177A-, or HA-R206A-Kir6.2 viruses could be adjusted to obtain similar protein expression levels (approximately fivefold of endogenous Kir6.2). 

Phrase: "2A"

Phrase: "illustrates"

Phrase: ","

Phrase: "the titer of each of the WT-,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0475208:Titer [Quantitative Concept]

Phrase: "R176A-,"

Phrase: "R177A-,"

Phrase: "or"

Phrase: "HA-R206A-Kir6.2 viruses"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0042776:Viruses [Virus]
   804   C0521026:viruses [Functional Concept]
   771 E C0319157:virus [Virus]

Phrase: "could"

Phrase: "be"

Phrase: "adjusted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456081:Adjusted [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "similar protein expression levels"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C1171362:protein expression [Genetic Function]
   858   C0428479:Protein level [Laboratory or Test Result]
   827   C3244092:expression level [Idea or Concept]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "(approximately fivefold of endogenous Kir6.2"

Phrase: ")."
Processing 00000000.tx.128: Immunofluorescent staining of HA-R206A-Kir6.2 also confirmed that the mutant protein is indeed incorporated into the channel complex and expressed at the cell surface (Fig. 2B). 

Phrase: "Immunofluorescent staining of HA-R206A-Kir6.2 also"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   754   C0183489:Immunofluorescent stain [Indicator, Reagent, or Diagnostic Aid]
           Immunofluorescent
   744   C0487602:Staining [Laboratory Procedure]
   744   C1704680:Staining [Finding]
   711 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "the mutant protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1564139:Mutant Protein [Amino Acid, Peptide, or Protein]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "indeed"

Phrase: "incorporated into the channel complex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439799:Channel [Spatial Concept]
   760   C0439855:Complex [Qualitative Concept]
   760   C1704241:Complex [Chemical Viewed Structurally]
   760   C1706095:Channel [Conceptual Entity]

Phrase: "and"

Phrase: "expressed at the cell surface"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0699040:Cell surface [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0205148:Surface [Spatial Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.129: View larger version (24K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(24K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.130: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.131: Overexpression of PIP2-insensitive mutants causes depolarized membrane potential and elevated insulin secretion at basal glucose. 

Phrase: "Overexpression of PIP2-insensitive mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1514559:Overexpression [Genetic Function]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "depolarized membrane potential"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0025251:Membrane Potential [Cell Function]
   827   C0025255:Membrane [Tissue]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   827   C3245505:Potential [Qualitative Concept]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "and"

Phrase: "elevated insulin secretion at basal glucose."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C1256369:insulin secretion [Cell Function]
   783   C0650607:Basal insulin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   783   C1719133:Glucose/Insulin [Quantitative Concept]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
Processing 00000000.tx.132: A: Western blots of endogenous and exogenous Kir6.2 or HA-R206A-Kir6.2 (which has slightly higher molecular mass) expressed in INS-1 cells using anti-Kir6.2 antibodies. 

Phrase: "A"

Phrase: ":"

Phrase: "Western blots of endogenous"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0949466:Western Blots [Laboratory Procedure]
   799 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   770   C1705493:Western [Spatial Concept]

Phrase: "and"

Phrase: "exogenous Kir6.2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1416578:Kir6.2 [Gene or Genome]
   827   C0205101:Exogenous [Spatial Concept]
   827   C0205228:Exogenous [Functional Concept]

Phrase: "or"

Phrase: "HA-R206A-Kir6.2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1416578:Kir6.2 [Gene or Genome]
   812   C0018909:Haemagglutinin, NOS [Immunologic Factor]

Phrase: "("

Phrase: "which"

Phrase: "has"

Phrase: "slightly higher molecular mass"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   812   C0577559:Mass [Finding]
   812   C1306372:*Mass [Quantitative Concept]

Phrase: ")"

Phrase: "expressed in"

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "anti-Kir6.2 antibodies."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   902   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   886 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.133: Note at the virus titer used for experiments shown in this study, the exogenous Kir6.2 protein is in approximately fivefold excess (as assessed by densitometry) to endogenous Kir6.2 detected in uninfected cells. 

Phrase: "Note at the virus titer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1316572:Note [Clinical Attribute]
   760   C1317574:Note [Intellectual Product]
   760   C1369612:Note [Clinical Attribute]

Phrase: "used for experiments"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   790   C0681814:Experiments [Research Activity]
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1706386:Experiment [Conceptual Entity]
   756 E C1947944:Use [Intellectual Product]
   706 E C1517586:Experimental [Qualitative Concept]

Phrase: "shown in this study,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]
   737   C1547282:Show [Intellectual Product]

Phrase: "the exogenous Kir6.2 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is in approximately fivefold excess"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332232:Approximately [Qualitative Concept]
   760   C1979886:Excess [Qualitative Concept]

Phrase: "("

Phrase: "as"

Phrase: "assessed by densitometry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0011321:Densitometry [Laboratory Procedure]
   790   C1516048:Assessed [Activity]

Phrase: ")"

Phrase: "to endogenous Kir6.2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1416578:Kir6.2 [Gene or Genome]
   827   C0205227:Endogenous [Functional Concept]

Phrase: "detected in uninfected cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.134: Molecular mass markers for all three blots are the same, as shown on the left. 

Phrase: "Molecular mass markers for all three blots"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0005516:molecular markers [Clinical Attribute]
           Marker

Phrase: "are"

Phrase: "the same,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0445247:Same [Qualitative Concept]

Phrase: "as"

Phrase: "shown on the left."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205091:Left [Spatial Concept]
   770   C1552822:left [Functional Concept]
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.135: B: Surface staining of HA-tagged R206A-Kir6.2 using an anti-HA antibody verifies that the mutant Kir6.2 is incorporated into the channel complex and expressed on the cell surface. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "Surface staining of HA-tagged R206A-Kir6.2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0487602:Staining [Laboratory Procedure]
   744   C1704680:Staining [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an anti-HA antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "verifies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711411:Verify [Functional Concept]

Phrase: "that"

Phrase: "the mutant Kir6.2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1416578:Kir6.2 [Gene or Genome]
   827   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "is"

Phrase: "incorporated into the channel complex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439799:Channel [Spatial Concept]
   760   C0439855:Complex [Qualitative Concept]
   760   C1704241:Complex [Chemical Viewed Structurally]
   760   C1706095:Channel [Conceptual Entity]

Phrase: "and"

Phrase: "expressed on the cell surface."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0699040:Cell surface [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0205148:Surface [Spatial Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.136: Staining of uninfected cells using the same antibody did not give rise to detectable fluorescent signal (not shown). 

Phrase: "Staining of uninfected cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0487602:Staining [Laboratory Procedure]
   770   C1704680:Staining [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the same antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "give"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "rise to detectable fluorescent signal"

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.137: C: Averaged membrane capacitance changes in response to voltage-clamp depolarization from 70 to 0 mV in control cells (infected with a GFP virus) and cells infected with the HA-R206A-Kir6.2 virus. 

Phrase: "C"

Phrase: ":"

Phrase: "Averaged membrane capacitance"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0025255:Membrane [Tissue]
   827   C0242264:capacitance [Quantitative Concept]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "changes in response"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0392747:Change [Functional Concept]
   790   C0443172:change [Quantitative Concept]
   790   C0871261:Response [Organism Attribute]
   790   C1704632:Response [Finding]
   790   C1705241:Change [Quantitative Concept]
   790   C1706817:Response [Intellectual Product]
   790   C2911692:Response [Mental Process]

Phrase: "to voltage-clamp depolarization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0872303:voltage clamp [Research Activity]

Phrase: "from 70"

Phrase: "to 0 mV"

Phrase: "in control cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0007634:Cells [Cell]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "("

Phrase: "infected with a GFP virus"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   778   C0042736:protein virus [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   748   C0016315:Fluorescence [Natural Phenomenon or Process]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0042776:Virus [Virus]
   748   C0319157:virus [Virus]
   748   C0332583:Green [Qualitative Concept]
   748   C0439663:Infected [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "infected with the HA-R206A-Kir6.2 virus."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1416578:Kir6.2 [Gene or Genome]
   744   C0018909:Haemagglutinin, NOS [Immunologic Factor]
   744   C0042776:Virus [Virus]
   744   C0319157:virus [Virus]
   744   C0439663:Infected [Functional Concept]
Processing 00000000.tx.138: There is no statistically significant difference between the two groups. 

Phrase: "There"

Phrase: "is"

Phrase: "no statistically significant difference between the two groups."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1705241:*Difference [Quantitative Concept]
   744   C1705242:Difference [Qualitative Concept]
Processing 00000000.tx.139: D: Insulin secretion in response to 3- or 12-mmol/l glucose stimulation. 

Phrase: "D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ":"

Phrase: "Insulin secretion in response"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C1256369:insulin secretion [Cell Function]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0036536:secretion [Biologic Function]
   770   C0036537:Secretion [Body Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "to 3-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "or"

Phrase: "12-mmol/l glucose stimulation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   804   C1948023:Stimulation [Natural Phenomenon or Process]
Processing 00000000.tx.140: The response is normalized to that observed in uninfected cells at 3 mmol/l glucose. 

Phrase: "The response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "is"

Phrase: "normalized to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1882115:Normalized [Research Activity]

Phrase: "observed in uninfected cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C1441672:Observed [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "at 3 mmol/l glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.141: Cells infected with the R176A, R177A, or HA-R206A virus showed significantly (*P < 0.001) elevated insulin secretion response at 3 mmol/l glucose (1.9  0.1-, 2.4  0.1-, and 3.6  0.4-fold, respectively, n = 59) compared with cells infected with the WT Kir6.2 virus (1.1  0.1). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "infected with the R176A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439663:Infected [Functional Concept]

Phrase: "R177A,"

Phrase: "or"

Phrase: "HA-R206A virus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0042776:Virus [Virus]
   827   C0319157:virus [Virus]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "significantly"

Phrase: "("

Phrase: "*P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "elevated insulin secretion response at 3 mmol/l glucose"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0871261:Response [Organism Attribute]
   742   C1704632:Response [Finding]
   742   C1706817:Response [Intellectual Product]
   742   C2911692:Response [Mental Process]

Phrase: "(1.9  0.1-,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: "2.4  0.1-,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0740116:+2 [Quantitative Concept]
   812   C2827735:2+ [Quantitative Concept]
   812   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "3.6  0.4-fold,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0332462:Fold [Spatial Concept]
   804   C1880834:FOLD [Phenomenon or Process]
   708   C0442757:3 4 [Finding]

Phrase: "respectively,"

Phrase: "n = 59"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "compared with cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C1707455:Compared [Activity]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "infected with the WT Kir6.2 virus"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C1416578:Kir6.2 [Gene or Genome]
   770   C1883559:Wild Type [Organism Attribute]
   767   C0441730:Type 2 [Classification]
   767   C0449572:Virus type [Intellectual Product]
   744   C0042776:Virus [Virus]
   744   C0319157:virus [Virus]
   744   C0332307:Type [Qualitative Concept]
   744   C0439663:Infected [Functional Concept]
   744   C0445392:Wild [Intellectual Product]
   744   C1547052:*Type [Quantitative Concept]

Phrase: "(1.1  0.1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.142: By contrast, no significant difference was observed at 12 mmol/l glucose. 

Phrase: "By contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "no significant difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1705241:*Difference [Quantitative Concept]
   861   C1705242:Difference [Qualitative Concept]
   789 E C0443199:Differential [Qualitative Concept]

Phrase: "was"

Phrase: "observed at 12 mmol/l glucose."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1532563:mmol/L [Quantitative Concept]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0439190:MMOLE [Quantitative Concept]
   753   C1441672:Observed [Functional Concept]
Processing 00000000.tx.143: E: Opening of KATP channels by diazoxide (250 mol/l) consistently reversed the effect of all three PIP2-insensitive Kir6.2 mutants on basal insulin secretion, although the extent of reversal varied.  

Phrase: "E"

Phrase: ":"

Phrase: "Opening of KATP channels"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1955862:KATP Channels [Amino Acid, Peptide, or Protein]
   770   C0175566:Opening [Spatial Concept]
   770   C1882151:Opening [Spatial Concept]
   737   C0439799:Channel [Spatial Concept]
   737   C1706095:Channel [Conceptual Entity]

Phrase: "by diazoxide"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0012022:Diazoxide [Organic Chemical,Pharmacologic Substance]
   944 E C0699324:Hyperstat [Organic Chemical,Pharmacologic Substance]

Phrase: "(250 mol/l) consistently"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0347982:mol/L [Quantitative Concept]
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1456781:mole [Neoplastic Process]
   812   C1824986:mol [Gene or Genome]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: "reversed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1555029:Reverse [Idea or Concept]

Phrase: "the effect of all three PIP2-insensitive Kir6.2 mutants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1280500:Effect [Qualitative Concept]
   739   C2348382:Effect [Qualitative Concept]

Phrase: "on basal insulin secretion,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0650607:Basal insulin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C1256369:insulin secretion [Cell Function]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0036536:secretion [Biologic Function]
   827   C0036537:Secretion [Body Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "although"

Phrase: "the extent of reversal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439792:Extent [Spatial Concept]

Phrase: "varied."
Processing 00000000.tx.144: Next, we evaluated insulin secretion response in cells expressing the various PIP2-insensitive Kir6.2 mutants at both low (3 mmol/l) and high (12 mmol/l) glucose concentrations. 

Phrase: "Next,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "we"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "insulin secretion response in cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0871261:Response [Organism Attribute]
   760   C1704632:Response [Finding]
   760   C1706817:Response [Intellectual Product]
   760   C2911692:Response [Mental Process]

Phrase: "expressing"

Phrase: "the various PIP2-insensitive Kir6.2 mutants at both low"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "(3 mmol/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439190:MMOLE [Quantitative Concept]

Phrase: "l)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "high"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205250:High [Qualitative Concept]
  1000   C1299351:High [Qualitative Concept]
  1000   C2700149:HIGH [Intellectual Product]

Phrase: "(12 mmol/l) glucose concentrations."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   823   C0427743:Glucose concentration [Laboratory Procedure]
   823   C1287281:Glucose concentration [Laboratory or Test Result]
   804   C0086045:Concentrations [Mental Process]
   771 E C1446561:Concentration [Quantitative Concept]
   721 E C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.145: These glucose concentrations represent basal and maximal insulin response to glucose stimulation, respectively, based on a glucose dose-response curve (020 mmol/l glucose) established in INS-1 cells (not shown) (22). 

Phrase: "These glucose concentrations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C0427743:Glucose concentration [Laboratory Procedure]
   983   C1287281:Glucose concentration [Laboratory or Test Result]
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "and"

Phrase: "maximal insulin response to glucose stimulation,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]

Phrase: "respectively,"

Phrase: "based on a glucose dose-response curve"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   814   C0683162:dose-response curve [Quantitative Concept]
   757   C1532459:Base curve [Clinical Attribute]
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0178602:Dose [Quantitative Concept]
   748   C0205134:Curve [Spatial Concept]
   748   C0869039:Dose [Quantitative Concept]
   748   C0871261:Response [Organism Attribute]
   748   C1114758:Dose # [Clinical Attribute]
   748   C1527178:Based [Functional Concept]
   748   C1704632:Response [Finding]
   748   C1705938:Based [Idea or Concept]
   748   C1706817:Response [Intellectual Product]
   748   C2911692:Response [Mental Process]
   714 E C0002055:base [Inorganic Chemical]
   714 E C0178499:Base [Chemical Viewed Functionally]
   714 E C1880279:Base [Biomedical or Dental Material]

Phrase: "(020 mmol/l glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: ")"

Phrase: "established in"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0443211:Established [Qualitative Concept]
   833   C1272684:Established [Qualitative Concept]

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.146: To exclude a direct effect of the Kir6.2 mutant on the insulin secretory machinery, we first measured membrane capacitance changes in response to 500 ms voltage-clamp depolarization. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "a direct effect of the Kir6.2 mutant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "on the insulin secretory machinery,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0337076:machinery [Manufactured Object]

Phrase: "we first measured membrane capacitance"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0025255:Membrane [Tissue]
   812   C0242264:capacitance [Quantitative Concept]
   812   C0596901:Membrane [Cell Component]
   812   C1706182:Membrane [Manufactured Object]
   741 E C0205287:Membranous [Qualitative Concept]

Phrase: "changes in response"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0392747:Change [Functional Concept]
   790   C0443172:change [Quantitative Concept]
   790   C0871261:Response [Organism Attribute]
   790   C1704632:Response [Finding]
   790   C1705241:Change [Quantitative Concept]
   790   C1706817:Response [Intellectual Product]
   790   C2911692:Response [Mental Process]

Phrase: "to 500 ms voltage-clamp depolarization."
Processing 00000000.tx.147: In these experiments, effects of channel-PIP2 interactions on the membrane potential are excluded and the capacitance change represents fusion of insulin granules that are available for immediate release upon the evoked membrane depolarization. 

Phrase: "In these experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "effects of channel-PIP2 interactions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on the membrane potential"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0025251:Membrane Potential [Cell Function]
   861   C0025255:Membrane [Tissue]
   861   C0596901:Membrane [Cell Component]
   861   C1706182:Membrane [Manufactured Object]
   861   C3245505:Potential [Qualitative Concept]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "are"

Phrase: "excluded"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]

Phrase: "and"

Phrase: "the capacitance change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0392747:Change [Functional Concept]
   861   C0443172:change [Quantitative Concept]
   861   C1705241:Change [Quantitative Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "fusion of insulin granules"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332466:Fusion [Functional Concept]
   770   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "that"

Phrase: "are"

Phrase: "available for immediate release"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0470187:Available [Functional Concept]

Phrase: "upon the evoked membrane depolarization."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1816453:membrane depolarization [Cell Function]
Processing 00000000.tx.148: Figure 2C shows that no significant difference in capacitance increase is detected between GFP virusinfected control cells and cells expressing HA-R206A-Kir6.2. 

Phrase: "Figure 2C"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "no significant difference in capacitance increase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1705241:*Difference [Quantitative Concept]
   753   C1705242:Difference [Qualitative Concept]

Phrase: "is"

Phrase: "detected between GFP virusinfected control cells"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   776   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   744   C0007634:Cells [Cell]
   744   C0016315:Fluorescence [Natural Phenomenon or Process]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0243148:control [Qualitative Concept]
   744   C0332583:Green [Qualitative Concept]
   744   C0442726:Detected [Finding]
   744   C1511790:Detected [Therapeutic or Preventive Procedure]
   744   C1550141:Control [Substance]
   744   C1882979:Control [Conceptual Entity]
   744   C2587213:Control [Functional Concept]
   744   C3274648:Control [Qualitative Concept]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "HA-R206A-Kir6.2."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1416578:Kir6.2 [Gene or Genome]
   812   C0018909:Haemagglutinin, NOS [Immunologic Factor]
Processing 00000000.tx.149: Insulin secretion assays demonstrated that at 3 mmol/l glucose, while cells infected with WT-Kir6.2 virus had insulin secretion response indistinguishable from that observed in uninfected control cells (1.1-fold), cells infected with each of the three PIP2-insensitive Kir6.2 mutants all exhibited significantly elevated insulin secretion (1.9-, 2.4-, and 3.6-fold that of uninfected cells for R176A, R177A, and HA-R206A, respectively; Fig. 2D). 

Phrase: "Insulin secretion assays"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]
   734   C1256369:insulin secretion [Cell Function]

Phrase: "demonstrated"

Phrase: "that at 3 mmol/l glucose,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1532563:mmol/L [Quantitative Concept]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0439190:MMOLE [Quantitative Concept]

Phrase: "while"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "infected with WT-Kir6.2 virus"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C1416578:Kir6.2 [Gene or Genome]
   778   C1883559:Wild Type [Organism Attribute]
   774   C0441730:Type 2 [Classification]
   774   C0449572:Virus type [Intellectual Product]
   748   C0042776:Virus [Virus]
   748   C0319157:virus [Virus]
   748   C0332307:Type [Qualitative Concept]
   748   C0439663:Infected [Functional Concept]
   748   C0445392:Wild [Intellectual Product]
   748   C1547052:*Type [Quantitative Concept]

Phrase: "had"

Phrase: "insulin secretion response"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]
   734   C1256369:insulin secretion [Cell Function]

Phrase: "indistinguishable from that"

Phrase: "observed in uninfected control cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   760   C0007634:Cells [Cell]
   760   C0243148:control [Qualitative Concept]
   760   C1441672:Observed [Functional Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "(1.1-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: ","

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "infected with each of the three PIP2-insensitive Kir6.2 mutants"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   756   C1416578:Kir6.2 [Gene or Genome]
   738   C0070798:PIP2 [Biologically Active Substance,Lipid,Organophosphorus Compound]
   738   C0205449:Three [Quantitative Concept]
   738   C0439663:Infected [Functional Concept]
   738   C0596988:mutants [Cell or Molecular Dysfunction]
   738   C3538724:PIP2 [Body Part, Organ, or Organ Component]

Phrase: "all"

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "significantly elevated insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C1256369:insulin secretion [Cell Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(1.9-,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "2.4-,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "3.6-fold"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]
   734   C0442759:3 6 [Finding]

Phrase: "that of uninfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "for R176A,"

Phrase: "R177A,"

Phrase: "and"

Phrase: "HA-R206A,"

Phrase: "respectively"

Phrase: "; Fig. 2D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1705052:2D [Spatial Concept]
   861   C2986796:2D [Functional Concept]

Phrase: ")."
Processing 00000000.tx.150: These results are consistent with the electrophysiological data (Fig. 1) showing depolarized membrane potential in cells expressing the PIP2-insensitive mutants. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "consistent with the electrophysiological data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "depolarized membrane potential in cells"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0025251:Membrane Potential [Cell Function]
   797   C0007603:cells membrane [Cell Component]
   781 E C3161472:Cell Membrane [Cell Component]
   760   C0025255:Membrane [Tissue]
   760   C0596901:Membrane [Cell Component]
   760   C1706182:Membrane [Manufactured Object]
   760   C3245505:Potential [Qualitative Concept]

Phrase: "expressing"

Phrase: "the PIP2-insensitive mutants."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:mutants [Cell or Molecular Dysfunction]
Processing 00000000.tx.151: As expected, at a high glucose concentration (12 mmol/l) no significant difference in insulin secretion response could be discerned between cells expressing the various Kir6.2 or uninfected cells because the membrane depolarizing effect caused by the mutant Kir6.2 is now masked by the depolarizing effect caused by high glucose stimulation. 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "at a high glucose concentration"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0427743:Glucose concentration [Laboratory Procedure]
   901   C1287281:Glucose concentration [Laboratory or Test Result]
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]
   734   C0860803:high glucose [Finding]

Phrase: "(12 mmol/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439190:MMOLE [Quantitative Concept]

Phrase: "l)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "no significant difference in insulin secretion response"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1705241:*Difference [Quantitative Concept]
   748   C1705242:Difference [Qualitative Concept]

Phrase: "could"

Phrase: "be"

Phrase: "discerned between cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "the various Kir6.2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1416578:Kir6.2 [Gene or Genome]
   827   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]

Phrase: "or"

Phrase: "uninfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "because"

Phrase: "the membrane depolarizing effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1280500:Effect [Qualitative Concept]
   827   C2348382:Effect [Qualitative Concept]

Phrase: "caused by the mutant Kir6.2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1416578:Kir6.2 [Gene or Genome]
   753   C0596988:Mutant [Cell or Molecular Dysfunction]
   719   C0015127:cause [Functional Concept]
   719   C1524003:Cause [Conceptual Entity]

Phrase: "is"

Phrase: "now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "masked by the depolarizing effect"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0150108:masked [Research Activity]
   760   C0150112:MASKED [Functional Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C1555580:masked [Idea or Concept]
   760   C2348382:Effect [Qualitative Concept]
   726 E C0024861:Mask [Medical Device]
   726 E C1538279:MASK [Gene or Genome]
   726 E C1845191:MASK [Gene or Genome]

Phrase: "caused by high glucose stimulation."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0860803:high glucose [Finding]
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0205250:High [Qualitative Concept]
   760   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   760   C1299351:High [Qualitative Concept]
   760   C1948023:Stimulation [Natural Phenomenon or Process]
   760   C2700149:HIGH [Intellectual Product]
   726   C0015127:cause [Functional Concept]
   726   C1524003:Cause [Conceptual Entity]
Processing 00000000.tx.152: Also consistent with the electrophysiological data, treatment of cells with diazoxide reversed the elevated basal level insulin secretion in cells expressing the PIP2-insensitive Kir6.2 mutants to various extents (Fig. 2E). 

Phrase: "Also consistent with the electrophysiological data,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "treatment of cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "with diazoxide"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0012022:Diazoxide [Organic Chemical,Pharmacologic Substance]
   944 E C0699324:Hyperstat [Organic Chemical,Pharmacologic Substance]

Phrase: "reversed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1555029:Reverse [Idea or Concept]

Phrase: "the elevated basal level insulin secretion in cells"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   770   C0428405:level insulin [Laboratory or Test Result]
   770   C1256369:insulin secretion [Cell Function]
   767 E C0202098:Insulin level [Laboratory Procedure]
   767   C0650607:Basal insulin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   750   C0030281:Insulin Cell [Cell]
   750   C1327616:Cell secretion [Cell Function]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0036536:secretion [Biologic Function]
   744   C0036537:Secretion [Body Substance]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]

Phrase: "expressing"

Phrase: "the PIP2-insensitive Kir6.2 mutants to various extents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "(Fig. 2E"

Phrase: ")."
Processing 00000000.tx.153: The results described above provide strong evidence that KATP channelPIP2 interactions are necessary to allow channel opening and to prevent insulin secretion when glucose concentrations are low. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "above"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "strong evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that KATP channelPIP2 interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1704675:Interaction [Functional Concept]

Phrase: "are"

Phrase: "necessary to"

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "channel opening"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0175566:Opening [Spatial Concept]
   861   C1882151:Opening [Spatial Concept]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "when"

Phrase: "glucose concentrations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C0427743:Glucose concentration [Laboratory Procedure]
   983   C1287281:Glucose concentration [Laboratory or Test Result]
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "are"

Phrase: "low."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205251:low [Qualitative Concept]
  1000   C1299352:Low [Qualitative Concept]
  1000   C1550472:low [Idea or Concept]
Processing 00000000.tx.154: Enhancing KATP channelPIP2 interactions reduces channel sensitivity to ATP inhibition and attenuates membrane depolarization and insulin secretion upon glucose stimulation. 

Phrase: "Enhancing KATP channelPIP2 interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1704675:Interaction [Functional Concept]

Phrase: "reduces"

Phrase: "channel sensitivity to ATP inhibition"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C1547341:Channel sensitivity [Idea or Concept]
   770   C0332324:Sensitive to [Functional Concept]
   760   C0036667:Sensitivity [Quantitative Concept]
   760   C0312418:Sensitivity [Mental Process]
   760   C0427965:Sensitivity [Finding]
   760   C1511883:Sensitivity [Quantitative Concept]
   760   C1522640:Sensitivity [Qualitative Concept]
   760   C2346484:SENSITIVITY [Phenomenon or Process]
   760   C2349185:Sensitivity [Qualitative Concept]

Phrase: "and"

Phrase: "attenuates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599946:Attenuate [Activity]

Phrase: "membrane depolarization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1816453:membrane depolarization [Cell Function]

Phrase: "and"

Phrase: "insulin secretion upon glucose stimulation."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C1256369:insulin secretion [Cell Function]
   797   C1719133:Glucose/Insulin [Quantitative Concept]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.155: To assess how increased interactions between KATP channels and PIP2 affect -cell excitability and insulin secretion, we sought to upregulate PIP2 levels by overexpressing lipid kinase PIP5K:WT (murine type I isoform ), which is involved in the synthesis of phosphatidylinositol 4,5-P2 (10,20,21). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "how increased interactions between KATP channels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "PIP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0070798:PIP2 [Biologically Active Substance,Lipid,Organophosphorus Compound]
  1000   C3538724:PIP2 [Body Part, Organ, or Organ Component]

Phrase: "affect -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "cell excitability"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0235169:Excitability [Sign or Symptom]
   789 E C0857393:excitable [Sign or Symptom]

Phrase: "and"

Phrase: "insulin secretion,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "we"

Phrase: "sought"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "upregulate"

Phrase: "PIP2 levels by overexpressing lipid kinase PIP5K"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   762   C0428304:levels phosphate [Laboratory or Test Result]
   762   C0428460:levels lipid [Laboratory or Test Result]
   745   C0456951:Level 5 [Qualitative Concept]
   742   C0441889:Levels [Qualitative Concept]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: ":"

Phrase: "WT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "(murine type I isoform"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0597298:Isoform [Amino Acid, Peptide, or Protein]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "is"

Phrase: "involved in the synthesis of phosphatidylinositol 4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C1157394:phosphatidylinositol synthesis [Molecular Function]
   748   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   748   C0220781:synthesis [Biologic Function]
   748   C1314939:Involved [Functional Concept]
   748   C1883254:Synthesis [Activity]
   748   C2348046:Phosphatidylinositol [Lipid]

Phrase: "5-P2 (10,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]
   827   C1384585:P2 [Immunologic Factor]
   827   C1419693:P2 [Gene or Genome]
   827   C1539372:p2 [Gene or Genome]

Phrase: "20,"

Phrase: "21"

Phrase: ")."
Processing 00000000.tx.156: Overexpression of PIP5K:WT in COSm6 cells has previously been shown to decrease the ATP sensitivity of KATP channels exogenously expressed in those cells (21). 

Phrase: "Overexpression of PIP5K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1514559:Overexpression [Genetic Function]

Phrase: ":"

Phrase: "WT in COSm6 cells"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C1883559:Wild Type [Organism Attribute]
   797   C0449475:cells type [Intellectual Product]
   781 E C0007634:Cell Type [Cell]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "has"

Phrase: "previously"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the ATP sensitivity of KATP channels exogenously"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   757   C1547341:Channel sensitivity [Idea or Concept]
   748   C0036667:Sensitivity [Quantitative Concept]
   748   C0312418:Sensitivity [Mental Process]
   748   C0427965:Sensitivity [Finding]
   748   C1511883:Sensitivity [Quantitative Concept]
   748   C1522640:Sensitivity [Qualitative Concept]
   748   C2346484:SENSITIVITY [Phenomenon or Process]
   748   C2349185:Sensitivity [Qualitative Concept]

Phrase: "expressed in those cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.157: As a negative control, we infected cells with viruses carrying a mutant kinase whose NH2-terminal 238 amino acids have been deleted to remove its enzymatic activity (referred to as PIP5K:1-238) (20,21). 

Phrase: "As a negative control,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C1639518:% negative control [Quantitative Concept]
  1000   C1947986:Negative Control [Conceptual Entity]
   861   C0205160:Negative [Qualitative Concept]
   861   C0243148:control [Qualitative Concept]
   861   C1513916:Negative [Finding]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C2825415:Negative [Conceptual Entity]
   861   C2825491:Negative [Qualitative Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "we"

Phrase: "infected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439663:Infected [Functional Concept]

Phrase: "cells with viruses"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "a mutant kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "whose NH2-terminal 238 amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   840   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   806 E C2917660:Amino Acid [Pharmacologic Substance]
   804   C0001128:Acids [Chemical]
   771 E C0202406:Acid [Laboratory Procedure]

Phrase: "have"

Phrase: "been"

Phrase: "deleted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880274:Deleted [Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "its enzymatic activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2267219:Enzymatic Activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "("

Phrase: "referred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205543:referred [Functional Concept]
  1000   C1691010:Referred [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "as"

Phrase: "PIP5K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ":"

Phrase: "1-238"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "(20,"

Phrase: "21"

Phrase: ")."
Processing 00000000.tx.158: Figure 3A is a Western blot showing similar expression level of PI4P5K:WT or PIP5K:1-238 in INS-1 cells. 

Phrase: "Figure 3A"

Phrase: "is"

Phrase: "a Western blot"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "similar expression level of PI4P5K"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C3244092:expression level [Idea or Concept]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: ":"

Phrase: "WT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "PIP5K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ":"

Phrase: "1-238 in"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C2827734:1+ [Quantitative Concept]
   790   C2981698:1+ [Classification]

Phrase: "INS-1 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.159: To validate that expression of PIP5K:WT increases PIP2 levels, we metabolically labeled cells with 32P and analyzed the 32P-labeled phospholipids by thin-layer chromatography (Fig. 3B). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "validate"

Phrase: "that expression of PIP5K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: ":"

Phrase: "WT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "PIP2 levels,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "we metabolically labeled cells with 32P"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "the 32P-labeled phospholipids by thin-layer chromatography"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0031676:Phospholipids [Biologically Active Substance,Lipid]
   711 E C0202177:Phospholipid [Laboratory Procedure]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.160: The amount of PIP2 in cells expressing PIP5K:WT was dramatically increased (30-fold) compared with uninfected cells or cells expressing PIP5K:1-238. 

Phrase: "The amount of PIP2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "PIP5K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ":"

Phrase: "WT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "was"

Phrase: "dramatically"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "(30-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: "compared with uninfected cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C1707455:Compared [Activity]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "PIP5K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ":"

Phrase: "1-238."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]
Processing 00000000.tx.161: View larger version (32K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(32K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.162: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.163: Infection of INS-1 cells with the PIP5K:WT virus increases cellular PIP2 level. 

Phrase: "Infection of"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   833   C0009450:Infection, NOS [Disease or Syndrome]
   761 E C0439663:Infected [Functional Concept]
   722 E C0030657:infectivity [Qualitative Concept]

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "with the PIP5K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ":"

Phrase: "WT virus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0449572:type virus [Intellectual Product]
   827   C0042776:Virus [Virus]
   827   C0319157:virus [Virus]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "cellular PIP2 level."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0441889:Level [Qualitative Concept]
   827   C0456079:Level [Classification]
   827   C1547707:Level [Geographic Area]
   827   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.164: A: Western blots of the PIP5K:WT and the NH2-terminal deletion mutant kinase (PIP5K:1-238). 

Phrase: "A"

Phrase: ":"

Phrase: "Western blots of the PIP5K"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   778   C0949466:Western Blots [Laboratory Procedure]
   748   C1705493:Western [Spatial Concept]
   745 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: ":"

Phrase: "WT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "the NH2-terminal deletion mutant kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(PIP5K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ":"

Phrase: "1-238"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.165: Titers of the two viruses used to infect cells were adjusted to achieve similar protein expression levels in this and the subsequent two figures. 

Phrase: "Titers of the two viruses"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C2713348:Virus Titer [Quantitative Concept]
   726   C0475208:Titer [Quantitative Concept]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "infect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439663:infect [Functional Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "adjusted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456081:Adjusted [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "achieve"

Phrase: "similar protein expression levels in this"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   790   C1171362:protein expression [Genetic Function]
   767   C0428479:Protein level [Laboratory or Test Result]
   756   C3244092:expression level [Idea or Concept]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "the subsequent two figures."
Processing 00000000.tx.166: B: PIP2 measured in uninfected cells, cells infected with the PIP5K:WT virus, or the PIP5K:1-238 virus. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "PIP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0070798:PIP2 [Biologically Active Substance,Lipid,Organophosphorus Compound]
  1000   C3538724:PIP2 [Body Part, Organ, or Organ Component]

Phrase: "measured in uninfected cells,"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0444706:Measured [Qualitative Concept]
   770   C3282337:Cells [Cell]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "infected with the PIP5K"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   753   C0031701:phosphate [Organophosphorus Compound]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0439663:Infected [Functional Concept]
   753   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: ":"

Phrase: "WT virus,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0449572:type virus [Intellectual Product]
   827   C0042776:Virus [Virus]
   827   C0319157:virus [Virus]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "or"

Phrase: "the PIP5K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ":"

Phrase: "1-238 virus."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0042776:Virus [Virus]
   827   C0319157:virus [Virus]
Processing 00000000.tx.167: Standards of phosphatidic acid (PA), phosphatidylinositol 4-P, and phosphatidylinositol 4,5-P2 were run on the same silica gel and visualized by iodine spray to help identify the different phospholipid species. 

Phrase: "Standards of phosphatidic acid (PA),"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0038137:standards [Intellectual Product]
   770   C0175675:Standards [Qualitative Concept]
   737 E C1442989:Standard [Qualitative Concept]
   737 E C2828392:Standard [Intellectual Product]

Phrase: "phosphatidylinositol 4-P,"

Phrase: "and"

Phrase: "phosphatidylinositol 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   861   C2348046:Phosphatidylinositol [Lipid]

Phrase: "5-P2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1384585:P2 [Immunologic Factor]
   861   C1419693:P2 [Gene or Genome]
   861   C1539372:p2 [Gene or Genome]

Phrase: "were"

Phrase: "run on"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0035953:run [Daily or Recreational Activity]
   861   C0600140:run [Finding]
   861   C1704688:Run [Functional Concept]
   861   C2346414:Run [Finding]

Phrase: "the same silica gel"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C2936385:Silica Gel [Biomedical or Dental Material,Inorganic Chemical]
   827   C0017243:Gel [Biomedical or Dental Material]
   827   C0037098:Silica [Biomedical or Dental Material,Inorganic Chemical]
   827   C1382104:Gel [Substance]
   743 E C0885771:silicas [Pharmacologic Substance]

Phrase: "and"

Phrase: "visualized by iodine"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0021966:Iodine- [Inorganic Chemical]
   790   C0021968:Iodine [Element, Ion, or Isotope,Pharmacologic Substance]
   790   C0234621:Visualized [Functional Concept]
   790   C0885449:iodine [Pharmacologic Substance]
   790   C2348268:Iodine [Element, Ion, or Isotope]

Phrase: "spray"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704413:{Spray} [Quantitative Concept]
  1000   C2003858:Spray [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "help"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018896:Help [Social Behavior]
  1000   C1552861:help [Idea or Concept]

Phrase: "identify"

Phrase: "the different phospholipid species."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1705920:Species [Conceptual Entity]
Processing 00000000.tx.168: 32P-labeled PIP2 was quantified using a PhosphorImager.  

Phrase: "32P-labeled PIP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0070798:PIP2 [Biologically Active Substance,Lipid,Organophosphorus Compound]
   827   C3538724:PIP2 [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "quantified"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a PhosphorImager."
Processing 00000000.tx.169: We next examined how the increased PIP2 affects KATP channel activity by inside-out patch-clamp recording. 

Phrase: "We next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "how"

Phrase: "the increased PIP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0070798:PIP2 [Biologically Active Substance,Lipid,Organophosphorus Compound]
   861   C3538724:PIP2 [Body Part, Organ, or Organ Component]

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "KATP channel activity by inside-out patch-clamp recording."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C1153410:channel activity [Molecular Function]
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.170: In these experiments, patches were excised into K-INT solution with no ATP and then exposed quickly to K-INT containing various concentrations of ATP (all in the absence of Mg2+) before any significant current rundown occurred to ensure accurate measurement of ATP dose response (Fig. 4A) (21). 

Phrase: "In these experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "patches"
Meta Candidates (Total=9; Excluded=8; Pruned=0; Remaining=1)
  1000   C0994894:Patches [Medical Device]
   966 E C0332461:Patch [Finding]
   966 E C0445403:Patch [Biomedical or Dental Material]
   966 E C0991556:Patch [Medical Device]
   966 E C1305400:Patch [Medical Device]
   966 E C1533128:Patch [Biomedical or Dental Material]
   966 E C1706366:{Patch} [Quantitative Concept]
   966 E C1707974:Patch [Biomedical or Dental Material]
   916 E C0205413:Patchy [Qualitative Concept]

Phrase: "were"

Phrase: "excised into K-INT solution"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0037633:Solution [Substance]
   760   C0063789:INT [Organic Chemical]
   760   C0525069:Solution [Biomedical or Dental Material]
   760   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C1708601:K' [Quantitative Concept]
   760   C3272375:INT [Intellectual Product]

Phrase: "with no ATP"

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "exposed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332157:Exposed [Clinical Attribute]

Phrase: "quickly to K-INT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0063789:INT [Organic Chemical]
   770   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   770   C1708601:K' [Quantitative Concept]
   770   C3272375:INT [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "various concentrations of ATP"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0086045:Concentrations [Mental Process]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: "("

Phrase: "all in the absence of Mg2+"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0332197:absence [Quantitative Concept]
   753   C0444868:All [Quantitative Concept]
   753   C1417500:MG2 [Gene or Genome]
   753   C1689985:Absence [Anatomical Abnormality]
   753   C2346927:Mg2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C3539085:All [Idea or Concept]

Phrase: ")"

Phrase: "before any significant current rundown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0848283:rundown [Sign or Symptom]

Phrase: "occurred"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1709305:Occurred [Activity]
   966 E C2745955:OCCUR [Temporal Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "accurate measurement of ATP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0242485:Measurement [Functional Concept]

Phrase: "dose response"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0178602:Dose [Quantitative Concept]
   861   C0869039:Dose [Quantitative Concept]
   861   C0871261:Response [Organism Attribute]
   861   C1114758:Dose # [Clinical Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")"

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.171: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.172: 4B, KATP channels in cells infected with the PIP5K:WT virus exhibited a 26-fold decrease in ATP sensitivity compared with channels in uninfected cells or cells infected with the PIP5K:1-238 virus. 

Phrase: "4B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450375:4b [Intellectual Product]

Phrase: "KATP channels in cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1955862:KATP Channels [Amino Acid, Peptide, or Protein]
   737   C0439799:Channel [Spatial Concept]
   737   C1706095:Channel [Conceptual Entity]

Phrase: "infected with the PIP5K"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   753   C0031701:phosphate [Organophosphorus Compound]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0439663:Infected [Functional Concept]
   753   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: ":"

Phrase: "WT virus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0449572:type virus [Intellectual Product]
   827   C0042776:Virus [Virus]
   827   C0319157:virus [Virus]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "a 26-fold decrease in ATP sensitivity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]

Phrase: "compared with channels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1707455:Compared [Activity]
   756   C0439799:Channel [Spatial Concept]
   756   C1706095:Channel [Conceptual Entity]

Phrase: "in uninfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "infected with the PIP5K"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   753   C0031701:phosphate [Organophosphorus Compound]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0439663:Infected [Functional Concept]
   753   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: ":"

Phrase: "1-238 virus."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0042776:Virus [Virus]
   827   C0319157:virus [Virus]
Processing 00000000.tx.173: The large rightward shift in ATP dose response is predicted to cause KATP channels to remain active even when the glucose level rises, resulting in hyperpolarized membrane potential and reduced insulin response. 

Phrase: "The large rightward shift in ATP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333051:Shift [Functional Concept]
   753   C2347509:Shift [Phenomenon or Process]

Phrase: "dose response"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0178602:Dose [Quantitative Concept]
   861   C0869039:Dose [Quantitative Concept]
   861   C0871261:Response [Organism Attribute]
   861   C1114758:Dose # [Clinical Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "is"

Phrase: "predicted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "KATP channels to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1955862:KATP Channels [Amino Acid, Peptide, or Protein]
   793   C0439799:Channel [Spatial Concept]
   793   C1706095:Channel [Conceptual Entity]

Phrase: "remain"

Phrase: "active even"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205177:Active [Functional Concept]

Phrase: "when"

Phrase: "the glucose level rises,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0337438:glucose level [Laboratory Procedure]
   734   C0428548:Glucose level [Laboratory or Test Result]

Phrase: "resulting in hyperpolarized membrane potential"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C0025251:Membrane Potential [Cell Function]
   806   C0332294:Resulting in [Functional Concept]
   760   C0025255:Membrane [Tissue]
   760   C0596901:Membrane [Cell Component]
   760   C0678226:resulting [Functional Concept]
   760   C1706182:Membrane [Manufactured Object]
   760   C3245505:Potential [Qualitative Concept]
   726 E C1274040:Result [Functional Concept]
   726 E C1546471:Result [Idea or Concept]
   726 E C2825142:Result [Finding]

Phrase: "and"

Phrase: "reduced insulin response."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]
Processing 00000000.tx.174: To test these, we examined the membrane potential at high glucose using a perforated patch-clamp technique. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "these,"

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the membrane potential at high glucose"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0025251:Membrane Potential [Cell Function]
   753   C0025255:Membrane [Tissue]
   753   C0596901:Membrane [Cell Component]
   753   C1706182:Membrane [Manufactured Object]
   753   C3245505:Potential [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a perforated patch-clamp technique."
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   923   C0242625:Technique, Patch-Clamp [Research Activity]
   861   C0920630:patch clamp [Research Activity]
   812   C0175721:Clamp [Medical Device]
   812   C0332461:Patch [Finding]
   812   C0445403:Patch [Biomedical or Dental Material]
   812   C0449851:Technique [Functional Concept]
   812   C0991556:Patch [Medical Device]
   812   C1305400:Patch [Medical Device]
   812   C1533128:Patch [Biomedical or Dental Material]
   812   C1705942:Clamp [Manufactured Object]
   812   C1706366:{Patch} [Quantitative Concept]
   812   C1707974:Patch [Biomedical or Dental Material]
   812   C1883710:Clamp [Functional Concept]
   741 E C0205413:Patchy [Qualitative Concept]
   729 E C0025664:techniques [Intellectual Product]
Processing 00000000.tx.175: As mentioned above, the perforated-patch recording permits measurement of membrane potential without disturbing intracellular factors that are involved in regulating KATP channel activity. 

Phrase: "As"

Phrase: "mentioned above,"

Phrase: "the perforated-patch recording"

Phrase: "permits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0023636:Permit [Regulation or Law]
  1000   C0329040:Permit [Fish]

Phrase: "measurement of membrane potential"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0242485:Measurement [Functional Concept]

Phrase: "without disturbing intracellular factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "that"

Phrase: "are"

Phrase: "involved in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1314939:Involved [Functional Concept]

Phrase: "regulating"

Phrase: "KATP channel activity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1153410:channel activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.176: Indeed, we found that at 12 mmol/l glucose, the averaged membrane potential is significantly more hyperpolarized in cells infected with the PIP5K:WT virus than in uninfected cells or cells infected with the PIP5K:1-238 virus (Fig. 4C). 

Phrase: "Indeed,"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that at 12 mmol/l glucose,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1532563:mmol/L [Quantitative Concept]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0439190:MMOLE [Quantitative Concept]

Phrase: "the averaged membrane potential"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0025251:Membrane Potential [Cell Function]
   827   C0025255:Membrane [Tissue]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   827   C3245505:Potential [Qualitative Concept]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "is"

Phrase: "significantly more"

Phrase: "hyperpolarized in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "infected with the PIP5K"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   753   C0031701:phosphate [Organophosphorus Compound]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0439663:Infected [Functional Concept]
   753   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: ":"

Phrase: "WT virus than"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0449572:type virus [Intellectual Product]
   770   C0042776:Virus [Virus]
   770   C0319157:virus [Virus]

Phrase: "in uninfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "infected with the PIP5K"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   753   C0031701:phosphate [Organophosphorus Compound]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0439663:Infected [Functional Concept]
   753   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: ":"

Phrase: "1-238 virus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0042776:Virus [Virus]
   827   C0319157:virus [Virus]

Phrase: "(Fig. 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.177: Similar results were obtained using whole-cell recordings with 12 mmol/l glucose in the bath solution and 5 mmol/l ATP plus 3 mmol/l Mg2+ in the pipette solution (not shown). 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "whole-cell recordings with 12 mmol/l glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   800   C0242624:Whole-Cell Recordings [Research Activity]

Phrase: "in the bath solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037633:Solution [Substance]
   861   C0525069:Solution [Biomedical or Dental Material]

Phrase: "and"

Phrase: "5 mmol/l ATP plus 3 mmol/l Mg2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C1417500:MG2 [Gene or Genome]
   791   C2346927:Mg2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "in the pipette solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037633:Solution [Substance]
   861   C0525069:Solution [Biomedical or Dental Material]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.178: Accordingly, while in uninfected cells or cells infected with the PIP5K:1-238 virus increasing the glucose concentration from 3 to 12 mmol/l led to a 9.5- and 8.4-fold increase in insulin release, respectively, in cells infected with the PIP5K:WT virus the same glucose concentration change only caused a 3.5-fold increase in insulin release (Fig. 5A). 

Phrase: "Accordingly,"

Phrase: "while in uninfected cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C0750519:while [Idea or Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "infected with the PIP5K"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   753   C0031701:phosphate [Organophosphorus Compound]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0439663:Infected [Functional Concept]
   753   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: ":"

Phrase: "1-238 virus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0042776:Virus [Virus]
   827   C0319157:virus [Virus]

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the glucose concentration from 3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0427743:Glucose concentration [Laboratory Procedure]
   806   C1287281:Glucose concentration [Laboratory or Test Result]
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "to 12 mmol/l"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1532563:mmol/L [Quantitative Concept]

Phrase: "led to a 9.5-"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   760   C1708698:LED [Manufactured Object]
   726 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   726 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   726 E C1522538:Lead [Functional Concept]
   726 E C2348269:Lead [Element, Ion, or Isotope]
   726 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "8.4-fold increase in insulin release,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0020459:INSULIN INCREASE [Disease or Syndrome]
   748   C0442805:Increase [Functional Concept]

Phrase: "respectively,"

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "infected with the PIP5K"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   753   C0031701:phosphate [Organophosphorus Compound]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0439663:Infected [Functional Concept]
   753   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: ":"

Phrase: "WT virus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0449572:type virus [Intellectual Product]
   827   C0042776:Virus [Virus]
   827   C0319157:virus [Virus]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "the same glucose concentration"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0427743:Glucose concentration [Laboratory Procedure]
   901   C1287281:Glucose concentration [Laboratory or Test Result]
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a 3.5-fold increase in insulin release"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0020459:INSULIN INCREASE [Disease or Syndrome]
   744   C0442805:Increase [Functional Concept]

Phrase: "(Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")."
Processing 00000000.tx.179: This reduced secretion is not due to an inability of insulin granules to fuse with the membrane because no difference in membrane capacitance increase was found between cells infected with the PIP5K:WT virus and uninfected cells either during the first depolarization or during an entire train of step voltage-clamp depolarizations (Fig. 5C). 

Phrase: "This reduced secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]

Phrase: "is"

Phrase: "not due to an inability of insulin granules to"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   764   C0678226:Due to [Functional Concept]
           due
   742   C0010837:Granules [Cell Component]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0993609:Granules [Biomedical or Dental Material]
   742   C1518422:Not [Functional Concept]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
   742   C3146286:Due [Idea or Concept]

Phrase: "fuse with the membrane"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0025255:Membrane [Tissue]
   770   C0596901:Membrane [Cell Component]
   770   C0699952:fuse [Functional Concept]
   770   C1414861:FUSE [Gene or Genome]
   770   C1706182:Membrane [Manufactured Object]
   770   C1708111:Fuse [Manufactured Object]

Phrase: "because"

Phrase: "no difference in membrane capacitance increase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1705241:*Difference [Quantitative Concept]
   753   C1705242:Difference [Qualitative Concept]

Phrase: "was"

Phrase: "found between cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C0150312:Found [Quantitative Concept]
   790   C3282337:Cells [Cell]
   756 E C0243095:Find [Finding]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "infected with the PIP5K"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   753   C0031701:phosphate [Organophosphorus Compound]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0439663:Infected [Functional Concept]
   753   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: ":"

Phrase: "WT virus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0449572:type virus [Intellectual Product]
   827   C0042776:Virus [Virus]
   827   C0319157:virus [Virus]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "and"

Phrase: "uninfected cells either during the first depolarization"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   748   C0007634:Cells [Cell]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "or during an entire train of step voltage-clamp depolarizations"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   760   C0872303:voltage clamp [Research Activity]
   739   C0175721:Clamp [Medical Device]
   739   C0336809:Train [Manufactured Object]
   739   C0439751:Entire [Quantitative Concept]
   739   C0444667:Entire [Quantitative Concept]
   739   C0598352:Voltage [Quantitative Concept]
   739   C1261552:Step [Conceptual Entity]
   739   C1552514:Train [Manufactured Object]
   739   C1704379:Step [Functional Concept]
   739   C1705117:Step [Quantitative Concept]
   739   C1705942:Clamp [Manufactured Object]
   739   C1883710:Clamp [Functional Concept]
   739   C2825408:Step [Manufactured Object]

Phrase: "(Fig. 5C"

Phrase: ")."
Processing 00000000.tx.180: In addition, overexpression of PIP5K did not alter voltage-gated Ca2+ currents during these experiments (shown as the charge influx in Fig. 5D) (32). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "overexpression of PIP5K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1514559:Overexpression [Genetic Function]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "voltage-gated Ca2+ currents during these experiments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0521116:currents [Temporal Concept]
   714 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "("

Phrase: "shown as the charge influx"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0007961:Charge [Quantitative Concept]
   760   C1706211:Charge [Organism Attribute]
   726   C1547282:Show [Intellectual Product]

Phrase: "in Fig. 5D"

Phrase: ")"

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.181: These results lead us to conclude that overexpression of PIP2 reduces insulin secretion at high glucose by rendering KATP channels insensitive to ATP. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "lead"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
  1000   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
  1000   C1522538:Lead [Functional Concept]
  1000   C2348269:Lead [Element, Ion, or Isotope]
  1000   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that overexpression of PIP2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514559:Overexpression [Genetic Function]

Phrase: "reduces"

Phrase: "insulin secretion at high glucose"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C1256369:insulin secretion [Cell Function]
   797   C0020459:high insulin [Disease or Syndrome]
   797   C1719133:Glucose/Insulin [Quantitative Concept]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "by rendering KATP channels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1955862:KATP Channels [Amino Acid, Peptide, or Protein]
   793   C0439799:Channel [Spatial Concept]
   793   C1706095:Channel [Conceptual Entity]

Phrase: "insensitive to ATP."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C0237677:Insensitivity [Finding]
Processing 00000000.tx.182: View larger version (26K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(26K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.183: 4. 

Phrase: "4."
Processing 00000000.tx.184: Overexpression of PIP5K:WT reduces KATP channel sensitivity to ATP and causes membrane hyperpolarization and attenuated insulin secretion at high glucose. 

Phrase: "Overexpression of PIP5K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1514559:Overexpression [Genetic Function]

Phrase: ":"

Phrase: "WT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "reduces"

Phrase: "KATP channel sensitivity to ATP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C1547341:Channel sensitivity [Idea or Concept]
   770   C0332324:Sensitive to [Functional Concept]
   760   C0036667:Sensitivity [Quantitative Concept]
   760   C0312418:Sensitivity [Mental Process]
   760   C0427965:Sensitivity [Finding]
   760   C1511883:Sensitivity [Quantitative Concept]
   760   C1522640:Sensitivity [Qualitative Concept]
   760   C2346484:SENSITIVITY [Phenomenon or Process]
   760   C2349185:Sensitivity [Qualitative Concept]

Phrase: "and"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "membrane hyperpolarization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2262820:membrane hyperpolarization [Cell Function]

Phrase: "and"

Phrase: "attenuated insulin secretion at high glucose."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C1256369:insulin secretion [Cell Function]
   783   C0020459:high insulin [Disease or Syndrome]
   783   C1719133:Glucose/Insulin [Quantitative Concept]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
Processing 00000000.tx.185: A: Representative inside-out patch clamp recordings of KATP currents from control INS-1 cells or cells overexpressing PIP5K:WT or PIP5K:1-238. 

Phrase: "A"

Phrase: ":"

Phrase: "Representative inside-out patch clamp recordings of KATP currents"

Phrase: "from control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "PIP5K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ":"

Phrase: "WT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "PIP5K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ":"

Phrase: "1-238."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]
Processing 00000000.tx.186: Patches were exposed to different concentrations of ATP as indicated by the bars above the recording. 

Phrase: "Patches"
Meta Candidates (Total=9; Excluded=8; Pruned=0; Remaining=1)
  1000   C0994894:Patches [Medical Device]
   966 E C0332461:Patch [Finding]
   966 E C0445403:Patch [Biomedical or Dental Material]
   966 E C0991556:Patch [Medical Device]
   966 E C1305400:Patch [Medical Device]
   966 E C1533128:Patch [Biomedical or Dental Material]
   966 E C1706366:{Patch} [Quantitative Concept]
   966 E C1707974:Patch [Biomedical or Dental Material]
   916 E C0205413:Patchy [Qualitative Concept]

Phrase: "were"

Phrase: "exposed to different concentrations of ATP"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0332157:Exposed to [Clinical Attribute]
           Exposed
   753   C0086045:Concentrations [Mental Process]
   753   C1705242:Different [Qualitative Concept]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "as"

Phrase: "indicated by the bars"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1444656:Indicated [Finding]
   770   C1707156:BARS [Gene or Genome]
   770   C3274014:BARS [Intellectual Product]
   770   C3541345:BARS [Intellectual Product]

Phrase: "above the recording."
Processing 00000000.tx.187: Experiments were done in symmetrical K-INT solution at 50 mV. 

Phrase: "Experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "done in symmetrical K-INT solution"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0037633:Solution [Substance]
   753   C0063789:INT [Organic Chemical]
   753   C0332516:Symmetrical [Spatial Concept]
   753   C0525069:Solution [Biomedical or Dental Material]
   753   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C1272695:Done [Qualitative Concept]
   753   C1708601:K' [Quantitative Concept]
   753   C2746065:Done [Temporal Concept]
   753   C3272375:INT [Intellectual Product]

Phrase: "at 50 mV."
Processing 00000000.tx.188: Inward currents were shown as upward deflections. 

Phrase: "Inward currents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0521116:currents [Temporal Concept]
   827 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "were"

Phrase: "shown as upward deflections."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1282911:Upward [Spatial Concept]
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.189: B: ATP dose-response curves derived from recordings shown in A. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "ATP dose-response curves"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   890   C0683162:dose-response curve [Quantitative Concept]
   812   C0178602:Dose [Quantitative Concept]
   812   C0869039:Dose [Quantitative Concept]
   812   C0871261:Response [Organism Attribute]
   812   C1114758:Dose # [Clinical Attribute]
   812   C1704632:Response [Finding]
   812   C1706817:Response [Intellectual Product]
   812   C2911692:Response [Mental Process]
   779   C0205134:Curve [Spatial Concept]

Phrase: "derived from recordings"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1441547:Derived [Qualitative Concept]
   790   C3245521:derived [Idea or Concept]

Phrase: "shown in A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.190: The curves were fit by the Hill equation (Irel = 1/{1 + [(ATP)/K1/2]H}; Irel = current in [ATP]/current in 0 ATP, where H = Hill coefficient and K1/2 = [ATP] causing half-maximal inhibition) to averaged data. 

Phrase: "The curves"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0205134:Curve [Spatial Concept]

Phrase: "were"

Phrase: "fit by the Hill equation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0036572:Fit [Sign or Symptom]
   760   C0424576:Fit [Finding]
   760   C2349186:Fit [Activity]

Phrase: "(Irel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419336:IREL [Gene or Genome]

Phrase: "= 1/{1 +"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "["

Phrase: "(ATP"

Phrase: ")"

Phrase: "/K1/2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1721009:K1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C3272787:K1 [Gene or Genome]

Phrase: "]H}"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "; Irel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419336:IREL [Gene or Genome]

Phrase: "= current in [ATP"

Phrase: "]/current in 0 ATP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0521116:Current [Temporal Concept]
   770   C1705970:Current [Natural Phenomenon or Process]

Phrase: "where H = Hill coefficient"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0442532:Hill [Spatial Concept]
   812   C1707429:*Coefficient [Quantitative Concept]

Phrase: "and"

Phrase: "K1/2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1721009:K1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C3272787:K1 [Gene or Genome]

Phrase: "="

Phrase: "[ATP"

Phrase: "] causing half-maximal inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0021467:Inhibition [Mental Process]
   812   C0021469:Inhibition [Molecular Function]
   812   C1628982:% inhibition [Quantitative Concept]
   812   C3463820:Inhibition [Activity]
   741 E C0311403:Inhibited [Qualitative Concept]

Phrase: ")"

Phrase: "to averaged data."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]
Processing 00000000.tx.191: Channels of uninfected cells exhibit an expected K1/2 of 8.4 mol/l (H = 1.04). 

Phrase: "Channels of uninfected cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0439799:Channel [Spatial Concept]
   737   C1706095:Channel [Conceptual Entity]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "an expected K1/2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1517001:Expected [Idea or Concept]
   827   C1721009:K1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C3272787:K1 [Gene or Genome]

Phrase: "of 8.4 mol/l (H = 1.04"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   845   C2827890:mol/L/h [Quantitative Concept]
   829   C0560019:mol/h [Quantitative Concept]
   818   C0347982:mol/L [Quantitative Concept]
   818   C0700308:h 1 [Element, Ion, or Isotope]
   795   C0027960:Mole [Neoplastic Process]
   795   C0324740:Mole [Mammal]
   795   C0439189:Mole [Quantitative Concept]
   795   C1456781:mole [Neoplastic Process]
   795   C1824986:mol [Gene or Genome]
   712 E C0026367:Molar [Body Part, Organ, or Organ Component]

Phrase: ")."
Processing 00000000.tx.192: By contrast, channels of cells overexpressing PIP5K:WT have a K1/2 of 260.7 mol/l (H = 1.4), 26-fold higher than channels of uninfected cells or cells infected with PIP5K:1-238 (K1/2 of 11.3 mol/l, H = 1.4). 

Phrase: "By contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "channels of cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0007634:Cells [Cell]
   790   C0439799:Channel [Spatial Concept]
   790   C1706095:Channel [Conceptual Entity]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "PIP5K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ":"

Phrase: "WT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "have"

Phrase: "a K1/2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1721009:K1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C3272787:K1 [Gene or Genome]

Phrase: "of 260.7 mol/l (H = 1.4"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   845   C2827890:mol/L/h [Quantitative Concept]
   829   C0560019:mol/h [Quantitative Concept]
   818   C0347982:mol/L [Quantitative Concept]
   818   C0700308:h 1 [Element, Ion, or Isotope]
   795   C0027960:Mole [Neoplastic Process]
   795   C0324740:Mole [Mammal]
   795   C0439189:Mole [Quantitative Concept]
   795   C1456781:mole [Neoplastic Process]
   795   C1824986:mol [Gene or Genome]
   712 E C0026367:Molar [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: ","

Phrase: "26-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "higher than"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   799   C0205250:High [Qualitative Concept]
   799   C1299351:High [Qualitative Concept]
   799   C2700149:HIGH [Intellectual Product]
   750 E C0489786:Height [Organism Attribute]

Phrase: "channels of uninfected cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0439799:Channel [Spatial Concept]
   770   C1706095:Channel [Conceptual Entity]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "infected with PIP5K"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0439663:Infected [Functional Concept]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: ":"

Phrase: "1-238"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "(K1/2 of 11.3 mol/l,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0347982:mol/L [Quantitative Concept]
   748   C0027960:Mole [Neoplastic Process]
   748   C0324740:Mole [Mammal]
   748   C0439189:Mole [Quantitative Concept]
   748   C1456781:mole [Neoplastic Process]
   748   C1721009:K1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1824986:mol [Gene or Genome]
   748   C3272787:K1 [Gene or Genome]

Phrase: "H = 1.4"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0700308:h 1 [Element, Ion, or Isotope]
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.193: C: Averaged membrane potential of uninfected INS-1 cells and cells infected with the PIP5K:WT or PIP5K:1-238 virus (n = 512) at 12 mmol/l glucose monitored using perforated patch-clamp recording. 

Phrase: "C"

Phrase: ":"

Phrase: "Averaged membrane potential of uninfected"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0025251:Membrane Potential [Cell Function]
   760   C0025255:Membrane [Tissue]
   760   C0596901:Membrane [Cell Component]
   760   C1706182:Membrane [Manufactured Object]
   760   C3245505:Potential [Qualitative Concept]

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "infected with the PIP5K"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   753   C0031701:phosphate [Organophosphorus Compound]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0439663:Infected [Functional Concept]
   753   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: ":"

Phrase: "WT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "PIP5K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ":"

Phrase: "1-238 virus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0042776:Virus [Virus]
   827   C0319157:virus [Virus]

Phrase: "(n = 512"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "at 12 mmol/l glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "monitored"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0030695:monitor [Health Care Activity]
   966   C0150369:monitor [Health Care Activity]
   966   C0181904:Monitor [Medical Device]
   966   C0596972:Monitor [Medical Device]
   966   C1521743:Monitor [Professional or Occupational Group]
   966   C1704646:Monitor [Manufactured Object]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "perforated patch-clamp recording."
Processing 00000000.tx.194: The error bar is the SE. 

Phrase: "The error bar"

Phrase: "is"

Phrase: "the SE."
Processing 00000000.tx.195: The RMP of cells infected with the PIP5K:WT virus is significantly more hyperpolarized than uninfected cells at high glucose. 

Phrase: "The RMP of cells"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   833   C0025251:resting membrane potential [Cell Function]
           Membrane Potential
           potential resting
   833   C1704297:Resting Membrane Potential [Cell Function]
           Resting Potential
   783   C0007603:cells membrane [Cell Component]
   767   C1512899:Resting Cell [Cell]
           resting
   767 E C3161472:Cell Membrane [Cell Component]
   753   C0025255:Membrane [Tissue]
   753   C0035253:Resting [Daily or Recreational Activity]
   753   C0596901:Membrane [Cell Component]
   753   C1706182:Membrane [Manufactured Object]
   753   C3245505:Potential [Qualitative Concept]
   719 E C1622890:ResT [Molecular Function]

Phrase: "infected with the PIP5K"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   753   C0031701:phosphate [Organophosphorus Compound]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0439663:Infected [Functional Concept]
   753   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: ":"

Phrase: "WT virus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0449572:type virus [Intellectual Product]
   827   C0042776:Virus [Virus]
   827   C0319157:virus [Virus]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "is"

Phrase: "significantly more"

Phrase: "hyperpolarized than uninfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "at high glucose."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0860803:high glucose [Finding]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.196: *P < 0.001.  

Phrase: "*P < 0.001."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.197: View larger version (21K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(21K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.198: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.199: Overexpression of PIP5K:WT attenuates insulin secretion response to glucose stimulation. 

Phrase: "Overexpression of PIP5K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1514559:Overexpression [Genetic Function]

Phrase: ":"

Phrase: "WT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "attenuates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599946:Attenuate [Activity]

Phrase: "insulin secretion response to glucose stimulation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]
Processing 00000000.tx.200: A: Insulin secretion at 3 or 12 mmol/l glucose was measured in uninfected (uninf) cells or cells infected with the PIP5K:WT or the PIP5K:1-238 virus. 

Phrase: "A"

Phrase: ":"

Phrase: "Insulin secretion at 3"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C1256369:insulin secretion [Cell Function]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0036536:secretion [Biologic Function]
   770   C0036537:Secretion [Body Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "or"

Phrase: "12 mmol/l glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "was"

Phrase: "measured in uninfected (uninf) cells"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0444706:Measured [Qualitative Concept]
   770   C3282337:Cells [Cell]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "infected with the PIP5K"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   753   C0031701:phosphate [Organophosphorus Compound]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0439663:Infected [Functional Concept]
   753   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: ":"

Phrase: "WT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "the PIP5K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ":"

Phrase: "1-238 virus."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0042776:Virus [Virus]
   827   C0319157:virus [Virus]
Processing 00000000.tx.201: The response is normalized to that observed in uninfected cells at 3 mmol/l glucose. 

Phrase: "The response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "is"

Phrase: "normalized to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1882115:Normalized [Research Activity]

Phrase: "observed in uninfected cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C1441672:Observed [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "at 3 mmol/l glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.202: Cells infected with the PIP5K:WT virus had significantly reduced insulin secretion response at 12 mmol/l glucose (3.6  0.4-fold) compared with uninfected cells (9.5  0.6-fold) or cells infected with the PIP5K:1-238 virus (8.4  0.7-fold; n = 59 in each case). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "infected with the PIP5K"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   753   C0031701:phosphate [Organophosphorus Compound]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0439663:Infected [Functional Concept]
   753   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: ":"

Phrase: "WT virus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0449572:type virus [Intellectual Product]
   827   C0042776:Virus [Virus]
   827   C0319157:virus [Virus]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "had"

Phrase: "significantly reduced insulin secretion response at 12 mmol/l glucose"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0871261:Response [Organism Attribute]
   739   C1704632:Response [Finding]
   739   C1706817:Response [Intellectual Product]
   739   C2911692:Response [Mental Process]

Phrase: "(3.6  0.4-fold"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0332462:Fold [Spatial Concept]
   804   C1880834:FOLD [Phenomenon or Process]
   708   C0442757:3 4 [Finding]

Phrase: ")"

Phrase: "compared with uninfected cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C1707455:Compared [Activity]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(9.5  0.6-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332462:Fold [Spatial Concept]
   804   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: "or"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "infected with the PIP5K"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   753   C0031701:phosphate [Organophosphorus Compound]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0439663:Infected [Functional Concept]
   753   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: ":"

Phrase: "1-238 virus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0042776:Virus [Virus]
   827   C0319157:virus [Virus]

Phrase: "(8.4  0.7-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332462:Fold [Spatial Concept]
   804   C1880834:FOLD [Phenomenon or Process]

Phrase: "; n = 59 in each case"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441922:N+ [Intellectual Product]
   760   C0868928:Case [Functional Concept]
   760   C1553036:[n] [Quantitative Concept]
   760   C1706255:CASE [Medical Device]
   760   C1706256:Case [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.203: By contrast, no significant difference was observed between cells infected with the PIP5K:WT virus or uninfected control cells at 3 mmol/l glucose. 

Phrase: "By contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "no significant difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1705241:*Difference [Quantitative Concept]
   861   C1705242:Difference [Qualitative Concept]
   789 E C0443199:Differential [Qualitative Concept]

Phrase: "was"

Phrase: "observed between cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C1441672:Observed [Functional Concept]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "infected with the PIP5K"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   753   C0031701:phosphate [Organophosphorus Compound]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0439663:Infected [Functional Concept]
   753   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: ":"

Phrase: "WT virus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0449572:type virus [Intellectual Product]
   827   C0042776:Virus [Virus]
   827   C0319157:virus [Virus]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "or"

Phrase: "uninfected control cells at 3 mmol/l glucose."
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   767   C0347983:cells/L [Quantitative Concept]
   767   C0726398:GLUCOSE CONTROL [Indicator, Reagent, or Diagnostic Aid]
   750 E C0022827:cell l [Cell]
   744   C0007634:Cells [Cell]
   744   C0243148:control [Qualitative Concept]
   744   C1550141:Control [Substance]
   744   C1882979:Control [Conceptual Entity]
   744   C2587213:Control [Functional Concept]
   744   C3274648:Control [Qualitative Concept]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.204: Note that at 3 mmol/l glucose, cells infected with the PIP5K:1-238 virus showed a twofold increase in insulin release; 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that at 3 mmol/l glucose,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1532563:mmol/L [Quantitative Concept]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0439190:MMOLE [Quantitative Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "infected with the PIP5K"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   753   C0031701:phosphate [Organophosphorus Compound]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0439663:Infected [Functional Concept]
   753   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: ":"

Phrase: "1-238 virus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0042776:Virus [Virus]
   827   C0319157:virus [Virus]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a twofold increase in insulin release"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0020459:INSULIN INCREASE [Disease or Syndrome]
   753   C0442805:Increase [Functional Concept]

Phrase: ";"
Processing 00000000.tx.205: this is likely due to the documented dominant-negative effect of the mutant on wild-type kinase activity (20,21), leading to a slight decrease in PIP2 levels and elevated basal insulin secretion. 

Phrase: "this"

Phrase: "is"

Phrase: "likely due to the documented dominant-negative effect of the mutant"
Meta Candidates (Total=19; Excluded=2; Pruned=0; Remaining=17)
   772   C1512032:Dominant-Negative Mutant [Cell or Molecular Dysfunction]
           Dominant Negative
   756   C0678226:Due to [Functional Concept]
           due
   738   C0205160:Negative [Qualitative Concept]
   738   C0332148:Likely [Qualitative Concept]
   738   C0596988:Mutant [Cell or Molecular Dysfunction]
   738   C0750492:Likely [Idea or Concept]
   738   C1280500:Effect [Qualitative Concept]
   738   C1301725:Documented [Health Care Activity]
   738   C1513916:Negative [Finding]
   738   C1527180:Dominant [Functional Concept]
   738   C1609436:documented [Idea or Concept]
   738   C2348382:Effect [Qualitative Concept]
   738   C2825415:Negative [Conceptual Entity]
   738   C2825491:Negative [Qualitative Concept]
   738   C3146286:Due [Idea or Concept]
   704 E C1301746:document [Intellectual Product]
   704 E C1547673:Document [Intellectual Product]

Phrase: "on wild-type kinase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1150423:kinase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "(20,"

Phrase: "21"

Phrase: ")"

Phrase: ","

Phrase: "leading to a slight decrease"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   760   C0332152:Leading [Temporal Concept]
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]
   760   C1522538:Leading [Functional Concept]
   760   C2937276:Slight [Qualitative Concept]
   760   C2945599:Slight [Qualitative Concept]
   726 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   726 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   726 E C2348269:Lead [Element, Ion, or Isotope]
   726 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in PIP2 levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "elevated basal insulin secretion."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0650607:Basal insulin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C1256369:insulin secretion [Cell Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.206: *P < 0.001. 

Phrase: "*P < 0.001."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.207: B: Membrane capacitance change in response to voltage-clamp depolarizations. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "Membrane capacitance change in response"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0392747:Change [Functional Concept]
   760   C0443172:change [Quantitative Concept]
   760   C1705241:Change [Quantitative Concept]

Phrase: "to voltage-clamp depolarizations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0872303:voltage clamp [Research Activity]
Processing 00000000.tx.208: The upper trace represents the voltage-clamp protocol used to evoke exocytosis, and the dotted lower traces the capacitance increase observed in PIP5K:WT overexpressing (gray) and uninfected control cells (white). 

Phrase: "The upper trace"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0442822:Trace [Quantitative Concept]
   861   C1524031:Trace [Qualitative Concept]
   861   C1883002:Trace [Functional Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the voltage-clamp protocol"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0442711:Protocol [Intellectual Product]
   827   C1507394:Protocol [Intellectual Product]
   827   C1522729:Protocol [Intellectual Product]
   827   C2348563:Protocol [Intellectual Product]
   734   C0872303:voltage clamp [Research Activity]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "evoke"

Phrase: "exocytosis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015283:Exocytosis [Cell Function]

Phrase: "and"

Phrase: "the dotted lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441994:Lower [Spatial Concept]
   861   C1548802:Lower [Body Location or Region]
   861   C2003888:Lower [Activity]

Phrase: "traces"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0442822:Trace [Quantitative Concept]
  1000   C1524031:Trace [Qualitative Concept]
  1000   C1883002:Trace [Functional Concept]

Phrase: "the capacitance increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:Increase [Functional Concept]

Phrase: "observed in PIP5K"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1441672:Observed [Functional Concept]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: ":"

Phrase: "WT overexpressing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1514559:overexpress [Genetic Function]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "(gray"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0556636:gray [Quantitative Concept]
  1000   C1269776:Gray [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "uninfected control cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   827   C0007634:Cells [Cell]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(white"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007457:White [Population Group]
  1000   C0043157:White [Population Group]
  1000   C0220938:White [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.209: C: Averaged capacitance increase during the first (left) and all six depolarizations (right) in experiments as in B (n = 812; color code as in A). 

Phrase: "C"

Phrase: ":"

Phrase: "Averaged capacitance increase during the first"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "(left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "all six depolarizations"

Phrase: "(right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: ")"

Phrase: "in experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "as in B (n = 812"

Phrase: "; color code"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0009219:code [Occupational Activity]
   861   C0805701:Code [Intellectual Product]

Phrase: "as in A"

Phrase: ")."
Processing 00000000.tx.210: D: Charge influx during the first depolarization from the same set of cells shown in C. 

Phrase: "D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ":"

Phrase: "Charge influx during the first depolarization"

Phrase: "from the same set"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0036849:Set [Mental Process]
   861   C1442518:Set [Functional Concept]
   861   C1705195:Set [Conceptual Entity]

Phrase: "of cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "shown in C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.211: With Cs in the pipette (see RESEARCH DESIGN AND METHODS), the vast majority of the current is through voltage-gated Ca channels (32).   

Phrase: "With Cs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540510:cs [Quantitative Concept]

Phrase: "in the pipette"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0182301:Pipette [Medical Device]
  1000   C1706407:Pipette [Medical Device]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0035171:Research Design [Research Activity]
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]
   861   C1707689:Design [Activity]
   861   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "the vast majority of the current"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0680220:majority [Social Behavior]

Phrase: "is through voltage-gated Ca channels"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0597675:voltage gated channel [Physiologic Function]
   790   C3258486:Voltage-gated [Qualitative Concept]
   753   C0598352:Voltage [Quantitative Concept]
   719   C0439799:Channel [Spatial Concept]
   719   C1706095:Channel [Conceptual Entity]

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.212: DISCUSSION TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Despite the effects of membrane phosphoinositides, especially PIP2, on KATP channel activity having been well documented in vitro studies for some time (11,12,33,34), the relevance of channel regulation by PIP2 to insulin secretion remains controversial (15,35). 

Phrase: "DISCUSSION TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES  Despite the effects of membrane phosphoinositides,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   748   C0025255:Membrane [Tissue]
   748   C0031621:Phosphoinositides [Biologically Active Substance,Lipid]
   748   C0596901:Membrane [Cell Component]
   748   C1280500:effects [Qualitative Concept]
   748   C1514811:Reference [Idea or Concept]
   748   C1706182:Membrane [Manufactured Object]
   748   C1706462:Reference [Conceptual Entity]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "especially PIP2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0070798:PIP2 [Biologically Active Substance,Lipid,Organophosphorus Compound]
   861   C3538724:PIP2 [Body Part, Organ, or Organ Component]

Phrase: "on KATP channel activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1153410:channel activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "having"

Phrase: "been"

Phrase: "well documented in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021135:In Vitro [Intellectual Product]
   861   C1533691:in vitro [Qualitative Concept]
           vitro
   861   C2827718:In Vitro [Functional Concept]

Phrase: "studies for some time"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   819   C0040227:Time Studies [Intellectual Product]
   819   C2349982:Study Time [Temporal Concept]
   770   C0040223:Time [Temporal Concept]
   770   C0557651:Study [Manufactured Object]
   770   C0947630:studies [Laboratory Procedure]
   770   C2603343:Study [Research Activity]
   770   C3541383:Time [Temporal Concept]
   715 E C0442043:Temporal [Spatial Concept]
   715 E C2362314:Temporal [Temporal Concept]

Phrase: "(11,"

Phrase: "12,"

Phrase: "33,"

Phrase: "34"

Phrase: ")"

Phrase: ","

Phrase: "the relevance of channel regulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2347946:Relevance [Qualitative Concept]

Phrase: "by PIP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0070798:PIP2 [Biologically Active Substance,Lipid,Organophosphorus Compound]
  1000   C3538724:PIP2 [Body Part, Organ, or Organ Component]

Phrase: "to insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "remains"

Phrase: "controversial"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0680243:controversies [Social Behavior]

Phrase: "(15,"

Phrase: "35"

Phrase: ")."
Processing 00000000.tx.213: To address this issue, it is necessary to directly correlate the interactions between KATP channels and PIP2 in -cells to insulin secretion. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "this issue,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033213:Issue [Finding]
  1000   C1706387:Issue [Intellectual Product]

Phrase: "it"

Phrase: "is"

Phrase: "necessary to directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1947931:Directly [Qualitative Concept]

Phrase: "correlate"

Phrase: "the interactions between KATP channels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "PIP2 in -cells to insulin secretion."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   767   C0030281:Insulin Cell [Cell]
   767   C1327616:Cell secretion [Cell Function]
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.214: INS-1 clone 832/13 is a rat insulinoma cell line widely used to study -cell function; 

Phrase: "INS-1 clone 832/13"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   812   C0009013:Clone [Cell]
   812   C1522642:Clone [Tissue]
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]
   741 E C1704387:Clonal [Qualitative Concept]
   712 E C0796368:clonality [Diagnostic Procedure]

Phrase: "is"

Phrase: "a rat insulinoma cell line widely"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   888   C1514733:Rat Cell Line [Cell]
   840   C0007600:Cell Line [Cell]
   804   C0007634:Cell [Cell]
   804   C0021670:insulinoma [Neoplastic Process]
   804   C0034693:Rat, NOS [Mammal]
   804   C0034721:Rat [Mammal]
   804   C0205132:Line [Spatial Concept]
   804   C1269647:Cell [Cell]
   804   C1550648:Line [Substance]
   804   C1552960:Line [Quantitative Concept]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "study -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "cell function"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0007613:Cell Function [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1705273:Function [Intellectual Product]
   861   C1948049:Cell [Spatial Concept]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.215: it exhibits robust glucose-stimulated insulin secretion, mediated by both KATP-dependent and independent pathways (22). 

Phrase: "it"

Phrase: "exhibits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "robust glucose-stimulated insulin secretion,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   853   C1719133:Glucose/Insulin [Quantitative Concept]
   840   C1256369:insulin secretion [Cell Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0036536:secretion [Biologic Function]
   804   C0036537:Secretion [Body Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "mediated by both KATP-dependent"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C0851827:Dependent [Qualitative Concept]
   760   C1701901:Dependent [Qualitative Concept]
   760   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "independent pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathways [Molecular Function]
   861   C1705987:Pathways [Conceptual Entity]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.216: Our studies demonstrate that alterations in KATP channelPIP2 interactions have profound effects on insulin secretion, establishing a physiological role of PIP2 in controlling insulin secretion through KATP channel regulation. 

Phrase: "Our studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "demonstrate"

Phrase: "that alterations in KATP channelPIP2 interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1515926:Alteration [Idea or Concept]

Phrase: "have"

Phrase: "profound effects on insulin secretion,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "establishing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establishing [Qualitative Concept]

Phrase: "a physiological role of PIP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in controlling insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C1256369:insulin secretion [Cell Function]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0036536:secretion [Biologic Function]
   827   C0036537:Secretion [Body Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "through KATP channel regulation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0851285:Regulation [Governmental or Regulatory Activity]
   827   C1327622:Regulation [Biologic Function]
Processing 00000000.tx.217: In altering channelPIP2 interactions, we took two approaches: one by manipulating the channel subunit Kir6.2, the other by manipulating cellular PIP2 levels. 

Phrase: "In altering channelPIP2 interactions,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1704675:Interaction [Functional Concept]

Phrase: "we"

Phrase: "took"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1515187:Take [Health Care Activity]

Phrase: "two approaches"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0449445:Approaches [Spatial Concept]
   861   C1292724:Approaches [Functional Concept]

Phrase: ":"

Phrase: "one by manipulating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205447:One [Quantitative Concept]

Phrase: "the channel subunit Kir6.2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1416578:Kir6.2 [Gene or Genome]
   812   C0439799:Channel [Spatial Concept]
   812   C1706095:Channel [Conceptual Entity]
   812   C1711351:Subunit [Quantitative Concept]

Phrase: "the"

Phrase: "other by manipulating cellular PIP2 levels."
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   753   C0007634:Cellular [Cell]
   753   C0070798:PIP2 [Biologically Active Substance,Lipid,Organophosphorus Compound]
   753   C0178539:Cellular [Functional Concept]
   753   C0205394:Other [Qualitative Concept]
   753   C0441889:Levels [Qualitative Concept]
   753   C2584326:Manipulating [Organism Function]
   753   C3538724:PIP2 [Body Part, Organ, or Organ Component]
   719 E C0456079:Level [Classification]
   719 E C0947647:Manipulate [Therapeutic or Preventive Procedure]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.218: While interpretation of experiments in which Kir6.2 subunit is the subject of manipulation is straightforward, interpretation of experiments involving the manipulation of PIP2 concentrations is more complicated due to its role in diverse cellular processes. 

Phrase: "While"

Phrase: "interpretation of experiments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0459471:Interpretation [Intellectual Product]
   790   C3173575:Interpretation [Clinical Attribute]

Phrase: "in which Kir6.2 subunit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1711351:Subunit [Quantitative Concept]
   734   C1416578:Kir6.2 [Gene or Genome]

Phrase: "is"

Phrase: "the subject of manipulation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0681850:Subject [Group]
   770   C1550501:{Subject} [Idea or Concept]
   770   C1706203:Subject [Idea or Concept]
   770   C2349001:Subject [Human]
   770   C2697811:Subject [Functional Concept]

Phrase: "is"

Phrase: "straightforward, interpretation of experiments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0459471:Interpretation [Intellectual Product]
   770   C3173575:Interpretation [Clinical Attribute]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "the manipulation of PIP2 concentrations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0185111:Manipulation, NOS [Therapeutic or Preventive Procedure]
   760   C0947647:Manipulation [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "complicated due to its role"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0035820:Role [Social Behavior]
   760   C0231242:Complicated [Functional Concept]
   760   C1705810:Role [Conceptual Entity]
   760   C3146286:Due [Idea or Concept]

Phrase: "in diverse cellular processes."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C0007613:Cellular Process [Cell Function]
   884   C1325880:cellular process [Cell Function]
   793   C1184743:Process [Body Part, Organ, or Organ Component]
   793   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.219: For example, recent studies indicate that PIP2 is required for recruitment of insulin granules to the release sites during the secondary phase of insulin secretion: a decrease in PIP2 levels reduces, whereas an increase in PIP2 levels enhances insulin secretion (18,19). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "indicate"

Phrase: "that PIP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0070798:PIP2 [Biologically Active Substance,Lipid,Organophosphorus Compound]
  1000   C3538724:PIP2 [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "required for recruitment of insulin granules"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0010837:Granules [Cell Component]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0993609:Granules [Biomedical or Dental Material]
   753   C1514873:Required [Functional Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C2949735:Recruitment [Activity]

Phrase: "to the release sites"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0030685:Release [Health Care Activity]
   861   C0205145:Sites [Spatial Concept]
   861   C0391871:Release [Functional Concept]
   861   C0439180:% release [Quantitative Concept]
   861   C0680255:release [Health Care Activity]
   861   C1283071:Release [Functional Concept]
   861   C1963578:Release [Therapeutic or Preventive Procedure]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "during the secondary phase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205390:Phase [Temporal Concept]

Phrase: "of insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ":"

Phrase: "a decrease in PIP2 levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]

Phrase: "reduces"

Phrase: ","

Phrase: "whereas"

Phrase: "an increase in PIP2 levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(18,"

Phrase: "19"

Phrase: ")."
Processing 00000000.tx.220: In addition, PIP2 has been shown to control the rate of endocytosis (3638). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "PIP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0070798:PIP2 [Biologically Active Substance,Lipid,Organophosphorus Compound]
  1000   C3538724:PIP2 [Body Part, Organ, or Organ Component]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "the rate of endocytosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0871208:Rate [Activity]
   770   C1521828:Rate [Quantitative Concept]

Phrase: "(3638"

Phrase: ")."
Processing 00000000.tx.221: Curiously, unlike that reported in primary -cells and chromaffin cells (18,39), we did not detect a significantly larger increase in membrane capacitance change upon direct voltage-clamp membrane depolarization in INS-1 cells with elevated PIP2 (Fig. 5B and C). 

Phrase: "Curiously,"

Phrase: "unlike that"

Phrase: "reported in primary -cells"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   770   C0007634:Cells [Cell]
   770   C0205225:Primary [Qualitative Concept]
   770   C0439631:Primary [Therapeutic or Preventive Procedure]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C3282337:Cells [Cell]
   770   C3496591:Reported [Clinical Attribute]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
   737 E C3273238:Report [Intellectual Product]

Phrase: "and"

Phrase: "chromaffin cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0376604:Chromaffin Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(18,"

Phrase: "39"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "a significantly larger increase in membrane capacitance change"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "upon direct voltage-clamp membrane depolarization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   840   C1816453:membrane depolarization [Cell Function]

Phrase: "in"

Phrase: "INS-1 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "with elevated PIP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0070798:PIP2 [Biologically Active Substance,Lipid,Organophosphorus Compound]
   861   C3538724:PIP2 [Body Part, Organ, or Organ Component]

Phrase: "(Fig. 5B"

Phrase: "and"

Phrase: "C)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.222: The discrepancy might be due to differences in the level of PIP2 overexpression; 

Phrase: "The discrepancy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1290905:Discrepancy [Finding]

Phrase: "might"

Phrase: "be due to differences"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0678226:Due to [Functional Concept]
           due
   770   C2987476:Be [Conceptual Entity]
   770   C3146286:Due [Idea or Concept]
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "in the level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0441889:Level [Qualitative Concept]
  1000   C0456079:Level [Classification]
  1000   C1547707:Level [Geographic Area]
  1000   C2946261:Level [Pharmacologic Substance]

Phrase: "of PIP2 overexpression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1514559:Overexpression [Genetic Function]

Phrase: ";"
Processing 00000000.tx.223: the prolonged high level of PIP2 seen in PIP5K:WT virusinfected INS-1 cells might lead to increased membrane endocytosis, masking the capacitance increase expected from enhanced exocytosis. 

Phrase: "the prolonged high level of PIP2"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0205250:High [Qualitative Concept]
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1299351:High [Qualitative Concept]
   753   C1547707:Level [Geographic Area]
   753   C2700149:HIGH [Intellectual Product]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "seen in PIP5K"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0205397:Seen [Qualitative Concept]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   726 E C0042789:see [Organism Function]
   726 E C1947903:See [Activity]

Phrase: ":"

Phrase: "WT virusinfected INS-1 cells"

Phrase: "might"

Phrase: "lead to increased membrane endocytosis,"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   797   C0861064:increased lead [Finding]
   797   C1372294:Increased Endocytosis [Cell Function]
   760   C0014139:Endocytosis [Cell Function]
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0025255:Membrane [Tissue]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C0596901:Membrane [Cell Component]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C1706182:Membrane [Manufactured Object]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C2984285:Endocytosis [Functional Concept]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "masking"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0150112:masking [Functional Concept]
   966 E C0024861:Mask [Medical Device]
   966 E C1538279:MASK [Gene or Genome]
   966 E C1845191:MASK [Gene or Genome]

Phrase: "the capacitance increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:Increase [Functional Concept]

Phrase: "expected from enhanced exocytosis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0015283:Exocytosis [Cell Function]
   770   C1517001:Expected [Idea or Concept]
   770   C2349975:Enhanced [Activity]
Processing 00000000.tx.224: Regardless, even if there is an effect of PIP2 that acts directly on the exocytotic machinery, this effect is likely to be small compared with the effect of PIP2 via KATP channels, as the net result of PIP2 overexpression in our experiments is a decrease in glucose-induced insulin secretion (Fig. 5A). 

Phrase: "Regardless,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3641650:Regardless [Qualitative Concept]

Phrase: "even"

Phrase: "if"

Phrase: "there"

Phrase: "is"

Phrase: "an effect of PIP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "that"

Phrase: "acts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "directly on the exocytotic machinery,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0337076:machinery [Manufactured Object]
   760   C1947931:Directly [Qualitative Concept]

Phrase: "this effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "be"

Phrase: "small"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700321:Small [Quantitative Concept]

Phrase: "compared with the effect of PIP2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0070798:PIP2 [Biologically Active Substance,Lipid,Organophosphorus Compound]
   753   C1280500:Effect [Qualitative Concept]
   753   C1707455:Compared [Activity]
   753   C2348382:Effect [Qualitative Concept]
   753   C3538724:PIP2 [Body Part, Organ, or Organ Component]

Phrase: "via KATP channels,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1955862:KATP Channels [Amino Acid, Peptide, or Protein]
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: "as"

Phrase: "the net result of PIP2 overexpression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C2825142:Result [Finding]

Phrase: "in our experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "is"

Phrase: "a decrease in glucose-induced insulin secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]

Phrase: "(Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")."
Processing 00000000.tx.225: Increased endocytosis due to elevated PIP2 might also affect the level of membrane proteins involved in stimulation-secretion coupling, such as KATP channels. 

Phrase: "Increased endocytosis due to elevated PIP2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1372294:Increased Endocytosis [Cell Function]
   753   C0014139:Endocytosis [Cell Function]
   753   C2984285:Endocytosis [Functional Concept]

Phrase: "might"

Phrase: "also"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the level of membrane proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   781   C0428479:Protein level [Laboratory or Test Result]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "involved in stimulation-secretion coupling,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]
   760   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   760   C1314939:Involved [Functional Concept]
   760   C1948023:Stimulation [Natural Phenomenon or Process]
   760   C1948027:Coupling [Functional Concept]

Phrase: "such as KATP channels."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1955862:KATP Channels [Amino Acid, Peptide, or Protein]
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]
Processing 00000000.tx.226: If true, this would lead to fewer KATP channels at the cell surface and increased insulin secretion, making our observed impact of enhanced channel-PIP2 interaction on insulin secretion an underestimate. 

Phrase: "If"

Phrase: "true,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205238:True [Qualitative Concept]

Phrase: "this"

Phrase: "would"

Phrase: "lead to fewer KATP channels"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C1955862:KATP Channels [Amino Acid, Peptide, or Protein]
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]
   726   C0439799:Channel [Spatial Concept]
   726   C1706095:Channel [Conceptual Entity]

Phrase: "at the cell surface"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0699040:Cell surface [Cell Component]
   861   C0205148:Surface [Spatial Concept]

Phrase: "and"

Phrase: "increased insulin secretion,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C1372360:Increased Insulin Secretion [Organ or Tissue Function]
   901   C0020459:increased insulin [Disease or Syndrome]
   901   C1256369:insulin secretion [Cell Function]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0036536:secretion [Biologic Function]
   827   C0036537:Secretion [Body Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "making"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "our observed impact of enhanced channel-PIP2 interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1825598:IMPACT [Gene or Genome]

Phrase: "on insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "an underestimate."
Processing 00000000.tx.227: Taken together, despite the multiple mechanisms by which PIP2 may affect insulin secretion, our observation that elevated PIP2 dramatically reduces the ATP sensitivity of endogenous KATP channels (Fig. 4) provides strong consistency with a critical role of membrane PIP2 in controlling -cell KATP channel activity and hence -cell excitability and insulin secretion. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "despite the multiple mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "by which PIP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0070798:PIP2 [Biologically Active Substance,Lipid,Organophosphorus Compound]
  1000   C3538724:PIP2 [Body Part, Organ, or Organ Component]

Phrase: "may"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "insulin secretion,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "our observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that elevated PIP2 dramatically"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0070798:PIP2 [Biologically Active Substance,Lipid,Organophosphorus Compound]
   827   C3538724:PIP2 [Body Part, Organ, or Organ Component]

Phrase: "reduces"

Phrase: "the ATP sensitivity of endogenous KATP channels"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   757   C1547341:Channel sensitivity [Idea or Concept]
   748   C0036667:Sensitivity [Quantitative Concept]
   748   C0312418:Sensitivity [Mental Process]
   748   C0427965:Sensitivity [Finding]
   748   C1511883:Sensitivity [Quantitative Concept]
   748   C1522640:Sensitivity [Qualitative Concept]
   748   C2346484:SENSITIVITY [Phenomenon or Process]
   748   C2349185:Sensitivity [Qualitative Concept]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "strong consistency with a critical role of membrane PIP2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0332529:Consistency [Qualitative Concept]
   742   C1547017:Consistency [Quantitative Concept]
   729   C0332290:Consistent with [Idea or Concept]

Phrase: "in controlling -cell KATP channel activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C1153410:channel activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "hence -cell excitability"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0235169:Excitability [Sign or Symptom]
   755 E C0857393:excitable [Sign or Symptom]

Phrase: "and"

Phrase: "insulin secretion."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.228: In conclusion, our study demonstrates that membrane phosphoinositides play an integral role in determining the activity of KATP channels in -cells. 

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "our study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "demonstrates"

Phrase: "that membrane phosphoinositides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031621:Phosphoinositides [Biologically Active Substance,Lipid]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "an integral role in determining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "the activity of KATP channels in -cells."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   757   C1153410:channel activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.229: Many hormones, neurotransmitters, and nutrients affect the metabolism of phosphoinositides in -cells (4044). 

Phrase: "Many hormones,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0019932:Hormones [Hormone]
   916 E C0458083:Hormonal [Qualitative Concept]

Phrase: "neurotransmitters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027908:Neurotransmitters [Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "nutrients"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0678695:Nutrients [Food]
   966 E C2347375:Nutrient [Conceptual Entity]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the metabolism of phosphoinositides in -cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1158430:phosphoinositide metabolism [Molecular Function]
   753   C0025519:Metabolism [Organism Function]
   753   C0025520:metabolism [Functional Concept]

Phrase: "(4044"

Phrase: ")."
Processing 00000000.tx.230: Our finding raises the possibility that variation in membrane phosphoinositides under normal and pathological conditions may affect insulin secretion by altering KATP channel activity. 

Phrase: "Our finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "raises"

Phrase: "the possibility"

Phrase: "that variation in membrane phosphoinositides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205419:Variation [Qualitative Concept]

Phrase: "under normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "pathological conditions"
Meta Candidates (Total=16; Excluded=11; Pruned=0; Remaining=5)
   861   C0030664:Pathological [Biomedical Occupation or Discipline]
   861   C1521733:Pathological [Functional Concept]
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   805 E C0040607:Training [Educational Activity]
   805 E C0220931:Training [Educational Activity]
   805 E C0336809:Train [Manufactured Object]
   805 E C1552514:Train [Manufactured Object]
   805 E C2673163:training [Qualitative Concept]
   789 E C0205469:pathology [Functional Concept]
   789 E C0677042:pathology [Pathologic Function]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "may"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "insulin secretion by altering KATP channel activity."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C1256369:insulin secretion [Cell Function]
   774   C1145751:insulin activity [Molecular Function]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0036536:secretion [Biologic Function]
   748   C0036537:Secretion [Body Substance]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
Processing 00000000.tx.231: Mutations in other Kir channels such as Kir2.1 that impair channel sensitivity to PIP2 have been shown to underlie Anderson syndromes (45). 

Phrase: "Mutations in other Kir channels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "such as Kir2.1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416584:KIR2.1 [Gene or Genome]

Phrase: "that"

Phrase: "impair"

Phrase: "channel sensitivity to PIP2"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C1547341:Channel sensitivity [Idea or Concept]
   797   C0332324:Sensitive to [Functional Concept]
   770   C0036667:Sensitivity [Quantitative Concept]
   770   C0312418:Sensitivity [Mental Process]
   770   C0427965:Sensitivity [Finding]
   770   C1511883:Sensitivity [Quantitative Concept]
   770   C1522640:Sensitivity [Qualitative Concept]
   770   C2346484:SENSITIVITY [Phenomenon or Process]
   770   C2349185:Sensitivity [Qualitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "underlie"

Phrase: "Anderson syndromes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0039082:Syndromes [Disease or Syndrome]
   861   C1558916:SYNDROMES [Finding]

Phrase: "(45"

Phrase: ")."
Processing 00000000.tx.232: Our study also raises the possibility that naturally occurring mutations in Kir6.2 that alter channel-PIP2 interactions may cause insulin secretion diseases.  

Phrase: "Our study also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "raises"

Phrase: "the possibility"

Phrase: "that naturally occurring mutations in Kir6.2"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0026882:Mutations [Genetic Function]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "channel-PIP2 interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1704675:Interaction [Functional Concept]

Phrase: "may"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "insulin secretion diseases."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0012634:Diseases [Disease or Syndrome]
   755 E C1836721:MALS [Finding]
   755 E C3538764:MALS [Gene or Genome]
   755 E C3540595:MAL [Gene or Genome]
   734   C1256369:insulin secretion [Cell Function]
Processing 00000000.tx.233: ACKNOWLEDGMENTS  This work was supported by National Institutes of Health (NIH) Grant DK57699 (to S.-L.S.) and the European Foundation for the Study of Diabetes (to S.B.). 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by National Institutes of Health (NIH) Grant DK57699"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   833   C0027468:National Institutes of Health [Health Care Related Organization]
           national health institutes
   744   C0018173:Grant [Quantitative Concept]
   744   C0018684:Health [Idea or Concept]
   744   C0021622:Institutes [Organization]
   744   C1521721:Supported [Conceptual Entity]
   744   C1548284:Grant [Idea or Concept]
   744   C3245503:national [Intellectual Product]
   711 E C0183683:Support [Medical Device]
   711 E C1272753:Institute [Idea or Concept]

Phrase: "(to S.-L.S."

Phrase: ")"

Phrase: "and"

Phrase: "the European Foundation for the Study of Diabetes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0016617:Foundation [Organization]

Phrase: "(to S.B."

Phrase: ")."
Processing 00000000.tx.234: S.B. was a recipient of a European Molecular Biology Organization long-term fellowship during the course of this study. 

Phrase: "S."

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "was"

Phrase: "a recipient of a European Molecular Biology Organization long-term fellowship"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1709854:Recipient [Human]

Phrase: "during the course"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750729:Course [Temporal Concept]

Phrase: "of this study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]
Processing 00000000.tx.235: We thank Dr. 

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.236: Carol A. 

Phrase: "Carol A."
Processing 00000000.tx.237: Vandenberg for providing the rat Kir6.2 clone, Dr. 

Phrase: "Vandenberg for providing"

Phrase: "the rat Kir6.2 clone,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0009013:Clone [Cell]
   812   C1522642:Clone [Tissue]
   741 E C1704387:Clonal [Qualitative Concept]
   712 E C0796368:clonality [Diagnostic Procedure]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.238: Christopher Newgard for the 832/13 clone of INS-1 cells, Dr. 

Phrase: "Christopher Newgard for the 832/13 clone of"

Phrase: "INS-1 cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.239: Peter Rotwein for the GFP adenovirus, and Dr. 

Phrase: "Peter Rotwein for the GFP adenovirus,"

Phrase: "and"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.240: J. 

Phrase: "J."
Processing 00000000.tx.241: Nathan Davis for the antiserum against PIP5K. 

Phrase: "Nathan Davis for the antiserum"

Phrase: "against PIP5K."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.242: We are grateful to Dr. 

Phrase: "We"

Phrase: "are"

Phrase: "grateful to Dr."
Processing 00000000.tx.243: Wolfhard Almers (Portland, OR; supported by NIH MH60600) for the use of capacitance measurement equipment and to Drs. 

Phrase: "Wolfhard Almers"

Phrase: "(Portland,"

Phrase: "OR"

Phrase: ";"

Phrase: "supported by NIH MH60600"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   853   C0027468:National Institutes of Health [Health Care Related Organization]
           national health institutes
   748   C0018684:Health [Idea or Concept]
   748   C0021622:Institutes [Organization]
   748   C1521721:Supported [Conceptual Entity]
   748   C3245503:national [Intellectual Product]
   714 E C0183683:Support [Medical Device]
   714 E C1272753:Institute [Idea or Concept]

Phrase: ")"

Phrase: "for the use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "of capacitance measurement equipment"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0014672:Equipment [Manufactured Object]
   827   C0220824:equipment [Manufactured Object]
   827   C1523994:Equipment [Manufactured Object]
   827   C2827396:Equipment [Manufactured Object]
   771 E C1706469:Gear [Qualitative Concept]
   771 E C1706470:GEARS [Manufactured Object]

Phrase: "and to Drs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]
Processing 00000000.tx.244: Elizabeth Wilson and Zhengfeng Zhou for advice on constructing adenoviruses.  

Phrase: "Elizabeth Wilson"

Phrase: "and"

Phrase: "Zhengfeng Zhou for advice"

Phrase: "on constructing adenoviruses."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0001483:Adenoviruses [Virus]
   827 E C0001486:Adenovirus [Disease or Syndrome]
   827 E C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.245: FOOTNOTES  C.-W. 

Phrase: "FOOTNOTES  C.-W."
Processing 00000000.tx.246: L. and F.Y. contributed equally to this work. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "F.Y."

Phrase: "contributed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1880177:Contribute [Activity]

Phrase: "equally to this work."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0043227:Work [Occupational Activity]
Processing 00000000.tx.247: Address correspondence and reprint requests to S.-L. 

Phrase: "Address correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0282413:Correspondence [Intellectual Product]

Phrase: "and"

Phrase: "reprint"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3273171:Reprint [Intellectual Product]

Phrase: "requests"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0686900:request [Functional Concept]
  1000   C1272683:Request [Functional Concept]
  1000   C1522634:Request [Intellectual Product]

Phrase: "to S.-L."
Processing 00000000.tx.248: Shyng, Center for Research on Occupational and Environmental Toxicology, Oregon Health & Science University, 3181 S.W. 

Phrase: "Shyng,"

Phrase: "Center for Research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0683939:center research [Manufactured Object,Organization]
   790   C0205099:Center [Spatial Concept]

Phrase: "on Occupational"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521127:Occupational [Functional Concept]

Phrase: "and"

Phrase: "Environmental Toxicology,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0178621:Environmental Toxicology [Biomedical Occupation or Discipline]
   861   C0040541:Toxicology [Biomedical Occupation or Discipline]
   861   C1548006:Toxicology [Intellectual Product]
   789 E C0205472:Toxicologic [Functional Concept]

Phrase: "Oregon Health & Science University,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0018684:Health [Idea or Concept]
   812   C0029195:Oregon [Geographic Area]
   812   C0036397:Science [Occupation or Discipline]
   812   C0041740:University [Manufactured Object,Organization]
   712 E C0031206:healthiness [Finding]

Phrase: "3181 S.W."
Processing 00000000.tx.249: Sam Jackson Park Rd., Portland, OR 97239. 

Phrase: "Sam Jackson Park Rd.,"

Phrase: "Portland,"

Phrase: "OR"

Phrase: "97239."
Processing 00000000.tx.250: E-mail: shyngs{at}ohsu.edu Received for publication May 6, 2005 and accepted in revised form July 11, 2005 GFP, green fluorescence protein; 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "shyngs{at}ohsu.edu"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0059804:EDU [Organic Chemical,Pharmacologic Substance]

Phrase: "Received for publication May 6,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0034036:Publication [Intellectual Product,Manufactured Object]
   760   C0034037:Publication [Occupational Activity]
   760   C1514756:Received [Qualitative Concept]
   760   C1704324:Publication [Intellectual Product]

Phrase: "2005"

Phrase: "and"

Phrase: "accepted in revised form July 11,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1272684:Accepted [Qualitative Concept]
   753   C1522492:Form [Functional Concept]
   753   C1527075:Revised [Therapeutic or Preventive Procedure]
   753   C1548435:Accepted [Idea or Concept]
   719 E C1548601:Accept [Idea or Concept]

Phrase: "2005 GFP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   899   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "green fluorescence protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   976   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.251: HA, influenza A virus hemagglutinin; 

Phrase: "HA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018909:Haemagglutinin, NOS [Immunologic Factor]

Phrase: "influenza A virus hemagglutinin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0018909:Haemagglutinin, NOS [Immunologic Factor]
   756   C0029347:Influenza A virus [Virus]
   708   C0029341:Influenza virus [Virus]

Phrase: ";"
Processing 00000000.tx.252: HBSS, HEPES balanced salt solution; 

Phrase: "HBSS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   756   C0543134:Balanced salt solution [Inorganic Chemical,Pharmacologic Substance]

Phrase: "HEPES balanced salt solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   756   C0543134:Balanced salt solution [Inorganic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.253: KATP channel, ATP-sensitive K+ channel; 

Phrase: "KATP channel,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439799:Channel [Spatial Concept]
   861   C1706095:Channel [Conceptual Entity]

Phrase: "ATP-sensitive K+ channel"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0332324:Sensitive [Functional Concept]
   812   C0439799:Channel [Spatial Concept]
   812   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C1550474:sensitive [Idea or Concept]
   812   C1706095:Channel [Conceptual Entity]
   812   C1708601:K' [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.254: PIP2, phosphatidylinositol 4,5-bisphosphates; 

Phrase: "PIP2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0070798:PIP2 [Biologically Active Substance,Lipid,Organophosphorus Compound]
  1000   C3538724:PIP2 [Body Part, Organ, or Organ Component]

Phrase: "phosphatidylinositol 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   861   C2348046:Phosphatidylinositol [Lipid]

Phrase: "5-bisphosphates"

Phrase: ";"
Processing 00000000.tx.255: PIP5K, phosphatidylinositol 4-phosphate 5 kinase; 

Phrase: "PIP5K,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "phosphatidylinositol 4-phosphate 5 kinase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0207206:phosphatidylinositol-4-phosphate 5-kinase [Amino Acid, Peptide, or Protein,Enzyme]
           phosphatidylinositol 4-phosphate kinase
   911   C0089793:Phosphatidylinositol 4-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0070799:phosphatidylinositol 4-phosphate [Lipid]

Phrase: ";"
Processing 00000000.tx.256: RMP, resting membrane potential  REFERENCES TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Aguilar-Bryan L, Bryan J: Molecular biology of adenosine triphosphate-sensitive potassium channels. 

Phrase: "RMP,"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
  1000   C0025251:resting membrane potential [Cell Function]
           resting potential
           Membrane Potential
  1000   C1704297:Resting Membrane Potential [Cell Function]
           Resting Potential
   827   C0025255:Membrane [Tissue]
   827   C0035253:Resting [Daily or Recreational Activity]
   827   C0596901:Membrane [Cell Component]
   827   C1512899:resting [Cell]
   827   C1706182:Membrane [Manufactured Object]
   827   C3245505:Potential [Qualitative Concept]
   793 E C1622890:ResT [Molecular Function]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "resting membrane potential"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
  1000   C0025251:resting membrane potential [Cell Function]
           resting potential
           Membrane Potential
  1000   C1704297:Resting Membrane Potential [Cell Function]
           Resting Potential
   827   C0025255:Membrane [Tissue]
   827   C0035253:Resting [Daily or Recreational Activity]
   827   C0596901:Membrane [Cell Component]
   827   C1512899:resting [Cell]
   827   C1706182:Membrane [Manufactured Object]
   827   C3245505:Potential [Qualitative Concept]
   793 E C1622890:ResT [Molecular Function]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0035171:Research Design [Research Activity]
   812   C0035168:research [Research Activity]
   812   C0242481:Research [Research Activity]
   812   C1707689:Design [Activity]
   812   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Aguilar-Bryan L,"

Phrase: "Bryan J"

Phrase: ":"

Phrase: "Molecular biology of adenosine triphosphate-sensitive potassium channels."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   744   C0005532:Biology [Biomedical Occupation or Discipline]
   744   C1521991:Molecular [Qualitative Concept]
Processing 00000000.tx.257: Endocr Rev20 :101 135,1999[Abstract/Free FullText] Ashcroft FM: Adenosine 5'-triphosphate-sensitive potassium channels. 

Phrase: "Endocr Rev20"

Phrase: ":"

Phrase: "101 135,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ashcroft FM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540627:FM [Gene or Genome]

Phrase: ":"

Phrase: "Adenosine 5'-triphosphate-sensitive potassium channels."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0032824:Potassium Channels [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0032821:Potassium [Element, Ion, or Isotope]
   799   C0597277:Potassium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   766   C0439799:Channel [Spatial Concept]
   766   C1706095:Channel [Conceptual Entity]
Processing 00000000.tx.258: Annu Rev Neurosci11 :97 118,1988[Medline] Ashcroft FM, Gribble FM: ATP-sensitive K+ channels and insulin secretion: their role in health and disease. 

Phrase: "Annu Rev Neurosci11"

Phrase: ":"

Phrase: "97 118,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439073:97 [Intellectual Product]
   861   C0439082:>97 [Quantitative Concept]

Phrase: "1988"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ashcroft FM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540627:FM [Gene or Genome]

Phrase: "Gribble FM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540627:FM [Gene or Genome]

Phrase: ":"

Phrase: "ATP-sensitive K+ channels"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0332324:Sensitive [Functional Concept]
   812   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C1550474:sensitive [Idea or Concept]
   812   C1708601:K' [Quantitative Concept]
   779   C0439799:Channel [Spatial Concept]
   779   C1706095:Channel [Conceptual Entity]

Phrase: "and"

Phrase: "insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ":"

Phrase: "their role in health"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "disease."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.259: Diabetologia42 :903 919,1999[Medline] Ashcroft FM, Kakei M: ATP-sensitive K+ channels in rat pancreatic beta-cells: modulation by ATP and Mg2+ ions. 

Phrase: "Diabetologia42"

Phrase: ":"

Phrase: "903 919,"

Phrase: "1999"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ashcroft FM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540627:FM [Gene or Genome]

Phrase: "Kakei M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "ATP-sensitive K+ channels in rat pancreatic beta-cells"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   762   C0022686:cells k [Cell]
   745 E C0022688:K cell [Cell]
   742   C0332324:Sensitive [Functional Concept]
   742   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   742   C1550474:sensitive [Idea or Concept]
   742   C1708601:K' [Quantitative Concept]
   708   C0439799:Channel [Spatial Concept]
   708   C1706095:Channel [Conceptual Entity]

Phrase: ":"

Phrase: "modulation by ATP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0443264:Modulation [Spatial Concept]

Phrase: "and"

Phrase: "Mg2+ ions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0022023:Ions [Element, Ion, or Isotope]
   827 E C1700702:ION [Functional Concept]
Processing 00000000.tx.260: J Physiol416 :349 367,1989[Abstract] Huopio H, Shyng SL, Otonkoski T, Nichols CG: KATP channels and insulin secretion disorders. 

Phrase: "J Physiol416"

Phrase: ":"

Phrase: "349 367,"

Phrase: "1989"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Huopio H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Shyng SL,"

Phrase: "Otonkoski T,"

Phrase: "Nichols CG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3540479:CG [Gene or Genome]

Phrase: ":"

Phrase: "KATP channels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1955862:KATP Channels [Amino Acid, Peptide, or Protein]
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: "and"

Phrase: "insulin secretion disorders."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0012634:Disorders [Disease or Syndrome]
   734   C1256369:insulin secretion [Cell Function]
Processing 00000000.tx.261: Am J Physiol Endocrinol Metab283 :E207 E216,2002[Abstract/Free FullText] Gloyn AL, Pearson ER, Antcliff JF, Proks P, Bruining GJ, Slingerland AS, Howard N, Srinivasan S, Silva JM, Molnes J, Edghill EL, Frayling TM, Temple IK, Mackay D, Shield JP, Sumnik Z, van Rhijn A, Wales JK, Clark P, Gorman S, Aisenberg J, Ellard S, Njolstad PR, Ashcroft FM, Hattersley AT: Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. 

Phrase: "Am"

Phrase: "J Physiol Endocrinol Metab283"

Phrase: ":"

Phrase: "E207 E216,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "] Gloyn AL,"

Phrase: "Pearson ER,"

Phrase: "Antcliff JF,"

Phrase: "Proks P,"

Phrase: "Bruining GJ,"

Phrase: "Slingerland AS,"

Phrase: "Howard N,"

Phrase: "Srinivasan S,"

Phrase: "Silva JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Molnes J,"

Phrase: "Edghill EL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1416870:EL [Gene or Genome]
   861   C1823249:EL [Gene or Genome]

Phrase: "Frayling TM,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0145779:TM [Amino Acid, Peptide, or Protein,Receptor]
   861   C3540468:TM [Gene or Genome]

Phrase: "Temple IK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1416378:IK [Gene or Genome]

Phrase: "Mackay D,"

Phrase: "Shield JP,"

Phrase: "Sumnik Z,"

Phrase: "van Rhijn A,"

Phrase: "Wales JK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1420098:JK [Gene or Genome]

Phrase: "Clark P,"

Phrase: "Gorman S,"

Phrase: "Aisenberg J,"

Phrase: "Ellard S,"

Phrase: "Njolstad PR,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0279759:PR+ [Laboratory or Test Result]
   861   C0279766:PR- [Laboratory or Test Result]
   861   C1418864:PR@ [Gene or Genome]
   861   C3538934:PR [Intellectual Product]
   861   C3538935:PR [Idea or Concept]

Phrase: "Ashcroft FM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540627:FM [Gene or Genome]

Phrase: "Hattersley AT"

Phrase: ":"

Phrase: "Activating mutations in the gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C0596611:gene mutations [Genetic Function]
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "the ATP-sensitive potassium-channel subunit Kir6.2"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   868   C1416547:POTASSIUM CHANNEL 2 [Gene or Genome]
   818   C0032824:Potassium Channel [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C1416578:Kir6.2 [Gene or Genome]
   795   C0032821:Potassium [Element, Ion, or Isotope]
   795   C0332324:Sensitive [Functional Concept]
   795   C0439799:Channel [Spatial Concept]
   795   C0597277:Potassium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   795   C1550474:sensitive [Idea or Concept]
   795   C1706095:Channel [Conceptual Entity]
   795   C1711351:Subunit [Quantitative Concept]

Phrase: "and"

Phrase: "permanent neonatal diabetes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0158981:Neonatal diabetes [Disease or Syndrome]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.262: N Engl J Med350 :1838 1849,2004[Abstract/Free FullText] Koster JC, Marshall BA, Ensor N, Corbett JA, Nichols CG: Targeted overactivity of -cell KATP channels induces profound neonatal diabetes. 

Phrase: "N Engl J Med350"

Phrase: ":"

Phrase: "1838 1849,"

Phrase: "2004"

Phrase: "[Abstract/Free FullText"

Phrase: "] Koster JC,"

Phrase: "Marshall BA,"

Phrase: "Ensor N,"

Phrase: "Corbett JA,"

Phrase: "Nichols CG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3540479:CG [Gene or Genome]

Phrase: ":"

Phrase: "Targeted overactivity of -cell KATP channels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1955862:KATP Channels [Amino Acid, Peptide, or Protein]
   766   C0439799:Channel [Spatial Concept]
   766   C1706095:Channel [Conceptual Entity]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "profound neonatal diabetes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0158981:Neonatal diabetes [Disease or Syndrome]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.263: Cell100 :645 654,2000[Medline] Aguilar-Bryan L, Bryan J, Nakazaki M: Of mice and men: KATP channels and insulin secretion. 

Phrase: "Cell100"

Phrase: ":"

Phrase: "645 654,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Aguilar-Bryan L,"

Phrase: "Bryan J,"

Phrase: "Nakazaki M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "Of mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "men"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0025266:Men [Population Group]
   966 E C0024554:MAN [Finding]
   966 E C0086418:Man [Human]

Phrase: ":"

Phrase: "KATP channels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1955862:KATP Channels [Amino Acid, Peptide, or Protein]
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: "and"

Phrase: "insulin secretion."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.264: Recent Prog Horm Res56 :47 68,2001[Abstract/Free FullText] Stanley CA: Hyperinsulinism in infants and children. 

Phrase: "Recent Prog Horm Res56"

Phrase: ":"

Phrase: "47 68,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450387:68 [Intellectual Product]

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Stanley CA"

Phrase: ":"

Phrase: "Hyperinsulinism in infants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0020459:Hyperinsulinism [Disease or Syndrome]

Phrase: "and"

Phrase: "children."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008059:Children [Age Group]
  1000   C0680063:Children [Family Group]
Processing 00000000.tx.265: Pediatr Clin North Am44 :363 374,1997[Medline] Fruman DA, Meyers RE, Cantley LC: Phosphoinositide kinases. 

Phrase: "Pediatr Clin North Am44"

Phrase: ":"

Phrase: "363 374,"

Phrase: "1997"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Fruman DA,"

Phrase: "Meyers RE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986904:RE [Idea or Concept]

Phrase: "Cantley LC"

Phrase: ":"

Phrase: "Phosphoinositide kinases."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0089793:Phosphoinositide Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.266: Annu Rev Biochem67 :481 507,1998[Medline] Baukrowitz T, Schulte U, Oliver D, Herlitze S, Krauter T, Tucker SJ, Ruppersberg JP, Fakler B: PIP2 and PIP as determinants for ATP inhibition of KATP channels. 

Phrase: "Annu Rev Biochem67"

Phrase: ":"

Phrase: "481 507,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450381:507 [Intellectual Product]

Phrase: "1998"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Baukrowitz T,"

Phrase: "Schulte U,"

Phrase: "Oliver D,"

Phrase: "Herlitze S,"

Phrase: "Krauter T,"

Phrase: "Tucker SJ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515101:SJ [Geographic Area]
   861   C2986905:SJ [Idea or Concept]

Phrase: "Ruppersberg JP,"

Phrase: "Fakler B"

Phrase: ":"

Phrase: "PIP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0070798:PIP2 [Biologically Active Substance,Lipid,Organophosphorus Compound]
  1000   C3538724:PIP2 [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "PIP as determinants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0279391:PIP [Therapeutic or Preventive Procedure]
   790   C1418587:PIP [Gene or Genome]

Phrase: "for ATP inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0021467:Inhibition [Mental Process]
   861   C0021469:Inhibition [Molecular Function]
   861   C1628982:% inhibition [Quantitative Concept]
   861   C3463820:Inhibition [Activity]
   789 E C0311403:Inhibited [Qualitative Concept]

Phrase: "of KATP channels."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1955862:KATP Channels [Amino Acid, Peptide, or Protein]
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]
Processing 00000000.tx.267: Science282 :1141 1144,1998[Abstract/Free FullText] Shyng SL, Nichols CG: Membrane phospholipid control of nucleotide sensitivity of KATP channels. 

Phrase: "Science282"

Phrase: ":"

Phrase: "1141 1144,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "] Shyng SL,"

Phrase: "Nichols CG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3540479:CG [Gene or Genome]

Phrase: ":"

Phrase: "Membrane phospholipid control of nucleotide sensitivity of KATP channels."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0243148:control [Qualitative Concept]
   742   C1550141:Control [Substance]
   742   C1882979:Control [Conceptual Entity]
   742   C2587213:Control [Functional Concept]
   742   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.268: Science282 :1138 1141,1998[Abstract/Free FullText] Baukrowitz T, Fakler B: KATP channels gated by intracellular nucleotides and phospholipids. 

Phrase: "Science282"

Phrase: ":"

Phrase: "1138 1141,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "] Baukrowitz T,"

Phrase: "Fakler B"

Phrase: ":"

Phrase: "KATP channels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1955862:KATP Channels [Amino Acid, Peptide, or Protein]
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: "gated by intracellular nucleotides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0175996:intracellular [Cell Component]
   770   C0178719:Intracellular [Spatial Concept]

Phrase: "and"

Phrase: "phospholipids."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0031676:Phospholipids [Biologically Active Substance,Lipid]
   966 E C0202177:Phospholipid [Laboratory Procedure]
Processing 00000000.tx.269: Eur J Biochem267 :5842 5848,2000[Abstract/Free FullText] Ashcroft FM: Exciting times for PIP2. 

Phrase: "Eur J Biochem267"

Phrase: ":"

Phrase: "5842 5848,"

Phrase: "2000"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ashcroft FM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540627:FM [Gene or Genome]

Phrase: ":"

Phrase: "Exciting times for PIP2."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0040223:times [Temporal Concept]
   770   C1632851:Times [Quantitative Concept]
   737 E C3541383:Time [Temporal Concept]
Processing 00000000.tx.270: Science282 :1059 1060,1998[Free FullText] Tarasov A, Dusonchet J, Ashcroft F: Metabolic regulation of the pancreatic -cell ATP-sensitive K+ channel: a pas de deux. 

Phrase: "Science282"

Phrase: ":"

Phrase: "1059 1060,"

Phrase: "1998"

Phrase: "[Free FullText"

Phrase: "] Tarasov A,"

Phrase: "Dusonchet J,"

Phrase: "Ashcroft F"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: ":"

Phrase: "Metabolic regulation of the pancreatic -cell ATP-sensitive K+ channel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0851285:Regulation [Governmental or Regulatory Activity]
   739   C1327622:Regulation [Biologic Function]

Phrase: ":"

Phrase: "a pas de deux."
Processing 00000000.tx.271: Diabetes53 (Suppl.3) :S113 S,2004 Hilgemann DW: Getting ready for the decade of the lipids. 

Phrase: "Diabetes53"

Phrase: "(Suppl.3"

Phrase: ")"

Phrase: ":"

Phrase: "S113"

Phrase: "S,"

Phrase: "2004 Hilgemann DW"

Phrase: ":"

Phrase: "Getting"

Phrase: "ready for the decade of the lipids."
Processing 00000000.tx.272: Annu Rev Physiol65 :697 700,2003[Medline] De Camilli P, Emr SD, McPherson PS, Novick P: Phosphoinositides as regulators in membrane traffic. 

Phrase: "Annu Rev Physiol65"

Phrase: ":"

Phrase: "697 700,"

Phrase: "2003"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] De Camilli P,"

Phrase: "Emr SD,"

Phrase: "McPherson PS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "Novick P"

Phrase: ":"

Phrase: "Phosphoinositides as regulators"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0031621:Phosphoinositides [Biologically Active Substance,Lipid]

Phrase: "in membrane traffic."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1513112:Membrane Traffic [Molecular Function]
Processing 00000000.tx.273: Science271 :1533 1539,1996[Abstract] Olsen HL, Hoy M, Zhang W, Bertorello AM, Bokvist K, Capito K, Efanov AM, Meister B, Thams P, Yang SN, Rorsman P, Berggren PO, Gromada J: Phosphatidylinositol 4-kinase serves as a metabolic sensor and regulates priming of secretory granules in pancreatic beta cells. 

Phrase: "Science271"

Phrase: ":"

Phrase: "1533 1539,"

Phrase: "1996"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Olsen HL,"

Phrase: "Hoy M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Zhang W,"

Phrase: "Bertorello"

Phrase: "AM"

Phrase: ","

Phrase: "Bokvist K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Capito K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Efanov"

Phrase: "AM"

Phrase: ","

Phrase: "Meister B,"

Phrase: "Thams P,"

Phrase: "Yang"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "SN,"

Phrase: "Rorsman P,"

Phrase: "Berggren PO,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442027:PO [Spatial Concept]

Phrase: "Gromada J"

Phrase: ":"

Phrase: "Phosphatidylinositol 4-kinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0089793:Phosphatidylinositol 4-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "serves as a metabolic sensor"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0183210:Sensor [Medical Device]
   760   C0311400:Metabolic [Functional Concept]
   760   C1524026:Metabolic [Cell Function]
   760   C1705193:Sensor [Manufactured Object]
   760   C2707259:Metabolic [Clinical Attribute]

Phrase: "and"

Phrase: "regulates"

Phrase: "priming of secretory granules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0871133:Priming [Functional Concept]

Phrase: "in pancreatic beta cells."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0030281:Pancreatic beta Cells [Cell]
           Beta cell
   827   C0007634:Cells [Cell]
   827   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C2004068:Beta [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.274: Proc Natl Acad Sci U S A100 :5187 5192,2003[Abstract/Free FullText] Lawrence JT, Birnbaum MJ: ADP-ribosylation factor 6 regulates insulin secretion through plasma membrane phosphatidylinositol 4,5-bisphosphate. 

Phrase: "Proc Natl Acad Sci U S A100"

Phrase: ":"

Phrase: "5187 5192,"

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lawrence JT,"

Phrase: "Birnbaum MJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: ":"

Phrase: "ADP-ribosylation factor 6"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0762175:ADP-ribosylation factor 6 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1412511:ADP-RIBOSYLATION FACTOR 6 [Gene or Genome]
   923   C0101671:ADP-Ribosylation Factor [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1527266:ADP-Ribosylation Factor [Conceptual Entity]
   861   C0596043:ADP ribosylation [Phenomenon or Process]
   812   C0523452:ADP [Laboratory Procedure]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "regulates"

Phrase: "insulin secretion through plasma membrane phosphatidylinositol 4,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C1256369:insulin secretion [Cell Function]
   774   C0857690:plasma insulin [Laboratory Procedure]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0036536:secretion [Biologic Function]
   748   C0036537:Secretion [Body Substance]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]

Phrase: "5-bisphosphate."
Processing 00000000.tx.275: Proc Natl Acad Sci U S A100 :13320 13325,2003[Abstract/Free FullText] Davis JN, Rock CO, Cheng M, Watson JB, Ashmun RA, Kirk H, Kay RJ, Roussel MF: Complementation of growth factor receptor-dependent mitogenic signaling by a truncated type I phosphatidylinositol 4-phosphate 5-kinase. 

Phrase: "Proc Natl Acad Sci U S A100"

Phrase: ":"

Phrase: "13320 13325,"

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "] Davis JN,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1428813:JN [Gene or Genome]

Phrase: "Rock CO,"

Phrase: "Cheng M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Watson JB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550751:JB [Temporal Concept]

Phrase: "Ashmun RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Kirk H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Kay RJ,"

Phrase: "Roussel MF"

Phrase: ":"

Phrase: "Complementation of growth factor receptor-dependent mitogenic signaling"

Phrase: "by a truncated type I phosphatidylinositol 4-phosphate 5-kinase."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   892   C0044602:Type I Phosphatidylinositol Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   890   C0207206:phosphatidylinositol-4-phosphate 5-kinase [Amino Acid, Peptide, or Protein,Enzyme]
           phosphatidylinositol 4-phosphate kinase
   855   C0089793:Phosphatidylinositol 4-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.276: Mol Cell Biol17 :7398 7406,1997[Abstract] Shyng SL, Barbieri A, Gumusboga A, Cukras C, Pike L, Davis JN, Stahl PD, Nichols CG: Modulation of nucleotide sensitivity of ATP-sensitive potassium channels by phosphatidylinositol-4-phosphate 5-kinase. 

Phrase: "Mol Cell Biol17"

Phrase: ":"

Phrase: "7398 7406,"

Phrase: "1997"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Shyng SL,"

Phrase: "Barbieri A,"

Phrase: "Gumusboga A,"

Phrase: "Cukras C,"

Phrase: "Pike L,"

Phrase: "Davis JN,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1428813:JN [Gene or Genome]

Phrase: "Stahl PD,"

Phrase: "Nichols CG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3540479:CG [Gene or Genome]

Phrase: ":"

Phrase: "Modulation of nucleotide sensitivity of ATP-sensitive potassium channels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0443264:Modulation [Spatial Concept]

Phrase: "by phosphatidylinositol-4-phosphate 5-kinase."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0207206:phosphatidylinositol-4-phosphate 5-kinase [Amino Acid, Peptide, or Protein,Enzyme]
           phosphatidylinositol 4-phosphate kinase
   911   C0089793:Phosphatidylinositol 4-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0070799:phosphatidylinositol 4-phosphate [Lipid]
Processing 00000000.tx.277: Proc Natl Acad Sci U S A97 :937 941,2000[Abstract/Free FullText] Hohmeier HE, Mulder H, Chen G, Henkel-Rieger R, Prentki M, Newgard CB: Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion. 

Phrase: "Proc Natl Acad Sci U S A97"

Phrase: ":"

Phrase: "937 941,"

Phrase: "2000"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hohmeier"

Phrase: "HE,"

Phrase: "Mulder H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Chen G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Henkel-Rieger R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: "Prentki M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Newgard CB"

Phrase: ":"

Phrase: "Isolation of"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0204727:Isolation [Therapeutic or Preventive Procedure]
   833   C0205409:Isolation [Functional Concept]
   833   C0220862:isolation [Laboratory Procedure]
   761 E C1548221:Isolated [Idea or Concept]

Phrase: "INS-1-derived cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0007600:Cell lines [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:lines [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: "with robust ATP-sensitive K+ channel-dependent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0851827:Dependent [Qualitative Concept]
   799   C1701901:Dependent [Qualitative Concept]
   799   C3244310:dependent [Functional Concept]

Phrase: "and -"

Phrase: "independent glucose-stimulated insulin secretion."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   853   C1719133:Glucose/Insulin [Quantitative Concept]
   840   C1256369:insulin secretion [Cell Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0036536:secretion [Biologic Function]
   804   C0036537:Secretion [Body Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.278: Diabetes49 :424 430,2000[Abstract] Cartier EA, Conti LR, Vandenberg CA, Shyng SL: Defective trafficking and function of KATP channels caused by a sulfonylurea receptor 1 mutation associated with persistent hyperinsulinemic hypoglycemia of infancy. 

Phrase: "Diabetes49"

Phrase: ":"

Phrase: "424 430,"

Phrase: "2000"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Cartier EA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014963:EA [Organic Chemical,Pharmacologic Substance]
   861   C1457900:EA [Quantitative Concept]

Phrase: "Conti LR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0023617:LR [Geographic Area]
   861   C2986899:LR [Idea or Concept]

Phrase: "Vandenberg CA,"

Phrase: "Shyng SL"

Phrase: ":"

Phrase: "Defective"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332452:Defective [Functional Concept]

Phrase: "trafficking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599896:trafficking [Cell Function]

Phrase: "and"

Phrase: "function of KATP channels"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1705273:Function [Intellectual Product]

Phrase: "caused by a sulfonylurea receptor 1 mutation"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0075586:sulfonylurea receptor [Amino Acid, Peptide, or Protein,Receptor]
   778   C1412082:SULFONYLUREA RECEPTOR [Gene or Genome]
   748   C0026882:Mutation [Genetic Function]
   748   C0038766:Sulfonylurea [Organic Chemical,Pharmacologic Substance]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C1705285:Mutation [Cell or Molecular Dysfunction]
   748   C3536898:Sulfonylurea [Pharmacologic Substance]
   714   C0015127:cause [Functional Concept]
   714   C1524003:Cause [Conceptual Entity]

Phrase: "associated with persistent hyperinsulinemic hypoglycemia of infancy."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   897   C0027773:Persistent Hyperinsulinemic Hypoglycemia of Infancy [Disease or Syndrome]
   897   C2931834:Persistent hyperinsulinaemic hypoglycaemia of infancy [Disease or Syndrome]
           Persistent Hyperinsulinemic Hypoglycemia
   814   C1456352:Hypoglycaemia of infancy [Pathologic Function]
   814   C2931833:HYPERINSULINEMIC HYPOGLYCEMIA, PERSISTENT [Disease or Syndrome]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   778   C1864903:Hyperinsulinemic hypoglycemia [Finding]
   748   C0020615:Hypoglycaemia [Disease or Syndrome]
   748   C0205322:Persistent [Temporal Concept]
   748   C0231330:Infancy [Temporal Concept]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.279: Proc Natl Acad Sci U S A98 :2882 2887,2001[Abstract/Free FullText] Cukras CA, Jeliazkova I, Nichols CG: The role of NH2-terminal positive charges in the activity of inward rectifier KATP channels. 

Phrase: "Proc Natl Acad Sci U S A98"

Phrase: ":"

Phrase: "2882 2887,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Cukras CA,"

Phrase: "Jeliazkova I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Nichols CG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3540479:CG [Gene or Genome]

Phrase: ":"

Phrase: "The role of NH2-terminal positive charges"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "in the activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "of inward rectifier KATP channels."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1955862:KATP Channels [Amino Acid, Peptide, or Protein]
   779   C0439799:Channel [Spatial Concept]
   779   C1706095:Channel [Conceptual Entity]
Processing 00000000.tx.280: J Gen Physiol120 :437 446,2002[Abstract/Free FullText] Loussouarn G, Rose T, Nichols CG: Structural basis of inward rectifying potassium channel gating. 

Phrase: "J Gen Physiol120"

Phrase: ":"

Phrase: "437 446,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "] Loussouarn G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Rose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035853:Rose [Plant]
  1000   C0995005:ROSE [Pharmacologic Substance]

Phrase: "T,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Nichols CG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3540479:CG [Gene or Genome]

Phrase: ":"

Phrase: "Structural basis of inward rectifying potassium channel gating."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1527178:Basis [Functional Concept]
   744   C1874451:Basis [Pharmacologic Substance]
Processing 00000000.tx.281: Trends Cardiovasc Med12 :253 258,2002[Medline] Schulze D, Krauter T, Fritzenschaft H, Soom M, Baukrowitz T: Phosphatidylinositol 4,5-bisphosphate (PIP2) modulation of ATP and pH sensitivity in Kir channels: a tale of an active and a silent PIP2 site in the N terminus. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Cardiovasc Med12"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1537677:MED12 [Gene or Genome]

Phrase: ":"

Phrase: "253 258,"

Phrase: "2002"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Schulze D,"

Phrase: "Krauter T,"

Phrase: "Fritzenschaft H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Soom M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Baukrowitz T"

Phrase: ":"

Phrase: "Phosphatidylinositol 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   861   C2348046:Phosphatidylinositol [Lipid]

Phrase: "5-bisphosphate"

Phrase: "(PIP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0070798:PIP2 [Biologically Active Substance,Lipid,Organophosphorus Compound]
  1000   C3538724:PIP2 [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: "modulation of ATP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0443264:Modulation [Spatial Concept]

Phrase: "and"

Phrase: "pH sensitivity in Kir channels"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   781   C1547341:Channel sensitivity [Idea or Concept]
   760   C0036667:Sensitivity [Quantitative Concept]
   760   C0312418:Sensitivity [Mental Process]
   760   C0427965:Sensitivity [Finding]
   760   C1511883:Sensitivity [Quantitative Concept]
   760   C1522640:Sensitivity [Qualitative Concept]
   760   C2346484:SENSITIVITY [Phenomenon or Process]
   760   C2349185:Sensitivity [Qualitative Concept]

Phrase: ":"

Phrase: "a tale of an active"

Phrase: "and"

Phrase: "a silent PIP2 site in the N terminus."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0205145:Site [Spatial Concept]
   744   C1515974:Site [Body Location or Region]
   744   C2825164:Site [Spatial Concept]
Processing 00000000.tx.282: J Biol Chem278 :10500 10505,2003[Abstract/Free FullText] Shyng SL, Cukras CA, Harwood J, Nichols CG: Structural determinants of PIP2 regulation of inward rectifier KATP channels. 

Phrase: "J Biol Chem278"

Phrase: ":"

Phrase: "10500 10505,"

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "] Shyng SL,"

Phrase: "Cukras CA,"

Phrase: "Harwood J,"

Phrase: "Nichols CG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3540479:CG [Gene or Genome]

Phrase: ":"

Phrase: "Structural determinants of PIP2 regulation of inward rectifier KATP channels."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   706   C1521761:Determinant [Functional Concept]
Processing 00000000.tx.283: J Gen Physiol116 :599 608,2000[Abstract/Free FullText] Koster JC, Remedi MS, Flagg TP, Johnson JD, Markova KP, Marshall BA, Nichols CG: Hyperinsulinism induced by targeted suppression of beta cell KATP channels. 

Phrase: "J Gen Physiol116"

Phrase: ":"

Phrase: "599 608,"

Phrase: "2000"

Phrase: "[Abstract/Free FullText"

Phrase: "] Koster JC,"

Phrase: "Remedi MS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   861   C2349943:Ms. [Conceptual Entity]
   861   C3539704:MS [Gene or Genome]

Phrase: "Flagg TP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541334:TP [Gene or Genome]

Phrase: "Johnson JD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1549972:JD [Intellectual Product]

Phrase: "Markova KP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022772:KP [Geographic Area]
   861   C1881334:kp [Quantitative Concept]

Phrase: "Marshall BA,"

Phrase: "Nichols CG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3540479:CG [Gene or Genome]

Phrase: ":"

Phrase: "Hyperinsulinism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020459:Hyperinsulinism [Disease or Syndrome]

Phrase: "induced by targeted suppression of beta cell KATP channels."
Meta Candidates (Total=19; Excluded=1; Pruned=0; Remaining=18)
   764   C0030281:Beta cell [Cell]
   764   C1955862:KATP Channels [Amino Acid, Peptide, or Protein]
   745   C0221284:Target cell [Cell]
   742   C0007634:Cell [Cell]
   742   C0205263:Induced [Functional Concept]
   742   C0221103:Suppression [Pathologic Function]
   742   C0301625:Suppression [Organism Function]
   742   C0330390:Beta [Plant]
   742   C0439096:Beta [Intellectual Product]
   742   C0439181:% suppression [Quantitative Concept]
   742   C0728721:suppression [Mental Process]
   742   C1269647:Cell [Cell]
   742   C1521840:Targeted [Functional Concept]
   742   C1704653:Cell [Medical Device]
   742   C1948049:Cell [Spatial Concept]
   742   C2004068:Beta [Qualitative Concept]
   708   C0439799:Channel [Spatial Concept]
   708   C1706095:Channel [Conceptual Entity]
   708 E C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.284: Proc Natl Acad Sci U S A99 :16992 16997,2002[Abstract/Free FullText] Becker TC, Noel RJ, Coats WS, Gomez-Foix AM, Alam T, Gerard RD, Newgard CB: Use of recombinant adenovirus for metabolic engineering of mammalian cells. 

Phrase: "Proc Natl Acad Sci U S A99"

Phrase: ":"

Phrase: "16992 16997,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "] Becker TC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041405:TC [Geographic Area]
   861   C1824670:TC [Gene or Genome]
   861   C3272447:TC [Gene or Genome]

Phrase: "Noel RJ,"

Phrase: "Coats WS,"

Phrase: "Gomez-Foix"

Phrase: "AM"

Phrase: ","

Phrase: "Alam T,"

Phrase: "Gerard RD,"

Phrase: "Newgard CB"

Phrase: ":"

Phrase: "Use of recombinant adenovirus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1524063:Use of [Functional Concept]
   770   C0042153:use [Functional Concept]
   770   C0457083:Use [Functional Concept]
   770   C1947944:Use [Intellectual Product]

Phrase: "for metabolic engineering"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3179022:Metabolic Engineering [Molecular Biology Research Technique]
   861   C0014279:Engineering [Occupation or Discipline]

Phrase: "of mammalian cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C1512977:Mammalian Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.285: Methods Cell Biol43 :161 189,1994[Medline] Krauter T, Ruppersberg JP, Baukrowitz T: Phospholipids as modulators of KATP channels: distinct mechanisms for control of sensitivity to sulphonylureas, K+ channel openers, and ATP. 

Phrase: "Methods Cell Biol43"

Phrase: ":"

Phrase: "161 189,"

Phrase: "1994"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Krauter T,"

Phrase: "Ruppersberg JP,"

Phrase: "Baukrowitz T"

Phrase: ":"

Phrase: "Phospholipids as modulators of KATP channels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0031676:Phospholipids [Biologically Active Substance,Lipid]
   719 E C0202177:Phospholipid [Laboratory Procedure]

Phrase: ":"

Phrase: "distinct mechanisms for control of sensitivity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0441712:Mechanisms [Functional Concept]
   719 E C1706376:Mechanism [Manufactured Object]

Phrase: "to sulphonylureas,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038766:sulphonylureas [Organic Chemical,Pharmacologic Substance]

Phrase: "K+ channel openers,"

Phrase: "and"

Phrase: "ATP."
Processing 00000000.tx.286: Mol Pharmacol59 :1086 1093,2001[Abstract/Free FullText] Koster JC, Sha Q, Nichols CG: Sulfonylurea and K+-channel opener sensitivity of KATP channels: functional coupling of Kir6.2 and SUR1 subunits. 

Phrase: "Mol Pharmacol59"

Phrase: ":"

Phrase: "1086 1093,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Koster JC,"

Phrase: "Sha Q,"

Phrase: "Nichols CG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3540479:CG [Gene or Genome]

Phrase: ":"

Phrase: "Sulfonylurea"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038766:Sulfonylurea [Organic Chemical,Pharmacologic Substance]
  1000   C3536898:Sulfonylurea [Pharmacologic Substance]

Phrase: "and"

Phrase: "K+-channel opener sensitivity of KATP channels"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   774   C1547341:Channel sensitivity [Idea or Concept]
   748   C0036667:Sensitivity [Quantitative Concept]
   748   C0312418:Sensitivity [Mental Process]
   748   C0427965:Sensitivity [Finding]
   748   C1511883:Sensitivity [Quantitative Concept]
   748   C1522640:Sensitivity [Qualitative Concept]
   748   C2346484:SENSITIVITY [Phenomenon or Process]
   748   C2349185:Sensitivity [Qualitative Concept]

Phrase: ":"

Phrase: "functional coupling of Kir6.2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1948027:Coupling [Functional Concept]

Phrase: "and"

Phrase: "SUR1 subunits."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1711351:Subunit [Quantitative Concept]
Processing 00000000.tx.287: J Gen Physiol114 :203 213,1999[Abstract/Free FullText] Horvath A, Szabadkai G, Varnai P, Aranyi T, Wollheim CB, Spat A, Enyedi P: Voltage dependent calcium channels in adrenal glomerulosa cells and in insulin producing cells. 

Phrase: "J Gen Physiol114"

Phrase: ":"

Phrase: "203 213,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "] Horvath A,"

Phrase: "Szabadkai G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Varnai P,"

Phrase: "Aranyi T,"

Phrase: "Wollheim CB,"

Phrase: "Spat A,"

Phrase: "Enyedi P"

Phrase: ":"

Phrase: "Voltage dependent calcium channels in adrenal glomerulosa cells"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   833   C0006685:Voltage-Dependent Calcium Channels [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Calcium Channels
   744   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   744   C0006726:Calcium [Inorganic Chemical]
   744   C0598352:Voltage [Quantitative Concept]
   744   C0851827:Dependent [Qualitative Concept]
   744   C1701901:Dependent [Qualitative Concept]
   744   C2936886:Calcium [Pharmacologic Substance]
   744   C3244310:dependent [Functional Concept]
   711   C0439799:Channel [Spatial Concept]
   711   C1706095:Channel [Conceptual Entity]

Phrase: "and in insulin producing cells."
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   781   C0030281:Insulin Cell [Cell]
   760   C0007634:Cells [Cell]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1515981:And [Idea or Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.288: Cell Calcium23 :33 42,1998[Medline] Fan Z, Makielski JC: Anionic phospholipids activate ATP-sensitive potassium channels. 

Phrase: "Cell Calcium23"

Phrase: ":"

Phrase: "33 42,"

Phrase: "1998"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Fan Z,"

Phrase: "Makielski JC"

Phrase: ":"

Phrase: "Anionic phospholipids"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0031676:Phospholipids [Biologically Active Substance,Lipid]
   827 E C0202177:Phospholipid [Laboratory Procedure]
   789   C0003075:Anion [Element, Ion, or Isotope]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "ATP-sensitive potassium channels."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1955862:ATP-Sensitive Potassium Channels [Amino Acid, Peptide, or Protein]
   861   C0032824:Potassium Channels [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0032821:Potassium [Element, Ion, or Isotope]
   812   C0332324:Sensitive [Functional Concept]
   812   C0597277:Potassium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C1550474:sensitive [Idea or Concept]
   779   C0439799:Channel [Spatial Concept]
   779   C1706095:Channel [Conceptual Entity]
Processing 00000000.tx.289: J Biol Chem272 :5388 5395,1997[Abstract/Free FullText] Hilgemann DW, Ball R: Regulation of cardiac Na+, Ca2+exchange and KATP potassium channels by PIP2. 

Phrase: "J Biol Chem272"

Phrase: ":"

Phrase: "5388 5395,"

Phrase: "1997"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hilgemann DW,"

Phrase: "Ball R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: ":"

Phrase: "Regulation of cardiac Na+,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]

Phrase: "Ca2+exchange"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678640:exchange [Social Behavior]

Phrase: "and"

Phrase: "KATP potassium channels by PIP2."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0032824:Potassium Channels [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C1955862:KATP Channels [Amino Acid, Peptide, or Protein]
   760   C0032821:Potassium [Element, Ion, or Isotope]
   760   C0597277:Potassium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   726   C0439799:Channel [Spatial Concept]
   726   C1706095:Channel [Conceptual Entity]
Processing 00000000.tx.290: Science273 :956 959,1996[Abstract] Larsson O, Barker CJ, Berggren PO: Phosphatidylinositol 4,5-bisphosphate and ATP-sensitive potassium channel regulation: a word of caution. 

Phrase: "Science273"

Phrase: ":"

Phrase: "956 959,"

Phrase: "1996"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Larsson O,"

Phrase: "Barker CJ,"

Phrase: "Berggren PO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442027:PO [Spatial Concept]

Phrase: ":"

Phrase: "Phosphatidylinositol 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   861   C2348046:Phosphatidylinositol [Lipid]

Phrase: "5-bisphosphate"

Phrase: "and"

Phrase: "ATP-sensitive potassium channel regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0851285:Regulation [Governmental or Regulatory Activity]
   804   C1327622:Regulation [Biologic Function]

Phrase: ":"

Phrase: "a word of caution."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1705313:Word [Idea or Concept]
   715 E C0439824:Verbal [Qualitative Concept]
Processing 00000000.tx.291: Diabetes49 :1409 1412,2000[Abstract] Itoh T, Takenawa T: Regulation of endocytosis by phosphatidylinositol 4,5-bisphosphate and ENTH proteins. 

Phrase: "Diabetes49"

Phrase: ":"

Phrase: "1409 1412,"

Phrase: "2000"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Itoh T,"

Phrase: "Takenawa T"

Phrase: ":"

Phrase: "Regulation of endocytosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1159767:regulation of endocytosis [Cell Function]
   790   C0851285:Regulation [Governmental or Regulatory Activity]
   790   C1327622:Regulation [Biologic Function]

Phrase: "by phosphatidylinositol 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   861   C2348046:Phosphatidylinositol [Lipid]

Phrase: "5-bisphosphate"

Phrase: "and"

Phrase: "ENTH proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.292: Curr Top Microbiol Immunol282 :31 47,2004[Medline] Padron D, Wang YJ, Yamamoto M, Yin H, Roth MG: Phosphatidylinositol phosphate 5-kinase I recruits AP-2 to the plasma membrane and regulates rates of constitutive endocytosis. 

Phrase: "Curr Top Microbiol Immunol282"

Phrase: ":"

Phrase: "31 47,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450355:31 [Intellectual Product]

Phrase: "2004"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Padron D,"

Phrase: "Wang YJ,"

Phrase: "Yamamoto M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Yin H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Roth MG"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439269:mg% [Quantitative Concept]
   861   C1960952:mg % [Quantitative Concept]
   861   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: ":"

Phrase: "Phosphatidylinositol phosphate 5-kinase I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0021966:I- [Inorganic Chemical]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "recruits"

Phrase: "AP-2 to the plasma membrane"

Phrase: "and"

Phrase: "regulates"

Phrase: "rates of constitutive endocytosis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0871208:Rate [Activity]
   737   C1521828:Rate [Quantitative Concept]
Processing 00000000.tx.293: J Cell Biol162 :693 701,2003[Abstract/Free FullText] Wenk MR, Pellegrini L, Klenchin VA, Di Paolo G, Chang S, Daniell L, Arioka M, Martin TF, De Camilli P: PIP kinase Igamma is the major PI(4,5)P2 synthesizing enzyme at the synapse. 

Phrase: "J Cell Biol162"

Phrase: ":"

Phrase: "693 701,"

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "] Wenk MR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347167:Mr. [Conceptual Entity]

Phrase: "Pellegrini L,"

Phrase: "Klenchin VA,"

Phrase: "Di Paolo G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "Chang S,"

Phrase: "Daniell L,"

Phrase: "Arioka M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Martin TF,"

Phrase: "De Camilli P"

Phrase: ":"

Phrase: "PIP kinase Igamma"

Phrase: "is"

Phrase: "the major PI(4,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205164:Major [Qualitative Concept]
   827   C0429863:PI [Clinical Attribute]
   827   C3537219:PI [Gene or Genome]
   827   C3539772:PI [Intellectual Product]

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "P2 synthesizing enzyme at the synapse."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
Processing 00000000.tx.294: Neuron32 :79 88,2001[Medline] Milosevic I, Sorensen JB, Lang T, Krauss M, Nagy G, Haucke V, Jahn R, Neher E: Plasmalemmal phosphatidylinositol-4,5-bisphosphate level regulates the releasable vesicle pool size in chromaffin cells. 

Phrase: "Neuron32"

Phrase: ":"

Phrase: "79 88,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Milosevic I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Sorensen JB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550751:JB [Temporal Concept]

Phrase: "Lang T,"

Phrase: "Krauss M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Nagy G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Haucke V,"

Phrase: "Jahn R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Neher E"

Phrase: ":"

Phrase: "Plasmalemmal phosphatidylinositol-4,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0031621:Phosphatidyl Inositol [Biologically Active Substance,Lipid]
   827   C2348046:Phosphatidylinositol [Lipid]
   755   C0007603:Plasmalemma [Cell Component]

Phrase: "5-bisphosphate level"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0456951:5 level [Qualitative Concept]
   827   C0441889:Level [Qualitative Concept]
   827   C0456079:Level [Classification]
   827   C1547707:Level [Geographic Area]
   827   C2946261:Level [Pharmacologic Substance]

Phrase: "regulates"

Phrase: "the releasable vesicle pool size in chromaffin cells."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   767   C0162658:cells size [Organism Attribute,Quantitative Concept]
   750   C1456849:cell vesicle [Cell Component]
   744   C0333262:Vesicle [Acquired Abnormality]
   744   C0337051:Pool [Geographic Area]
   744   C0456389:size [Spatial Concept]
   744   C1509144:pool [Clinical Attribute]
   744   C1622418:vesicle [Cell Component]
   744   C2349200:Pool [Functional Concept]
Processing 00000000.tx.295: J Neurosci25 :2557 2565,2005[Abstract/Free FullText] Khan FA, Goforth PB, Zhang M, Satin LS: Insulin activates ATP-sensitive K+ channels in pancreatic -cells through a phosphatidylinositol 3-kinasedependent pathway. 

Phrase: "J Neurosci25"

Phrase: ":"

Phrase: "2557 2565,"

Phrase: "2005"

Phrase: "[Abstract/Free FullText"

Phrase: "] Khan FA,"

Phrase: "Goforth PB,"

Phrase: "Zhang M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Satin LS"

Phrase: ":"

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "ATP-sensitive K+ channels in pancreatic -cells"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   774   C0022686:cells k [Cell]
   757 E C0022688:K cell [Cell]
   748   C0332324:Sensitive [Functional Concept]
   748   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C1550474:sensitive [Idea or Concept]
   748   C1708601:K' [Quantitative Concept]
   714   C0439799:Channel [Spatial Concept]
   714   C1706095:Channel [Conceptual Entity]

Phrase: "through a phosphatidylinositol 3-kinasedependent pathway."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1704259:Pathway [Molecular Function]
   812   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.296: Diabetes50 :2192 2198,2001[Abstract/Free FullText] Iismaa TP, Kerr EA, Wilson JR, Carpenter L, Sims N, Biden TJ: Quantitative and functional characterization of muscarinic receptor subtypes in insulin-secreting cell lines and rat pancreatic islets. 

Phrase: "Diabetes50"

Phrase: ":"

Phrase: "2192 2198,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Iismaa TP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541334:TP [Gene or Genome]

Phrase: "Kerr EA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014963:EA [Organic Chemical,Pharmacologic Substance]
   861   C1457900:EA [Quantitative Concept]

Phrase: "Wilson JR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: "Carpenter L,"

Phrase: "Sims N,"

Phrase: "Biden TJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039247:TJ [Geographic Area]

Phrase: ":"

Phrase: "Quantitative"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392762:Quantitative [Quantitative Concept]

Phrase: "and"

Phrase: "functional characterization of muscarinic receptor subtypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880022:Characterization [Activity]

Phrase: "in insulin-secreting cell lines"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   923   C0030281:Insulin-secreting cell [Cell]
           Insulin Cell
   861   C0007600:Cell lines [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:lines [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: "and"

Phrase: "rat pancreatic islets."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   827   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
Processing 00000000.tx.297: Diabetes49 :392 398,2000[Abstract] Cheng PY, Yasuda H, Katori T, Oka H: Phosphoinositides turnover and insulin secretion in pancreatic islets. 

Phrase: "Diabetes49"

Phrase: ":"

Phrase: "392 398,"

Phrase: "2000"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Cheng PY,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0030428:PY [Geographic Area]
   861   C3538810:PY [Idea or Concept]

Phrase: "Yasuda H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Katori T,"

Phrase: "Oka H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ":"

Phrase: "Phosphoinositides turnover"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0031227:turnover [Quantitative Concept]
   861   C0243127:turnover [Functional Concept]
   861   C0443331:Turnover [Health Care Activity]

Phrase: "and"

Phrase: "insulin secretion in pancreatic islets."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C1256369:insulin secretion [Cell Function]
   797   C0030296:Pancreatic Secretion [Body Substance]
   797   C0232787:Pancreatic secretion [Organ or Tissue Function]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.298: Endocrinol Jpn34 :189 202,1987[Medline] Doyle ME, Egan JM: Pharmacological agents that directly modulate insulin secretion. 

Phrase: "Endocrinol Jpn34"

Phrase: ":"

Phrase: "189 202,"

Phrase: "1987"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Doyle"

Phrase: "ME,"

Phrase: "Egan JM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: ":"

Phrase: "Pharmacological agents"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   933   C1254351:Pharmacologic Agent [Pharmacologic Substance]
           Agent
   827   C0450442:Agent [Chemical Viewed Functionally]
   827   C1521826:Agent [Intellectual Product]

Phrase: "that directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "insulin secretion."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.299: Pharmacol Rev55 :105 131,2003[Abstract/Free FullText] Nunemaker CS, Zhang M, Satin LS: Insulin feedback alters mitochondrial activity through an ATP-sensitive K+ channel-dependent pathway in mouse islets and -cells. 

Phrase: "Pharmacol Rev55"

Phrase: ":"

Phrase: "105 131,"

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "] Nunemaker CS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540510:cs [Quantitative Concept]

Phrase: "Zhang M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Satin LS"

Phrase: ":"

Phrase: "Insulin feedback"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0015744:Feedback [Phenomenon or Process]
   861   C2911691:Feedback [Mental Process]

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "mitochondrial activity through an ATP-sensitive K+ channel-dependent pathway"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   757   C1153410:channel activity [Molecular Function]
   739   C0205177:Activity [Functional Concept]
   739   C0439167:% activity [Quantitative Concept]
   739   C0441655:Activity [Activity]
   739   C1561536:*Activity [Idea or Concept]

Phrase: "in mouse islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522528:Mouse Islets [Tissue]

Phrase: "and -"

Phrase: "cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.300: Diabetes53 :1765 1772,2004[Abstract/Free FullText] Lopes CM, Zhang H, Rohacs T, Jin T, Yang J, Logothetis DE: Alterations in conserved Kir Channel-PIP2 interactions underlie channelopathies. 

Phrase: "Diabetes53"

Phrase: ":"

Phrase: "1765 1772,"

Phrase: "2004"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lopes CM,"

Phrase: "Zhang H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Rohacs T,"

Phrase: "Jin T,"

Phrase: "Yang"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "J,"

Phrase: "Logothetis DE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011198:DE [Geographic Area]
   861   C0017480:DE [Geographic Area]
   861   C3541240:DE [Idea or Concept]

Phrase: ":"

Phrase: "Alterations in conserved Kir Channel-PIP2 interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1515926:Alteration [Idea or Concept]

Phrase: "underlie"

Phrase: "channelopathies."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1720983:Channelopathies [Disease or Syndrome]
Processing 00000000.tx.301: Neuron34 :933 944,2002[Medline]

Phrase: "Neuron34"

Phrase: ":"

Phrase: "933 944,"

Phrase: "2002"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

